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ABSTRACT 
 
Epithelial cells and endothelial cells initiate distinct branching morphogenetic programs 
during their coordinated invasion and proliferation into the interstitial compartment, a tissue 
comprised of mesenchymal stromal cells and extracellular matrix (ECM). While mammary gland 
development occurs in a specialized stromal environment dominated by adipocytes and fibroblasts, 
endothelial cell branching proceeds throughout all tissues in the absence of a specific stromal cell 
population. Nevertheless, both epithelial cells and endothelial cells engaged in morphogenetic 
responses have been posited to mobilize proteolytic enzymes to penetrate ECM barriers. However, 
transgenic mouse models have failed to identify required proteolytic effectors or uncover the 
mechanisms whereby proteolytic changes in tissue microenvironments regulate cell behavior. 
Herein, we characterize functional roles performed by the two dominant transmembrane 
proteinases expressed during epithelial and endothelial cell branching processes, the membrane-
anchored matrix metalloproteinases, MT1-MMP and MT2-MMP. Using a series of transgenic 
mouse models, we identify new and unanticipated roles for MT1-MMP and MT2-MMP in 
mammary gland morphogenesis as well as angiogenesis. Tissue-specific targeting of MT1-MMP 
and MT2-MMP demonstrate that early mammary gland branching, which takes place within an 
immature ECM, proceeds independently of either proteinase. Instead, both proteinases play 
important, but diametrically opposed, roles in mammary gland adipocytes, where MT1-MMP 
stimulates adipogenesis and lipid metabolism, while MT2-MMP represses the development of 
thermogenic beige/brown adipocytes. In marked contrast, during the major phases of postnatal 
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mammary gland development where a mature ECM is actively deposited, branching requires 
stromal cell-, rather than epithelial cell-, derived MT1-MMP, where the proteinase regulates 
branching by remodeling a periductal network of ECM macromolecules dominated by type I 
collagen.  Endothelial cells also rely on MT1-MMP to direct branching, but unexpectedly, the 
proteinase also controls proliferative responses via a novel regulatory axis wherein pericellular 
proteolysis of the ECM governs the cytoskeletal-nuclear membrane interactions responsible for 
regulating transcriptional activity. Together, these data create new paradigms relevant to 
morphogenesis and tissue remodeling, as well as identify novel roles for membrane-anchored 
metalloproteinases in governing ECM proteolysis and associated transcriptional programs. 
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CHAPTER 1: Introduction  
 
Branching morphogenesis as a general developmental paradigm.  
Epithelial and endothelial organ development, function and homeostasis require the 
formation and remodeling of ramified tubular networks, processes known as branching 
morphogenesis and angiogenesis, respectively (Andrew and Ewald, 2010; Carmeliet and Jain, 
2011; Scarpa and Mayor, 2016; Vandekeere et al., 2015). The established tubules control the 
transport of fluids, gases, nutrients and waste products under physiologic as well as 
pathophysiologic conditions (Carmeliet and Jain, 2011; Scarpa and Mayor, 2016; Vandekeere et 
al., 2015). The tissue sculpting that occurs coincident with branching morphogenesis drives the 
formation of the respiratory, circulatory and secretory organ systems of developing vertebrate as 
well as invertebrate organisms. Malformation and dysfunction of these branching tubular networks 
contribute to embryonic lethality and the pathogenesis of many diseases, ranging from 
inflammatory disorders, pulmonary hypertension, and blinding ocular diseases to cancer 
(Carmeliet and Jain, 2011). Across organ systems, epithelial and endothelial tubules branch 
through a combination of either single cell movement or collective patterns of cell migration where 
groups of cells move together in a coordinated fashion (Ewald et al., 2008; Ewald et al., 2012; 
Scarpa and Mayor, 2016). Further, both types of branching networks are composed of an inner 
compartment of adherent cells (i.e. epithelial cells and endothelial cells) that are inter- 
2 
 
connected by junctional complexes, and an outer compartment of mesenchymal stromal cells that 
regulate proliferation, cell survival and differentiation (Carmeliet and Jain, 2011; Howard and Lu, 
2014). However, the relative roles of these two compartments in coordinating branching 
morphogenesis in vivo remains undefined.  
Early evidence implicating cell movement and collective cell migrations in branching 
morphogenesis came from seminal work performed with fruit flies (Drosophila melanogaster) and 
the development of their respiratory tubules (trachea). Similar to vertebrate branching programs, 
tracheal development begins when ectoderm-derived tracheal epithelial cell clusters form 
epithelial placodes and invaginate into underlying stromal tissue in response to inductive 
chemokines secreted from the surrounding mesenchyme (Affolter and Caussinus, 2008; 
Sutherland et al., 1996). Primary branches form when individual tracheal epithelial cells migrate 
outward in stereotyped directions and undergo further ramification for maximal oxygen transport 
(Affolter and Caussinus, 2008; Glasheen et al., 2010; Sutherland et al., 1996). Tracheal cells at the 
tip of elongating terminal ends exert leader roles, display long cellular protrusions, and are thought 
to drive collective migration. The trailing adherent “follower” cells, referred to as stalk cells, show 
fewer cellular protrusions and instead contribute to branch elongation via their intercalation 
(Affolter and Caussinus, 2008; Carmeliet and Jain, 2011; Lebreton and Casanova, 2014; Scarpa 
and Mayor, 2016; Vandekeere et al., 2015). Unlike the Drosophila trachea and vertebrate 
vasculature, branching of epithelial organ systems, such as the mammary gland, is thought to 
largely occur in the absence of leader cell protrusions (Andrew and Ewald, 2010; Ewald et al., 
2008; Williams and Daniel, 1983); and the molecular machinery required for single cell migration 
and coordinated tubule elongation in vertebrate models have not been defined.  
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Herein, we focus on two different postnatal branching programs in vertebrates using 
transgenic mouse models and primary cell cultures: (1) the branching morphogenesis of epithelial 
cells during mouse mammary gland development, and (2) the branching of endothelial cells during 
angiogenesis. These two systems offer a unique means to evaluate how distinct branching 
programs coordinate the cell proliferation, differentiation, motility, adhesion and signaling 
cascades required for functional morphogenesis.  
 
Mammary gland branching morphogenesis.  
The outgrowth of branching mammary epithelial tubules depends on complex reciprocal 
crosstalk between the epithelium and the surrounding mammary mesenchyme - composed of 
fibroblasts, adipocytes, endothelial cells, and immune cells - for inducing the proliferative 
responses, signaling cascades, and differentiation programs required for morphogenesis (Ewald et 
al., 2008; Ewald et al., 2012). However, the relative roles that the epithelial and stromal 
compartments in this dynamic tissue sculpting process remain unclear. Mouse mammary gland 
development begins during embryonic development on gestation day 10 (E10), with the formation 
of two ventral-oriented mammary lines just inside the fore- and hind-limb buds from the neck to 
the genital region (Inman et al., 2015; Veltmaat et al., 2003). Between E11 and E14, lens-shaped 
multi-layered ectoderm-derived structures (referred to as mammary placodes or anlagen) appear 
at five reproducible and symmetric positions along each mammary line and transform into 
epithelial buds that protrude into the underlying dermis (Inman et al., 2015; Veltmaat et al., 2003) 
(Fig. 1-1 A). In male embryos, testosterone secreted from the developing testes activates androgen 
receptor signaling in the mammary gland mesenchyme around E14 and induces apoptosis of the 
epithelial rudiments, thereby eliminating the mammary epithelial compartment (Brisken and 
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O'Malley, 2010; Durnberger and Kratochwil, 1980). In female embryos, mammary gland 
branching resumes on or near E15 when each mammary bud sprouts toward the adjacent 
mesenchyme and undergoes reiterative branching into the primordial stromal tissue beneath the 
dermis to form small primitive branching networks by birth (Inman et al., 2015; Robinson, 2007; 
Watson and Khaled, 2008) (Fig. 1-1 A,B). In female embryos, these initial stages of mammary 
gland development are largely independent of systemic hormone signaling and rely more on 
reciprocal cross-talk between branching epithelial cells and the surrounding mesenchyme (Brisken 
and O'Malley, 2010; Sternlicht, 2006).  
Unlike other epithelial organ systems, mammary gland development predominantly occurs 
after the onset of puberty (at approximately 3 weeks after birth in mice), when the steroid sex 
hormones, estrogen and progesterone, stimulate the resident mammary epithelial tubules to extend, 
bifurcate, and branch throughout an adipocyte-populated stroma, termed the mammary “fat pad” 
(Inman et al., 2015) (Fig. 1-1 C). Mammary epithelial tubules (ducts) are bipolar structures 
composed of inner-facing luminal epithelial cells and basal-oriented myoepithelial cells (Fig. 1-1 
D,E). During puberty, mammary gland branching is thought to largely depend on the hormone-
dependent development and dichotomous branching of bulbous epithelial structures at the tips of 
the elongating ducts, known as terminal end buds (TEBs), which have implied motility based on 
their proliferative activity and position facing the epithelium-free, unoccupied expanse of the 
mammary fat pad (Hinck and Silberstein, 2005; Jackson-Fisher et al., 2004; Kurley et al., 2012) 
(Fig. 1-1 F).  
Mammary gland TEBs have a similar bilayered architecture to the ducts with an outer 
monolayer of undifferentiated/ basal progenitor “cap” cells that give rise to the myoepithelial cells 
that surround the ducts, and an inner multilayered compartment of luminal progenitor cells referred 
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to as “body” cells (Hinck and Silberstein, 2005; Jackson-Fisher et al., 2004; Khokha and Werb, 
2011) (Fig. 1-1 F). During this mammary duct elongation process, secondary branches sprout 
laterally from the ductal regions of existing mammary tubules and further ramify in the absence of 
TEBs (Khokha and Werb, 2011). Structural defects in TEBs correspond with impaired branching 
morphogenesis and stunted ductal invasion through the mammary fat pad (Jackson-Fisher et al., 
2004; Kurley et al., 2012), suggesting a critical role for TEBs in mammary epithelial branching. 
While TEBs regress once the fat pad is laced with mammary ductal structures, at ~ 9 weeks of age 
(Lu et al., 2008), the established mammary ductal tree continues to expand and retract with regard 
to tertiary branch number every 4-to-5 days as a consequence of the epithelial cell proliferation 
and apoptosis induced by cycling ovarian hormone levels (Fata et al., 2001; Sternlicht, 2006).  
Adult mammary glands also undergo extensive remodeling with each round of pregnancy 
at which time progesterone and pituitary-derived prolactin stimulate the resident mammary 
epithelium to undergo extensive proliferation as well as differentiation (Hennighausen and 
Robinson, 2001; Inman et al., 2015). Indeed, in the later stages of pregnancy epithelial cell number 
increases ~ 100-fold in tandem with the generation of secretory luminal epithelial (alveolar) 
structures and a commensurate decrease in mammary gland adipocyte numbers (Khokha and 
Werb, 2011). Changes in circulating hormone levels induce these alveolar epithelial cells to 
synthesize and secrete milk proteins into the lumen during lactation, which is maintained by the 
suckling newborns and subsequent milk clearance (Inman et al., 2015; Khokha and Werb, 2011). 
Weaning and milk stasis induces a mammary gland involution program characterized by rapid 
regression of the differentiated secretory epithelium and reformation of the epithelial and stromal 
compartments to resemble the virgin mammary gland (Khokha and Werb, 2011).   
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Angiogenesis and blood vessel remodeling. 
 Coincident with epithelial cell branching morphogenesis, endothelial cells and their 
associated stromal cells, including pericytes and vascular smooth muscle cells, drive sprouting 
angiogenesis into the surrounding mesenchyme (Betterman et al., 2012; Carmeliet and Jain, 2011). 
Blood vessels provide developing epithelial organ systems, including the mammary gland, with 
oxygen and critical instructive signals for their morphogenesis (Pierreux et al., 2010; Ramasamy 
et al., 2015). Vascular development begins early in embryogenesis when endothelial progenitor 
cells (angioblasts) assemble a primordial vascular plexus of small capillaries that expands by 
vessel sprouting and remodeling to form a highly ramified network of endothelial vessels (Fig. 1-
2 A,B). Further, this network is ensheathed by pericytes and vascular smooth muscle cells that 
together with the endothelium regulate blood vessel stability and permeability (Carmeliet and Jain, 
2011; Ramasamy et al., 2015) (Fig. 1-2 C).  
After birth, sprouting angiogenesis continues to contribute to organ growth and 
development. By adulthood, however, most blood vessels are largely quiescent unless exposed to 
(patho)-physiologic stimuli such as inflammation or tissue damage (Carmeliet and Jain, 2011; 
Ramasamy et al., 2015). Similar to the epithelial-stromal cell cross-talk required for mammary 
gland branching morphogenesis, blood vessel development and remodeling requires a balance of 
stimulatory and inhibitory signals from the mesenchyme. New blood vessel sprouts initiate when 
local concentrations of chemo-attractive angiogenic growth factors (including vascular endothelial 
growth factor, VEGF-A) stimulate individual endothelial cells to loosen their junctions and send 
out polarized cellular protrusions (filopodia) into the surrounding mesenchyme (Carmeliet and 
Jain, 2011) (Fig. 1-2 D). The endothelial cells that express the highest levels of VEGF-A receptor, 
VEGFR2, often termed, tip cells, guide sprouting and inhibit their neighboring endothelial cells 
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from adopting a migratory phenotype by activating NOTCH signaling in adjacent endothelial cells, 
which in turn down-regulates VEGFR2 expression and VEGF-A responsiveness (Carmeliet and 
Jain, 2011; Vandekeere et al., 2015) (Fig. 1-2 D). The cell shape changes in the protrusive 
endothelial tip cells are thought to activate the cytoskeleton-dependent contractile responses that 
trigger proliferation and morphogenesis (Adams and Alitalo, 2007; Tung et al., 2012; Zhou et al., 
2008). Mesenchyme-supplied angiogenic growth factors then induce sprout elongation by 
directing the migration of the endothelial tip cells and stimulating the proliferation of the trailing 
stalk cells (Tung et al., 2012; Zhou et al., 2008) (Fig. 1-2 D). However, the mechanisms by which 
attendant cell shape informs cell function during sprouting angiogenesis remain unknown.  
  
Extracellular matrix (ECM) and its relationship with branching tubular structures.  
During all branching morphogenesis programs, advancing tubular structures navigate 
through a complex environment of densely arrayed extracellular networks of collagens, 
glycoproteins and proteoglycans, collectively known as the extracellular matrix (ECM). A 
specialized 100-to-300nm-thick sheet-like ECM predominantly composed of intertwined 
supramolecular networks of polymeric laminin glycoproteins and type IV collagen, referred to as 
basement membrane (BM), envelopes branching epithelium and separates endothelial cells, 
smooth muscle cells and adipocytes from the underlying stromal mesenchyme (Rowe and Weiss, 
2008; Williams and Daniel, 1983) (Fig. 1-3 A,B). The laminin constituents are heterotrimeric 
(composed of α, β and ɣ chains) and are thought to assemble a provisional template of enmeshed 
heterotrimers at the plasma membrane surface, via their binding interactions with cellular surface 
receptors (Kelleher et al., 2004; Rowe and Weiss, 2008).  The laminin template then guides the 
assembly of supramolecular polygonal networks of type IV collagen polymers that are stabilized 
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by covalent cross-links, thereby providing the BM with its mechanical integrity (Kelleher et al., 
2004; Rowe and Weiss, 2008) (Fig. 1-3 B,C). The resulting pore size of ~ 50 nm only allows the 
passive diffusion of small molecules, as migrating cells cannot negotiate pores less than 2 µm in 
size due to the deformation limits of their nuclei, the most rigid component of a cell (Rowe and 
Weiss, 2008).  
Outside the BM, branching epithelial and endothelial structures are further surrounded by 
a dynamic periductal stroma dominated by a type I collagen-enriched interstitial ECM (Fig. 1-3 
D,E). Type I collagen is a triple-helical heterotrimer of two distinct polypeptide chains (α1- and 
α2- chains) whose synthesis is essential for embryonic development and blood vessel stability 
(Kelleher et al., 2004; Lohler et al., 1984; Niederreither et al., 1995). Homozygous disruption of 
the type I collagen α1-chain (Col1a1) results in necrosis of mesenchymal cells in the developing 
embryo and embryonic lethality between E12 and E14 due to rupture of large blood vessels (Lohler 
et al., 1984), highlighting the importance of type I collagen in the maintenance of the vertebrate 
circulatory systems. Interstitial fibronectin binds to type I collagen and is also crucial for the 
organization and integrity of the heart and blood vessels (George et al., 1993). Following targeted 
homozygous disruption of fibronectin (Fn1) in mice, both embryonic and extra-embryonic 
vasculature fail to develop and severe defects in mesoderm-derived tissues result in embryonic 
lethality by E11 (George et al., 1993). The tissue defects and embryonic lethality observed in 
mouse models bearing mutations in these and other ECM genes illustrate the functional importance 
of ECM architecture in normal tissue development (Bateman et al., 2009). 
Both BM and interstitial ECM provide structural scaffolding and mechanical support for 
tissue architecture as well as functional cues by virtue of their resident repertoire of adhesion 
receptor ligands for cell surface receptors with roles in regulating migration and homeostasis, 
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proliferation, apoptosis and differentiation (Bateman et al., 2009; Bonnans et al., 2014; Rowe and 
Weiss, 2008). Further, ECM serves as a reservoir for sequestered, matrix-bound, growth factors 
and signaling molecules implicated in branching programs, such as epidermal growth factor 
(EGF), fibroblast growth factor (FGF), hepatocyte growth factor (HGF), Wnt ligands and 
transforming growth factor (TGFβ)  (Bonnans et al., 2014; Rowe and Weiss, 2008).  
 
Current in vitro and ex vivo models to dissect cell-ECM interactions.  
Various in vitro and ex vivo model systems have been designed to recapitulate the in vivo 
setting and dissect the requirements of in vivo branching programs. Standard two-dimensional (2-
D) culture systems (i.e., performed classically with cells grown/ maintained in tissue-culture 
plastic ware) fall short of recapitulating cellular processes that normally operate within a more 
complex three-dimensional (3-D) ECM environment in vivo, as manifested by differences in cell 
morphology, cell-cell crosstalk and cell-ECM interactions (Baker and Chen, 2012; Rowe and 
Weiss, 2008; Yamada and Cukierman, 2007). 3-D in vitro models have therefore been developed 
to bridge the disconnect between conventional 2-D cell culture and the in vivo setting wherein 
single cells or multicellular aggregates are embedded within purified ECM, synthetic hydrogels or 
tissue extracts (Baker and Chen, 2012; Rowe and Weiss, 2008; Yamada and Cukierman, 2007). In 
many cases, cells embedded with 3-D ECM have been shown to adopt similar morphologies and 
cytoskeletal arrangements, as well as engage similar cell-ECM adhesive interactions and 
differentiation programs to those observed in vivo (Chun et al., 2006; Rowe and Weiss, 2008; Tang 
et al., 2013). For instance, endothelial cells embedded in 3-D hydrogels of the coagulation protein, 
fibrin, or purified type I collagen can be triggered to undergo angiogenic processes that mimic the 
behavior of neovessels developing in the interstitial ECM in vivo (Zhou et al., 2008). 
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Alternatively, ex vivo culture of intact organ explants allows for the maintenance of native 
tissue architecture and has been widely used for short-term visualization of embryonic branching 
programs, including those for the lung, kidney, mammary gland, and submandibular salivary 
glands (Hens et al., 2009; Oblander et al., 2005; Rebustini et al., 2009; Riggins et al., 2010; 
Yamada and Cukierman, 2007). For such studies, rudimentary epithelial buds are isolated with 
their associated mesenchyme from E12-to-E14 embryos and shown to undergo branching ex vivo 
in response to mitogenic stimuli when cultured at the air-liquid interface (Oblander et al., 2005; 
Rebustini and Hoffman, 2009; Rebustini et al., 2009; Riggins et al., 2010). 
 
The mammary organoid model system.  
 As postnatal mouse mammary gland branching morphogenesis takes place within an 
adipocyte-rich stroma that scatters light and limits ex vivo imaging, studies aimed at dissecting the 
molecular machinery required for mammary epithelial branching have largely relied on in vitro 
model systems (Ewald et al., 2012). Current dogma in the literature maintains that mammary gland 
branching morphogenesis - and epithelial organ development, in general - relies on the epithelium 
as the functional tissue remodeling unit, while the surrounding stromal cells serve only to supply 
the necessary growth factors and steroid hormones required for regulated morphogenesis (Bonnans 
et al., 2014; Haslam et al., 2008; Khokha and Werb, 2011). An in vitro model system has been 
therefore established wherein primary mouse mammary epithelial cells are largely stripped of their 
surrounding mesenchymal tissue through collagenase-mediated digestion of minced mammary 
gland tissue, and isolated as intact clusters of luminal and myo-epithelial cells (termed mammary 
“organoids”) for culture in 3-D ECM (Ewald et al., 2012; Haslam et al., 2008; Simian et al., 2001) 
(Fig. 1-4 A). In keeping with the notion that the mammalian epithelium drives branching 
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morphogenesis, mammary organoids have been shown to mount a branching program within 
purified type I collagen or ECM hydrogels in a largely stromal cell-independent fashion when 
stimulated with mitogenic growth factors, including EGF, basic FGF/ FGF2, and HGF (Ewald et 
al., 2012; Haslam et al., 2008; Simian et al., 2001) (Fig. 1-4 A). However, the in vivo application 
of observations gleaned from such in vitro and ex vivo studies remains unclear and the subject of 
ongoing debate.  
 
Models for angiogenesis. 
Angiogenesis involves a range of cell types and organ systems, and several different pro-
angiogenic growth factors, including VEGF, FGF2 and HGF (Baker et al., 2012). In vitro and ex 
vivo models have therefore been established to interrogate the requirements of blood vessel 
branching outside the paracrine effects of adjacent tissues and/or stromal cell types (Baker et al., 
2012). Since type I collagen is the dominant interstitial ECM barrier surrounding blood vessels in 
vivo, isolated vascular cells (i.e. endothelial cells and smooth muscle cells) and tissue fragments 
are routinely embedded within 3-D hydrogels of type I collagen (Baker et al., 2012; Yana et al., 
2007; Zhou et al., 2008).  With regard to inducing neovessel formation in vitro, VEGF is known 
to induce an increase in blood vessel permeability during sprouting angiogenesis in vivo that allows 
circulating fibrinogen to leak out into the surrounding tissues where it forms a network of cross-
linked fibrin within the interstitial compartment (Carmeliet and Jain, 2011; Zhou et al., 2008). To 
recapitulate a similar scenario in vitro, vascular cell morphogenesis of endothelial cells is 
commonly examined in 3-D fibrin or type I collagen matrices. In this setting, isolated endothelial 
cells stretch, proliferate, and form tubular structures when suspended within 3-D hydrogels of 
either fibrin or type I collagen in response to angiogenic growth factors VEGF, HGF and FGF2 
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(Yana et al., 2007; Zhou et al., 2008) (Fig. 1-4 B,C). Murine and rat tissue explants can also be 
cultured in 3-D ECM ex vivo to examine sprouting angiogenesis from native tissue, thereby 
preserving the intercellular crosstalk that drives branching morphogenesis in vivo. Indeed, 
fragments of intracostal muscle, diaphragm, or aorta can each undergo sprouting angiogenesis, 
ultimately forming anastomosing networks of endothelial vessels in 3-D type hydrogels (Chun et 
al., 2004; Yana et al., 2007) (Fig. 1-4 D,E).  
 
Matrix metalloproteinases and developmental tissue sculpting. 
Although temporal and spatial changes in ECM biosynthesis take place during tissue 
morphogenesis, increasing evidence supports a model where branching tubules - of either 
epithelial or endothelial cell origin - mobilize proteolytic machinery to establish and remodel the 
mature structures found in adult tissue (Inman et al., 2015; Khokha and Werb, 2011). More than 
600 proteinases are encoded within the mammalian genome of the aspartate, cysteine, metallo, 
serine and threonine subfamilies (Page-McCaw et al., 2007), and hundreds of these proteinases are 
capable of operating in the extracellular milieu (Rowe and Weiss, 2008). However, an 
evolutionarily conserved subclass of zinc-dependent endopeptidases from the metalloproteinase 
gene family, known as the matrix metalloproteinases (MMPs), has been shown to play dominant 
roles in remodeling ECM components, and comprise some of the key proteolytic enzymes 
implicated in developmental tissue sculpting (Bonnans et al., 2014; Rowe and Weiss, 2008).  
 
The Matrix Metalloproteinase (MMP) family.  
While the discovery of the first MMP was reported in 1962, in a study of the interstitial 
collagen remodeling that coincides with tadpole tail metamorphosis (Gross and Lapiere, 1962), an 
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absolute requirement for MMP activity in development was not established until 2003 in 
Drosophila, a model organism that expresses only two MMP family members (Bond et al., 2011; 
Guha et al., 2009; Jia et al., 2014; Page-McCaw et al., 2003; Srivastava et al., 2007; Wang et al., 
2010). However, efforts to identify roles for MMPs or ECM remodeling in branching 
morphogenesis in more complex mammalian systems have remained inconclusive due to the 
continued reliance on in vitro or ex vivo model systems. Indeed, the relative requirements for 
mammalian MMPs in controlling branching morphogenesis in vivo remain largely undefined. This 
stand-still is, in part, due to the complexity of the mammalian genome. In contrast with Drosophila, 
more than 24 proteinases make up the mammalian MMP gene family and belong to two general 
classes – the secreted MMPs (of > 18 in number), and the membrane-tethered (MT)-MMPs (6 in 
number) that are anchored to the cell membrane surface either by a single-pass hydrophobic 
transmembrane domain or a glycosylphosphatidyl inositol (GPI)-anchor (Page-McCaw et al., 
2007).  
In mammalian systems, both secreted and membrane-associated MMPs are synthesized as 
latent zymogens with a conserved modular domain structure containing (i) an auto-inhibitory 
propeptide domain that stabilizes the zymogen in an inactive state, (ii) an N-terminal zinc-
dependent catalytic domain, and (iii) a C-terminal hemopexin domain with functional roles in 
protein-protein interactions and substrate recognition (Li et al., 2008; Page-McCaw et al., 2007; 
Pei and Weiss, 1995; Pei and Weiss, 1996) (Fig. 1-5 A). Unlike most secreted MMPs, MT-MMP 
zymogens also contain a short sequence of basic amino acids (RRKR) located between the 
propeptide and the catalytic domains that functions as a recognition site for the proprotein 
convertase family member, furin (Pei and Weiss, 1995; Pei and Weiss, 1996; Wu et al., 2007) (Fig. 
1-5 B). As a consequence, while most secreted MMPs are activated in the extracellular space, MT-
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MMPs undergo intracellular activation through the proteolytic removal of their pro-domains via a 
proprotein convertase-dependent pathway that results in the display of the active enzyme on the 
cell surface (Pei and Weiss, 1995; Pei and Weiss, 1996; Wu et al., 2007) (Fig. 1-5 B). Global 
knockouts have been generated for most of the mammalian MMP family members, and none of 
the knockouts display marked defects in embryonic development (Page-McCaw et al., 2007), a 
finding that has thus far been rationalized on the basis of either genetic redundancy or functional 
compensation between MMP family members.  
In vivo assessments of mammalian MMPs are further complicated by their endogenous 
regulation by proteinaceous tissue inhibitors of MMPs (TIMPs), which harbor N-terminal domains 
that interact with MMP catalytic domains (Seals and Courtneidge, 2003).  The mammalian genome 
expresses 4 homologous TIMP family members, which differ in the efficacy of their MMP 
inhibition. For example, while TIMP1 specifically inhibits secreted and GPI-anchored MMPs, 
TIMP2 and TIMP3 target all secreted and membrane-anchored MMP family members (Arpino et 
al., 2015; Rowe and Weiss, 2008). Yet, the TIMPs are not entirely specific for the MMP family 
members as they have also been shown to inhibit a closely related family of zinc-dependent 
proteinases termed the adamalysins (Arpino et al., 2015). These proteinases display active-site 
domains that bear considerable homology to those of the MMP family (Seals and Courtneidge, 
2003). Further, increasing evidence implicates adamalysins in the proteolytic activation of several 
cell surface proteins that drive epithelial tissue morphogenesis, including HB-EGF, TGFα and 
Amphiregulin, as well as receptor tyrosine kinases of the EGFR family (Black et al., 1997; Peschon 
et al., 1998; Sternlicht et al., 2005). Further, TIMP family members also have metalloproteinase-
independent functions; as exemplified by TIMP1 and TIMP3, which regulate angiogenesis by 
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interacting directly with the β1-integrin receptor and VEGF receptor, respectively (Arpino et al., 
2015).  
 
Invertebrate evidence implicating (MT)-MMPs in postnatal tissue sculpting. 
The MMP and TIMP families are evolutionarily conserved among multicellular organisms 
with homologs in vertebrate and invertebrate phyla. Given the limited number of Drosophila 
melanogaster (fruit fly) MMPs (termed dMMPs), that harbor the same conserved MMP domain 
structure as that present in mammalian MMPs, this model organism provided a simpler model 
system for interrogating the general roles of MMPs in developmental morphogenesis (Page-
McCaw, 2008). Further, the Drosophila genome also only encodes one TIMP protein (dTIMP) that 
inhibits both dMMPs. Importantly, one Drosophila MMP is secreted (dMMP1) while the other is 
membrane-tethered via a GPI anchor (dMMP2) (Page-McCaw, 2008), offering an unbiased 
platform from which the relative roles of secreted and membrane-associated MMPs in tissue 
morphogenesis might be assessed.  
Interestingly, following the targeted deletion of either dMMP1 alone, dMMP2 alone, or 
both dMMPs in combination, embryonic development proceeds in a normal fashion (Page-McCaw 
et al., 2003), thereby demonstrating that MMPs are not required during embryogenesis. Instead, 
Drosophila MMP knockouts display major defects during later stages of larval (early postnatal) 
maturation and die before reaching adulthood (Page-McCaw et al., 2003), suggesting a previously 
unsuspected role for the proteinases in postnatal developmental events that potentially extends to 
mammalian systems. Interestingly, while knockout screens reveal critical, albeit complex, roles 
for dMMP1 (i.e., the secreted dMMP) in epithelial cell adhesion and apical membrane expansion 
in larval trachea (Glasheen et al., 2010; Jia et al., 2014; Page-McCaw et al., 2003), growing 
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evidence supports dominant roles for membrane-associated dMMP2 in both larval tissue sculpting 
(histolysis) and the ECM remodeling events that drive metamorphosis as flies transition from 
larval to adult body plans (Bond et al., 2011; Guha et al., 2009; Jia et al., 2014; Page-McCaw et 
al., 2003).  Unlike mutants for dMmp1, null mutants for dMmp2 retain larval tissue, fail to undergo 
larval histolysis, and display stunted development of the dorsal air sacs associated with the tracheal 
tubes – all of which correlate with a failure to remodel ECM (Bond et al., 2011; Guha et al., 2009). 
Importantly, these phenotypes also recapitulate the defects observed following dTIMP 
overexpression (Guha et al., 2009).  
 
Shifting the focus to mammalian MT1-MMP (and MT2-MMP). 
Given the fly phenotypes, one might well posit that more careful analyses of mouse MMP 
knockouts would similarly reveal a host of postnatal defects. To date, however, MMP global 
knockouts display only subtle defects in postnatal development that are either transient, or at best 
subtle, with the exception of one membrane-tethered MMP family member, MT1-MMP/ MMP14. 
Mmp14 global knockout (Mmp14-/-) mice are born indistinguishable from their wild-type and 
heterozygous littermates, but mice undergo progressive postnatal wasting characterized by striking 
skeletal abnormalities, dwarfism and death by 3-to-12 weeks after birth (Holmbeck et al., 1999; 
Zhou et al., 2000). While MT1-MMP was first discovered based on its ability to directly activate 
a subset of secreted MMP family members, namely Gelatinase A/ MMP2 (Sato et al., 1994) and 
MMP13 (Knauper et al., 1996), growing evidence supports direct roles for MT1-MMP  in 
hydrolyzing a wide variety of substrates, ranging from cell surface molecules and growth factors 
to ECM components, including those associated with the BM and interstitial compartment 
(Barbolina and Stack, 2008; Itoh, 2015; Rowe and Weiss, 2009). While major defects in postnatal 
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branching have not been reported to date, MT1-MMP has been posited to control branching events 
in vitro by both proteolytic mechanisms whereby epithelial cells dissolve confronting ECM 
barriers as well as proteinase-independent mechanisms by acting as a scaffolding hub for signal 
transduction cascades critical to cell motility and cell sorting (Alcaraz et al., 2011; Brownfield et 
al., 2013; Mori et al., 2009; Simian et al., 2001; Weaver et al., 2014). However, these data are 
confined to in vitro models and the roles of endogenous MT1-MMP during postnatal development 
in vivo remain unknown. 
 Interestingly, the closely related membrane-tethered MMP, MT2-MMP/ MMP15, which 
shares >50% homology with MT1-MMP at the amino acid level (Tanaka et al., 1997), is enriched 
in the epithelial cell compartment of the developing mammary gland (Szabova et al., 2005), and 
has also been reported to regulate branching morphogenesis in vitro by remodeling the BM and 
regulating growth factor expression (Rebustini et al., 2009). Nevertheless, conclusions regarding 
roles for MT2-MMP in branching morphogenesis and tissue sculpting again derive entirely from 
model systems. In fact, Mmp15 has remained one of the few untargeted MMPs in the mammalian 
genome, begging the question of its functional roles during development.  
Similar to the postnatal branching of epithelial structures, endothelial and mural cells (i.e., 
pericytes and vascular smooth muscle cells) have been reported to mobilize MT1-MMP in vitro to 
form capillary-like sprouts in 3-D hydrogels (Chun et al., 2004; Hiraoka et al., 1998; Tung et al., 
2012; Zhou et al., 2008). Nevertheless, the in vivo roles of MT1-MMP in supporting angiogenic 
responses have yet to be determined as do the mechanisms by which matrix remodeling impacts 
cell function. Unlike epithelial cells, which are always subtended by a BM and subsequently 
separated from the interstitial compartment, endothelial cells break through their underlying BM 
during the initial phases of new blood vessel development and make direct contact with the 
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interstitial ECM (Chun et al., 2004). Much of the difficulty in assigning roles to MT1-MMP in 
vivo arises from the fact that the morbid status and shortened lifespan of Mmp14-null mice, coupled 
with organ failure in multiple systems, precludes mechanism-based analyses of specific tissues. 
To circumvent this issue, the Weiss lab recently generated and characterized the first Mmp14 
conditional knockout mouse model (Tang et al., 2013). Likewise, while Mmp15 global knockouts 
might be predicted to display similar phenotypes, Mmp15 conditional knockout mice had not yet 
been generated by any group. However, the Weiss lab recently engineered Mmp15-lacZ knock-in 
and Mmp15-flox mice to begin assessing its role(s) in vivo.  
  Herein, using recently derived global knockout and conditional knockout mouse lines, we 
provide the first in vivo evidence of a heretofore overlooked mammary gland branching program, 
which occurs during the first 10 days of early postnatal development through sparsely populated 
interstitial ECM (Chapter 2). While embryonic and early postnatal mammary gland branching 
morphogenesis through this more primitive ECM does not depend on either MT1-MMP or MT2-
MMP (Chapter 2); a critical requirement for MT1-MMP was uncovered following the onset of 
puberty, when sex hormones estrogen and progesterone stimulate a more robust branching 
program through a more mature ECM (Chapter 3). Importantly, postnatal mammary gland 
branching morphogenesis proceeds independently of epithelial cell-derived MMPs (Chapter 3). 
Unexpectedly, and contrary to current dogma, mammary gland branching relies on MT1-MMP 
expression from the periductal mammary stroma to orchestrate the remodeling of stromal ECM; 
introducing a novel role for stromal cell-derived proteolytic machinery in directing tissue sculpting 
(Chapter 3). Further, in the process of examining endothelial and vascular smooth muscle cell 
responses to growth factor stimulation within 3-D ECM microenvironments, an unexpected link 
was established between MT1-MMP, nuclear architecture, and the regulation of transcriptional 
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activity in both in vitro and in vivo settings (Chapter 4).  Both the mammary gland and the 
vasculature therefore rely on MT1-MMP-dependent pericellular remodeling of 3-D interstitial 
ECM for regulated tissue morphogenesis.  
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Fig. 1-1. 
 
Fig. 1-1. Embryonic and postnatal mammary gland development. 
(A) Cartoon schematic of embryonic mammary gland morphogenesis, which occurs between 
gestation days 10.5 (E10.5) and E18.5, and establishes a primitive ductal tree by E18.5 (Robinson, 
2007). (B) Carmine staining of mammary gland whole mount shows the branching network at 
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E18.5 (scale bar = 0.5 mm) (Sternlicht, 2006). (C) Carmine staining of mammary gland whole 
mounts at 3 weeks and 11 weeks after birth show the branching structures (ducts) before and after 
the onset of puberty (scale bar = 1 mm) (Sternlicht, 2006). (B,C) Arrow heads indicate the initial 
branching site/ nipple region (LN = lymph node). (D) Cartoon of the luminal epithelial and 
myoepithelial cells which compose mammary epithelial ducts and the surrounding stromal cells 
dominated by fibroblasts (green) and lipid-laden adipocytes (orange). (E) Immunofluorescence of 
myoepithelial cell-associated cytokeratin-14 (CK14) and luminal epithelial cell-associated 
cytokeratin-18 (CK18) in cross-section through mammary gland duct. (F) Ductal network at 5 
weeks after birth, which is characterized by bulb-like structures, known as terminal end buds, at 
the ends of growing ducts (Williams and Daniel, 1983). H&E staining of cross-section through 
terminal end bud with arrows indicating the lumen (L)-facing body epithelial cells and outer-lying 
cap epithelial cells (Hinck and Silberstein, 2005). 
  
22 
 
Fig. 1-2.  
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Fig. 1-2. Embryonic and postnatal blood vessel development.  
(A) Cartoon illustrating the formation of primitive vascular networks during embryonic 
development from the coalescence of precursor cells (angioblasts), which differentiate into the 
endothelial cells that constitute mature blood vessels (Hendrix et al., 2003). (B) Immuno-
fluorescence of endothelial cell-associated CD31 shows the vascular networks in E10.5 (left), 
E11.5 (middle), and E12.5 (right) whole limbs and the avascular areas of developing digit 
structures (Eshkar-Oren et al., 2009). (C) Cartoon of a mature blood vessel to show the inner-
facing endothelial cells and the outer-lying stromal vascular smooth muscle cells (Carmeliet and 
Jain, 2011). (D) Schematic illustrating the initiation and development of new blood vessel sprouts 
from pre-existing blood vessels in response to local concentrations of VEGF.  
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Fig. 1-3.  
 
Fig. 1-3. Extracellular matrix (ECM) and its relationship with branching tubular structures.  
(A) Cartoon representing the epithelium and endothelium of branching structures, and the 
extracellular basement membrane (BM) that encloses and separates both epithelial and endothelial 
structures from surrounding mesenchymal stromal cells. (B) Scanning electron micrograph (SEM) 
highlights the sheet-like structure of BM with an asterisk indicating the fibrillar interstitial matrix 
lying beneath. Inset shows a lower magnification image (scale bar = 20 µm). Immuno-staining for 
type IV collagen and laminin in the peritoneal BM. The two layers are the upper and lower surfaces 
of the peritoneum that are lined by BM (Hotary et al., 2006). (C) Cartoon illustrating the complex 
meshwork of structural molecules that constitute mature BM. (D) Cartoon of the fibrillar 
interstitial ECM which surrounds the mesenchymal stromal cells. (E) Confocal reflection 
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micrograph of a 3-dimensional (3-D) type I collagen matrix shows the fibrillar architecture of 
interstitial type I collagen.  
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Fig. 1-4.  
 
Fig. 1-4. In vitro and ex vivo models to dissect cell-ECM interactions.  
(A) Schematic describing the isolation of mammary epithelial fragments (organoids) from intact 
mammary glands for culture within 3-D ECM. Mammary organoids undergo morphogenesis in 
vitro in response to mitogenic growth factor, FGF2, to form branching structures by day 5 of 
culture. (B) Schematic illustrating the in vitro morphogenesis of endothelial cells, which stretch 
and proliferate in 3-D ECM in response to angiogenic growth factors, VEGF and HGF, over a 4-
day culture period. (C) Bright-field images of endothelial cells cultured within 3-D fibrin gels with 
27 
 
angiogenic growth factors at 0, 2, 4 and 6 days in culture. Endothelial cell number within 3-D 
fibrin matrices in the presence or absence of growth factors. Patent endothelial cell tubules form 
by day 6 of culture, as visualized by H&E staining and a transmission electron micrograph (Zhou 
et al., 2008). (D) Cartoon of aortic ring assay illustrating the retrieval of an aortic fragment (ring) 
for embedding in 3-D type I collagen. (E) Bright-field images of the neovessels formed from 
mouse aortic ring explants following 5 days of culture in 3-D type I collagen with angiogenic 
growth factors. Immunofluorescence of CD31 with DAPI nuclear counter-staining to visualize the 
branching endothelial cells. Aortic ring explants from wild-type and Mt1-mmp-/- mice in 3-D type 
I collagen (Chun et al., 2004).  
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Fig. 1-5.  
 
Fig 1-5. The matrix metalloproteinase (MMP) family.  
(A) Schematics of secreted and membrane-tethered MMPs. Both secreted and membrane-tethered 
MMP precursors (Pro-MMPs) undergo post-translational processing for the removal of their auto-
inhibitory pro-domains and generation of active enzyme. (B) Cartoon schematic of the processing 
and trafficking of membrane-tethered MMP14/ MT1-MMP, which undergoes intracellular 
activation in the trans Golgi network via a proprotein convertase, furin-dependent pathway, where 
furin recognizes and cleaves a short basic amino acid motif (RXKR) in the prodomain. Processed 
MT1-MMP is then trafficked to the cell surface in secretory vesicles and displayed on the cell 
surface as an active protease. 
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CHAPTER 2: Functional Roles of MT1-MMP and MT2-MMP in Early Postnatal 
Mammary Gland Development 
 
Abstract.    
During embryogenesis, mammary epithelial cells initiate migration programs that drive 
ductal invasion into the surrounding adipose-rich mesenchyme.  Currently, branching 
morphogenesis is thought to depend on the mobilization of the membrane-anchored matrix 
metalloproteinases, MT1-MMP/MMP14 and MT2-MMP/MMP15, which drive epithelial cell 
invasion by remodeling the extracellular matrix and triggering associated signaling 
cascades.  However, the roles that these proteinases play during mammary gland development in 
vivo remain undefined.  Herein, we characterize the impact of global Mt1-mmp and Mt2-mmp 
targeting on early postnatal mammary gland development.  Unexpectedly, both Mt1-mmp-/- and 
Mt2-mmp-/- mammary glands retain the ability to generate intact ductal networks.  Though neither 
proteinase is required for branching morphogenesis, transcriptome profiling reveals a key role for 
MT1-MMP and MT2-MMP in regulating mammary gland adipocyte differentiation.  Whereas 
MT1-MMP promotes the generation of white fat depots critical for energy storage, MT2-MMP 
differentially controls the formation of thermogenic brown fat.  Taken together, these data not only 
indicate that current paradigms relevant to proteinase-dependent morphogenesis need be revisited, 
but also identify new roles for the enzymes in regulating adipocyte fate determination in the 
developing mammary gland.
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 Introduction. 
During postnatal mammary gland development, epithelial ducts circumscribed by a 
contiguous basement membrane mount cell invasion programs that allow them to penetrate a 
periductal interstitial matrix populated by fibroblasts and a surrounding adipocyte-rich 
mesenchyme (Ewald et al., 2008; Ewald et al., 2012; Watson and Khaled, 2008). Similar to other 
epithelial organ systems, branching morphogenesis begins between gestation days E12 and E15 
with the invagination of ectoderm-derived placodes to form primary buds that sprout and undergo 
reiterative branching into the underlying mesenchyme (Ewald et al., 2008; Ewald et al., 2012; 
Hogg et al., 1983; Watson and Khaled, 2008). Between E16 and E20, these solid, multi-layered 
mammary epithelial cords give rise to polarized, bilayered mammary tubules composed of inner-
facing luminal epithelial cells and basal-oriented myoepithelial cells (Hogg et al., 1983). In tandem 
with epithelial development, the adipose-rich tissue that surrounds the developing mammary 
epithelium, termed the mammary fat pad, likewise undergoes morphogenesis (Hovey and Aimo, 
2010; Inman et al., 2015). Beginning during late gestation (i.e., E14 to E18) and continuing through 
early postnatal development, the fat pad is eventually dominated by committed adipocytes that 
express adipokines and morphogens that support epithelial morphogenesis and tissue homeostasis 
(Wang et al., 2015). At birth, the mammary gland rudiment is a small, simply branched structure 
that is believed to lie dormant until the onset of puberty (~3 weeks of age) (Ewald et al., 2008; 
Ewald et al., 2012; Hogg et al., 1983; Watson and Khaled, 2008).   
Recent studies emphasize critical roles for proteolytic enzymes belonging to the matrix 
metalloproteinase (MMP) family in the tissue remodeling events that are activated during 
branching morphogenesis, with specific focus on two closely related membrane-anchored MMPs, 
termed MT1-MMP and MT2-MMP (Alcaraz et al., 2011; Bonnans et al., 2014; Brownfield et al., 
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2013; Mori et al., 2009; Rebustini et al., 2009; Weaver et al., 2014). Consistent with their >50% 
homology at the amino acid level (Itoh, 2015; Tanaka et al., 1997), both MT1-MMP and MT2-
MMP are synthesized as zymogens, and undergo intracellular processing to form mature, 
catalytically active enzymes with an N-terminal catalytic domain, a more C-terminal hemopexin 
domain and a single-pass, type I transmembrane domain terminating in a short cytoplasmic tail 
(Itoh, 2015). Both MT1-MMP and MT2-MMP are capable of hydrolyzing a variety of substrates 
ranging from cell surface molecules and growth factors to extracellular matrix (ECM) components 
(Barbolina and Stack, 2008; Itoh, 2015; Rowe and Weiss, 2009). With particular regard to 
mammary gland morphogenesis, MT1-MMP has been reported to control branching events by 
both proteolytic mechanisms whereby epithelial cells dissolve confronting ECM barriers as well 
as proteinase-independent mechanisms by acting as a scaffolding hub for signal transduction 
cascades that control cell motility and cell sorting (Alcaraz et al., 2011; Brownfield et al., 2013; 
Mori et al., 2009; Simian et al., 2001; Weaver et al., 2014). Similarly, MT2-MMP has been 
reported to regulate branching morphogenesis and associated proliferative responses as a 
consequence of its ability to proteolytically remodel the basement membrane and regulate growth 
factor expression (Rebustini et al., 2009). Nevertheless, conclusions regarding roles for MT1-
MMP and MT2-MMP in branching morphogenesis largely derive from in vitro and ex vivo models, 
and the roles that these enzymes play in vivo within the developing mammary gland remain 
undefined.  
Herein, we describe a heretofore overlooked mammary gland branching program that 
occurs during the first 10 days of early postnatal development and gives rise to an organized 
network of polarized ductal structures that penetrate a mature adipocyte-populated stroma, offering 
a robust platform in which to characterize the protease-dependent and protease-independent roles 
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of MT1-MMP and MT2-MMP in vivo. Using Mt1-mmp-/- mice as well as a newly generated Mt2-
mmp-/- mouse line, we provide the first full-scale analysis of the differential functions of these MT-
MMPs in early postnatal mammary gland development.  
 
Results. 
Early postnatal morphogenesis of the developing mouse mammary gland.  
At birth (i.e., postnatal day 0; P0), mammary gland rudiments of female mice appear as 
primitive ductal trees whose ill-defined branches are found adjacent to the nipple (Fig. 2-1 A).  In 
H&E stained cross-sections, the mammary epithelium is organized into cohesive structures 
containing a mixture of solid cords and hollow ducts (Fig. 2-1 B).  Immunohistochemical analyses 
further reveal that epithelial structures are dominated by cells expressing low levels of the luminal 
marker, cytokeratin 18 (CK18), in tandem with a heterogeneous distribution of cells expressing 
the basal marker, cytokeratin 14 (CK14) (Fig. 2-1 C) (Ewald et al., 2008; Ewald et al., 2012; Hogg 
et al., 1983; Watson and Khaled, 2008).  Epithelial cells expressing the myoepithelial marker, α-
smooth muscle actin (αSMA) (Ewald et al., 2008; Ewald et al., 2012; Hogg et al., 1983; Watson 
and Khaled, 2008), are confined to the basal compartment, but in a scattered fashion that outlines 
the rudiments (Fig. 2-1 C).  In marked contrast, between P5 and P10, the mammary gland 
undergoes a heretofore overlooked morphogenic program wherein an established network of 
hollow ducts advances through the surrounding mesenchyme (Fig. 2-1 A,B).  In the course of this 
early maturation process, CK18 expression is up-regulated in the luminal compartment while 
CK14 is confined primarily to basal epithelial cells in association with the continuous 
circumferential expression of αSMA (Fig. 2-1 C).  These changes in epithelial cell and ductal tree 
organization are complemented by striking changes in the mammary gland fat pad wherein small 
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lipid-laden adipocyte/adipocyte precursors mature into large, unilocular adipocytes (Fig. 2-1 B).  
While the P0-P10 mammary ducts are consistently invested by a laminin- and type IV collagen- 
rich basement membrane (Fig. 2-1 D), a periductal network of organized type I collagen fibrils 
does not fully develop until P5-P10 (Fig. 2-1 E). Hence, during the early postnatal period, both the 
mammary epithelia and stroma activate a morphogenetic program that generates an organized 
network of ducts that predate those more frequently associated with pubertal development (Inman 
et al., 2015; Watson and Khaled, 2008). 
 
MT1-MMP dependent regulation of branching morphogenesis:  In vitro versus in vivo. 
Based largely on in vitro evidence, MT1-MMP has been proposed to regulate branching 
morphogenesis by both proteinase- dependent and independent mechanisms (Alcaraz et al., 2011; 
Brownfield et al., 2013; Mori et al., 2009; Weaver et al., 2014).  Using Mt1-mmplacZ/+ mice (Yana 
et al., 2007), β-galactosidase activity is detected in the branching ductal tree as well as the 
surrounding mesenchyme at birth and P5 (Fig. 2-2 A). By P10, LacZ-expressing cells delineate 
and circumscribe the entire neonatal mammary gland, from the ducts closest to the nipple to their 
terminal ends (Fig. 2-2 A) with cross-sections highlighting MT1-MMP expression in luminal 
epithelial cells and myoepithelial cells as well as the surrounding stroma (Fig. 2-2 B). LacZ 
expression also correlates with an increase in Mt1-mmp levels in the developing gland (Fig. 2-2 
C).  
To first assess the role of mammary epithelial cell-derived MT1-MMP in vitro, Mt1-
mmplacZ/+ mammary epithelial organoids were embedded in 3-dimensional (3-D) type I collagen 
hydrogels (Chun et al., 2004; Haslam et al., 2008; Sabeh et al., 2009; Simian et al., 2001).  As 
shown, Mt1-mmp is expressed both at time 0 and during the formation of an arborized branching 
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network generated in the presence of FGF-2 (Fig. 2-2 D) (Haslam et al., 2008; Simian et al., 2001).  
Consistent with the premise that MMPs are able to drive type I collagen-invasive activity (Alcaraz 
et al., 2011; Brownfield et al., 2013; Chun et al., 2004; Mori et al., 2009; Sabeh et al., 2009; Simian 
et al., 2001; Tang et al., 2013; Weaver et al., 2014), branching morphogenesis is inhibited 
completely when organoids are cultured in the presence of the pan-specific MMP inhibitor, BB-
94 (Chun et al., 2004; Sabeh et al., 2009) (Fig. 2-2 E).  More importantly, organoids recovered 
from MT1-MMP-deleted mice display a complete loss of branching activity (Fig. 2-2 E), a result 
consistent with MT1-MMP’s role as the dominant pericellular type I collagenase operative in 
mammalian cells (Chun et al., 2004; Rowe and Weiss, 2009; Sabeh et al., 2009; Tang et al., 2013).  
Nevertheless, an MT1-MMP-dependent block in branching morphogenesis through native type I 
collagen matrices could also result from protease-independent effects on epithelial cell sorting, 
motility or metabolism (Brownfield et al., 2013; Mori et al., 2009; Sakamoto et al., 2014). As such, 
Mt1-mmp+/+ and Mt1-mmp-/- mammary epithelial organoids were alternatively embedded in 3-D 
hydrogels of Matrigel (Ewald et al., 2008; Ewald et al., 2012; Lo et al., 2012), a mixture of 
basement membrane-associated proteins whose proteolytic remodeling is not required to support 
cell invasion programs (Rowe and Weiss, 2008). As reported previously (Ewald et al., 2008; Ewald 
et al., 2012; Lo et al., 2012), wild-type mammary organoids embedded in Matrigel hydrogels form 
budding lobular structures in response to FGF-2-mediated signaling (Fig. 2-2 F). Inconsistent, 
however, with the contention that MT1-MMP regulates morphogenesis via proteinase-independent 
mechanisms (Brownfield et al., 2013; Mori et al., 2009), neither Matrigel-embedded organoids 
cultured in the presence of BB-94 nor Mt1-mmp-/- organoids display defects in branching activity 
(Fig. 2-2 F). Hence, in the presence of a permissive ECM environment, MMPs are not necessarily 
required to support morphogenic programs.  
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While in vitro models provide useful tools for dissecting cell function, isolated epithelial 
cell-based model systems are unlikely to recapitulate the morphogenic programs occurring in vivo 
where the surrounding mesenchyme play active roles in branching (Nelson and Larsen, 2015; 
Varner and Nelson, 2014). As such, we next sought to directly assess requirements for MT1-MMP 
during mammary gland morphogenesis in vivo. Though the morbid status of Mt1-mmp-/- mice and 
their failure to undergo sexual maturation preclude efforts to analyze late stage mammary gland 
development (Holmbeck et al., 1999; Zhou et al., 2000), the newly described P0-P10 program 
provides a unique window of opportunity for such analyses. Interestingly, mammary glands 
harvested from P0 Mt1-mmp-/- mice generate branching ductal networks comparable to those of 
wild-type and Mt1-mmp+/- littermates (Fig. 2-3 A,B). More remarkably, at P5 and P10, Mt1-mmp 
-/- mice mount a mammary gland branching program similar, if not identical, to those observed in 
Mt1-mmp+/+ or Mt1-mmp+/- littermates (Fig. 2-3 C-F).  Further, immunohistologic assessments of 
Mt1-mmp-/- mammary gland sections reveal no differences in the expression or organization of 
CK18, CK14 or α-SMA from P0 through P10 (Fig. 2-4 A,B). Likewise, epithelial cell organization, 
as assessed by the apical distribution of the tight junction protein, zonula occludens (ZO)-1, or the 
adherens junction marker, E-cadherin (Ewald et al., 2008; Ewald et al., 2012; Inman et al., 2015), 
is indistinguishable between Mt1-mmp+/+, Mt1-mmp+/- or Mt1-mmp-/-  mice (Fig. 2-4 B). While 
MT1-MMP has previously been implicated in the proliferation-associated signaling cascades that 
drive branching morphogenesis (Gutierrez-Fernandez et al., 2015; Riggins et al., 2010), neither 
Ki67 expression, TUNEL staining nor senescence are affected in Mt1-mmp-/- glands (Fig. 2-4 
C,D). Finally, deleting MT1-MMP did not discernably alter basement membrane or interstitial 
matrix assembly, respectively, as reflected in comparable type IV collagen and laminin staining 
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(Fig. 2-4 E) or levels of type I collagen as assessed by immunofluorescence and Sirius Red staining 
(Fig. 2-4 F). 
Neonatal mammary gland branching morphogenesis also coincides with the increased 
expression of two secreted members of the MMP gene family that have been previously implicated 
in mammary gland branching and development, i.e., Gelatinase A/Mmp2 and Stromelysin-1/Mmp3 
(Correia et al., 2013; Kessenbrock et al., 2013; Lochter et al., 1997; Wiseman et al., 2003; Witty 
et al., 1995) (Fig. 2-S1 A,C).  Further, MT1-MMP can activate MMP2 in vivo, a proteinase thought 
to mediate MT1-MMP function and compensate partially for Mt1-mmp deficiency (Itoh, 2015; Oh 
et al., 2004). Nevertheless, as previously described, Mmp2-/- mammary glands develop comparable 
branching structures relative to those of littermate controls in pre-pubertal mice (Fig. 2-S1 B) 
(Wiseman et al., 2003). Further, while recent reports have identified critical protease-dependent as 
well as protease-independent roles for MMP3 in mammary gland development (Correia et al., 
2013; Kessenbrock et al., 2013; Lochter et al., 1997; Wiseman et al., 2003; Witty et al., 1995), 
Mmp3-/- mammary glands establish branching structures that are comparable in length and 
complexity to those of Mmp3+/+ and Mmp3+/- littermates with normal distribution of luminal 
epithelial and myoepithelial cell populations (Fig. 2-S1 D,E). 
 
Neonatal mammary gland branching proceeds in the absence of MT2-MMP. 
Membrane-anchored MT2-MMP is structurally related to MT1-MMP, enriched in the 
mammary epithelium (Szabova et al., 2005), and has recently been implicated in branching 
morphogenesis ex vivo (Rebustini et al., 2009). Using Mt2-mmplacZ knock-in mice (Fig. 2-5 A), 
Mt2-mmp expression can be detected throughout the mammary epithelial cell compartment at birth 
as well as through P10 (Fig. 2-5 B,C), a result further corroborated by up-regulated Mt2-mmp 
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levels (Fig. 2-5 D). Mt2-mmp-targeted mice were therefore employed to address the requirement 
for Mt2-mmp in branching morphogenesis wherein exons 4 and 5 of the catalytic domain were 
flanked by loxP sites (Fig. 2-S2 A), and deleted by breeding Mt2-mmpflox/flox mice with EIIA-Cre 
mice. Crosses between Mt2-mmp+/- mice generated Mt2-mmp+/+, Mt2-mmp+/- and Mt2-mmp-/- mice 
in normal Mendelian ratios, yielding a total of 68 Mt2-mmp+/+, 146 Mt2-mmp+/- and 70 Mt2-mmp 
-/- mice in 284 total offspring; and Mt2-mmp-/- mice remained similarly viable throughout 
adulthood. Importantly, germline deletion of Mt2-mmp did not affect Mt1-mmp expression (Fig. 
2-5 E), ruling out any compensatory interactions between these closely related MMP family 
members.   
In vivo assessments of Mt2-mmp+/+, Mt2-mmp+/- and Mt2-mmp-/- mammary glands revealed 
correspondingly similar branching structures as assessed by carmine staining at birth as well as 
P10 (Fig. 2-5 F-G). Similarly, explanted Mt2-mmp-/- and Mt2-mmp+/+ mammary epithelial cell 
organoids in 3-D type I collagen or Matrigel mounted comparable branching programs (Fig. 2-5 
H,I). Further, Mt2-mmp-/- mammary epithelial ducts display an unaltered pattern of CK18, CK14, 
αSMA and E-cadherin expression (Fig 2-S2 B-D). Though MT2-MMP has been reported to 
regulate the proliferative and apoptotic responses required for epithelial morphogenesis (Abraham 
et al., 2005; Rebustini et al., 2009), Ki67 as well as apoptotic levels are unchanged in the absence 
of Mt2-mmp (Fig. 2-S2 E). Similarly, while MT2-MMP can function as a basement membrane 
remodeling enzyme during branching morphogenesis ex vivo (Rebustini et al., 2009) as well as a 
type I collagenase (Chun et al., 2004; Hotary et al., 2000), neither type IV collagen, laminin nor 
type I collagen levels are affected in the absence of Mt2-mmp (Fig. 2-S2 F). 
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Differential roles for MT1-MMP and MT2-MMP in mammary gland development. 
 At this juncture, a preferential focus on the roles of MT1-MMP and MT2-MMP in 
controlling tissue-invasive activity and branching morphogenesis was predicated on the basis of a 
number of previously established precedencies – largely performed in vitro.  In order to probe for 
unanticipated functional roles of MT1-MMP and MT2-MMP in the early postnatal mammary 
gland, we analyzed the transcriptome of the ductal networks and associated stroma in wild-type 
versus null mice. In Mt1-mmp-/- mice, gene expression profiling revealed >250 differentially 
expressed genes relative to Mt1-mmp+/+ mammary tissue (using a 2-fold enrichment cutoff), with 
functional annotation clusters bridging 16 different gene ontology (GO) categories, including 
many associated with the epithelial cell compartment, such as cell adhesion, endocytosis, 
responses to endogenous stimuli, and G protein-coupled signaling cascades (DAVID 
Bioinformatics Resource, NIH, p-value/Ease < 0.05; Fig. 2-6 A).  Of note, gene expression 
profiling did not uncover significant changes in the proliferation- or senescence- associated 
signaling cascades highlighted in earlier work (Gutierrez-Fernandez et al., 2015; Riggins et al., 
2010). However, given the number of genes associated with epithelial cell adhesion complexes 
and cytoskeletal organization [e.g., Calmin, Plakophilin 2, Folliculin; (Arimoto et al., 2014; 
Khabibullin et al., 2014; Loo et al., 2013)] , we examined mammary ducts recovered from P10 
Mt1-mmp+/+ and Mt1-mmp-/- mice by transmission electron microscopy (TEM).  Interestingly, 
Mt1-mmp-/- ducts form more intimate cell-cell junctions with a marked increase in the number of 
apical microvilli (Fig. 2-S3 A,B) – despite mounting a normal branching program.  By contrast, 
the transcriptome of Mt2-mmp-/- mammary tissues uncovered only ~30 differentially expressed 
genes whose classification lacked any major associations with mammary epithelium-related GO 
categories (Fig. 2-S4 A). Accordingly, TEM analyses of Mt2-mmp-/- ducts appear largely normal 
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(Fig. 2-S4 B,C).  Hence, while these data confirm active roles for MT1-MMP and MT2-MMP in 
early postnatal mammary gland development, the observed transcriptional changes do not 
significantly impact ductal network organization or the penetration of the surrounding 
mesenchymal tissues.  
 Independent of the roles played by MT1-MMP or MT2-MMP in the mammary epithelial 
compartment, analyses of differentially expressed transcript profiles indicate that both MT-MMPs 
exert significant effects on the mammary gland stroma.  In Mt1-mmp-/- mice, the down-regulated 
GO categories with the highest enrichment scores are tightly linked with the mammary gland fat 
pad, with decreased expression of multiple transcripts associated with sterol and fatty acid 
metabolism, lipid biosynthesis and adipocyte maturation (Fig. 2-6 B). In tandem with these 
changes, mammary gland adipocytes display a marked 2-fold decrease in overall size (mean 
adipocyte diameter of 43.3 µm ± 1.01 µm in Mt1-mmp+/+ mammary glands versus 22.8 µm ± 1.60 
µm in Mt1-mmp-/- mammary glands (n=3 per genotype, p=0.0004)) (Fig. 2-6 C).  In an almost 
diametrically opposed fashion, the metabolic genes repressed in Mt1-mmp-/- tissue are either 
upregulated or unchanged in Mt2-mmp-targeted mice as most clearly evidenced by the differential 
expression of the adipokine, Leptin (Fig. 2-6 D) (Wang et al., 2015; Wu et al., 2013).  
Unexpectedly, transcriptome analysis of Mt2-mmp-/- mammary tissue further reveals a marked 
increase in a core suite of positive regulators of brown or induced brown (beige) adipocytes (Fig. 
2-S4 A) – thermogenic adipocytes that can be identified based on their restricted expression of 
uncoupling protein-1 (UCP1) (Wang et al., 2015; Wu et al., 2013).  Indeed, whereas adipocyte size 
is unaffected in many regions of the Mt2-mmp-/- mammary glands, large clusters of small, 
multilocular adipocytes – the hallmark of beige/brown fat – are found throughout the knockout 
tissues in 4 of 6 animals characterized (Fig. 2-6 E).  As confirmed by qPCR, Mt2-mmp-/- mammary 
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tissues display a ~5-fold increase in Ucp1 transcript levels as well as increased expression of 
multiple genes required for mitochondrial biogenesis, adipocyte thermogenesis and Ucp1 
induction, including Dio2, Fabp3, Prdm16 and Pgc1α (Cohen et al., 2014; Marsili et al., 2011; 
Vergnes et al., 2011; Wu et al., 2013) (Fig. 2-6 F). Cross-sections of Mt2-mmp-/- mammary glands 
further document increased UCP1 protein levels (Fig. 2-6 G).  Finally, corroborating the divergent 
roles of MT1-MMP and MT2-MMP in mammary fat pad development, brown/beige-associated 
transcripts or protein levels remain unchanged in Mt1-mmp-/- glands (Fig. 2-6 G,H). Hence, while 
MT1-MMP promotes white fat-associated adipogenesis in the developing mammary gland, MT2-
MMP alternatively serves as an endogenous suppressor of beige/brown fat production. 
 
Discussion. 
MT1-MMP and MT2-MMP have been reported to play roles in a range of morphogenesis-
associated processes, including cell adhesion and motility, invasion, proliferation,  energy 
metabolism, senescence, the proteolytic processing of growth factors, cytokines and chemokines 
as well ECM remodeling  (Ager et al., 2015; Alcaraz et al., 2011; Barbolina and Stack, 2008; 
Bonnans et al., 2014; Brownfield et al., 2013; Chun et al., 2004; Fahlman et al., 2014; Fu et al., 
2013; Itoh, 2015; Kajita et al., 2001; Koshikawa et al., 2000; Koziol et al., 2012; Mori et al., 2009; 
Rebustini et al., 2009; Rowe and Weiss, 2009; Sabeh et al., 2009; Sakamoto et al., 2014; Shimizu-
Hirota et al., 2012; Simian et al., 2001; Tang et al., 2013; Taylor et al., 2015; Weaver et al., 2014; 
Yana et al., 2007). Consistent, in part, with previous reports linking MT-MMPs with epithelial cell 
tissue-invasive and branching programs (Alcaraz et al., 2011; Bonnans et al., 2014; Brownfield et 
al., 2013; Mori et al., 2009; Rebustini et al., 2009; Weaver et al., 2014), we find that MT1-MMP, 
but not MT2-MMP, is required for mammary epithelial organoid branching through 3-D type I 
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collagen barriers in vitro. However, in contrast to earlier findings (Mori et al., 2009), we find that 
MT1-MMP-expressing mammary epithelial cells in 3D culture lack a competitive sorting 
advantage relative to MT1-MMP-null epithelial cells. Further, when Mt1-mmp-/- or Mt2-mmp-/- 
epithelial organoids are embedded in Matrigel, a hydrogel that recapitulates the assembly of 
basement membrane-like structures (Ewald et al., 2008; Ewald et al., 2012; Lo et al., 2012), 
morphogenesis proceeds in an unperturbed fashion – even in the presence of a pan-specific MMP 
inhibitor. Given these divergent outcomes, and the fact that model systems do not fully recapitulate 
mammary gland architecture or stromal cell interactions (Nelson and Larsen, 2015), we turned to 
the in vivo setting.  
Unlike in vitro culture conditions, the primordial mammary ducts of newborn female mice 
are encased in a coat of type IV collagen and laminin that is surrounded by low levels of type I 
collagen.  Nevertheless, given the broad substrate repertoire of MT1-MMP and the multiple 
biological activities that have been assigned to its functions (Ager et al., 2015; Alcaraz et al., 2011; 
Barbolina and Stack, 2008; Bonnans et al., 2014; Brownfield et al., 2013; Chun et al., 2004; 
Fahlman et al., 2014; Fu et al., 2013; Itoh, 2015; Kajita et al., 2001; Koshikawa et al., 2000; Koziol 
et al., 2012; Mori et al., 2009; Rebustini et al., 2009; Rowe and Weiss, 2009; Sabeh et al., 2009; 
Sakamoto et al., 2014; Shimizu-Hirota et al., 2012; Simian et al., 2001; Tang et al., 2013; Taylor 
et al., 2015; Weaver et al., 2014; Yana et al., 2007), we were surprised to find that deleting the 
proteinase in vivo exerted little, if any, effect on morphogenesis or ductal invasion through the 
mesenchyme. Likewise, despite the ex vivo requirement for MT2-MMP in submandibular gland 
proliferation, matrix remodeling and branching (Rebustini et al., 2009), mammary glands from 
Mt2-mmp-targeted mice and littermate controls displayed similar ductal networks at birth as well 
as P10. While our measurements may lack sufficient sensitivity to detect transient differences in 
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epithelial cell sorting or organization during branching, the overall similarities of the ductal 
networks generated in Mt1-mmp-/- or Mt2-mmp-/- mice suggest that any in vivo defects related to 
branching or tissue-invasive activity are, at best, subtle. Of note, a subset of the Mt1-mmp-/- mice 
(i.e., 3 of 15 total) displayed an unusually reduced body size relative to littermate controls with 
partial mammary gland defects noted at P10 (i.e., mammary ducts branched comparably, but 
appeared more primitive in their architecture). However, given the reduced size and feeding of this 
cohort and the known influence of nutrient deprivation on tissue morphogenesis (Londhe et al., 
2013), we did not include these animals in our analyses.  
Despite the retention of mammary gland branching programs in Mt1-mmp-/- or Mt2-mmp-/- 
mice, we did not directly rule out a potential compensatory role for MT1-MMP and MT2-MMP 
in postnatal morphogenesis.  As Mt1-mmp/Mt2-mmp double-null mice die during embryogenesis 
(Szabova et al., 2010), we have alternatively targeted both proteinases selectively in the mammary 
epithelial compartment, but preliminary studies demonstrate that branching morphogenesis 
nevertheless proceeds in a normal fashion from birth through adulthood (Chapter 3). While MT1-
MMP and MT2-MMP have previously been shown to endow neoplastic cells with the ability to 
degrade and transmigrate BM barriers (Ota et al., 2009), it should be stressed that there is no 
evidence that mammary epithelial cells dissolve their underlying BM during morphogenesis in 
vivo.  Indeed, during postnatal development, mammary epithelial cells remain separated from the 
periductal type I collagen meshwork by a patent BM while time-lapse analyses of ductal invasion 
programs fail to detect membrane- based protrusions extending into the ECM at the advancing 
front (Ewald et al., 2008; Ewald et al., 2012; Williams and Daniel, 1983). More recently, Yamada 
and colleagues concluded that basement membranes undergo proteolytic remodeling during 
branching morphogenesis ex vivo (Harunaga et al., 2014), but efforts to implicate MMPs in this 
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process were confined to the use of BB-94, an inhibitor that not only targets all MMP family 
members, but also ADAM/ADAM-TS family members that play critical roles in proteoglycan 
turnover as well as the shedding of growth factors critical to morphogenesis (Rowe and Weiss, 
2009). Indeed, in their studies, TIMP-2, a potent MMP inhibitor (Chun et al., 2004; Sabeh et al., 
2009), did not affect branching (Harunaga et al., 2014).  Finally, we note that the early postnatal 
branching programs tracked in our studies were not  mediated by other MMP family members 
implicated in branching organ development, including MMP2 or MMP3 (Correia et al., 2013; 
Kessenbrock et al., 2013; Wiseman et al., 2003).    
Given the paucity of obvious structural defects in ductal morphogenesis found in Mt1-mmp 
-/- or Mt2-mmp-/- mice, we interrogated the mammary gland transcriptomes of the knockout tissues.  
Though MT1-MMP and MT2-MMP share considerable sequence and structural homology (Itoh, 
2015; Tanaka et al., 1997), effects on mammary gland gene expression were notably distinct. For 
example, Mt1-mmp-/-, but not Mt2-mmp-/-, mammary glands increased expression of a number of 
cell adhesion/cytoskeleton-associated transcripts with Mt1-mmp-/- ducts displaying subtle changes 
in epithelial cell-cell junctions and apical microvilli.  While further work will be needed to define 
the functional consequences of these changes or provide mechanistic insights into their origins, 
the observed structural alterations highlight the fact that MT1-MMP does, in fact, affect mammary 
gland development, but not in a fashion that impacts branching-associated invasion programs per 
se.  In contrast with the epithelial cell-associated changes observed in Mt1-mmp-/- mammary 
glands, the effects of deleting Mt2-mmp were far more subtle with only a small subset of genes 
affected. We are, however, unable to assess catalytic activity of MT2-MMP per se as specific 
antibodies capable of distinguishing between the pro- and active forms of the enzyme have not 
been generated. Nevertheless, it is intriguing that the breast cancer-associated transcripts, γ-
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synuclein (Ahmad et al., 2007) and Peroxiredoxin 2 (Stresing et al., 2013), are among the most 
significantly affected (i.e., ~5-fold increase and ~7-fold decrease, respectively). 
In the mammary gland, the adipocyte-rich stroma plays important roles in regulating 
morphogenetic responses (Hovey and Aimo, 2010; Inman et al., 2015). Intriguingly, early in 
postnatal life, the mammary gland-associated pool of adipocytes contains both white and brown 
fat (Gouon-Evans and Pollard, 2002; Master et al., 2002), but the factors that control their 
differential expression have not been defined previously.  Independent of the effects of MT1-MMP 
and MT2-MMP on mammary epithelial cells, their more global and differential effects on 
mammary fat pad development were unanticipated. Mt1-mmp targeting alone triggers a 
widespread down-regulation of transcripts associated with adipogenesis (Wang et al., 2015). By 
contrast, an Mt2-mmp-null status exerts little effect on white fat development, but instead strongly 
enhances the formation of brown and/or beige fat as evidenced by the increased expression of a 
cohort of thermogenic genes (Wu et al., 2013). Our lab has previously established roles for MT1-
MMP in coordinating adipocyte maturation in vivo, as evidenced by the aborted white adipose 
tissue development in the dermal and inguinal adipose tissue depots of male Mt1-mmp-/- mice 
(Chun et al., 2006), but the role of MT1-MMP in the mammary gland stromal fat pad has not been 
previously appreciated. Indeed, we have recently reported that Mt1-mmp-/- mesenchymal stem cells 
preferentially commit to the adipocyte lineage with resultant increases in bone marrow adiposity 
(Tang et al., 2013). At this juncture, we posit that the incongruous functional consequences of Mt1-
mmp deletion in bone marrow versus subcutaneous and mammary gland adipocytes likely derives 
from reported differences in progenitor cell populations and local tissue environments (Gupta et 
al., 2012; Tran et al., 2012)  
45 
 
The discovery of a heretofore unrecognized early postnatal mammary gland branching 
program has provided us with a new platform to dissect the roles of a select group of MMPs in 
morphogenesis.  Recent studies have emphasized the ability of secreted as well as membrane-
anchored MMPs to cleave hundreds of intracellular, cell surface-associated or extracellular 
substrates (Barbolina and Stack, 2008; Fahlman et al., 2014; Fu et al., 2013; Itoh, 2015; Koziol et 
al., 2012; Rowe and Weiss, 2009).  Given these results, it is surprising, if not perplexing, that 
global targeting of Mt1-mmp or Mt2-mmp – as well as Mmp2 and Mmp3 – did not derail ductal 
invasion programs or morphogenesis to a more striking degree.  Indeed, while MT1-MMP has 
been implicated – to varying degrees – in early lung, kidney and submandibular gland 
development, these findings do not extend to mammary gland development (Atkinson et al., 2005; 
Oblander et al., 2005; Riggins et al., 2010). While results such as ours are often countered by the 
argument that the mouse genome encodes more than 20 Mmp family members, virtually all of 
these genes have now been targeted, and with the exception of Mt1-mmp, each knockout gives rise 
to viable mice with normal lifespans (Bonnans et al., 2014; Holmbeck et al., 1999; Itoh, 2015; 
Rowe and Weiss, 2009; Zhou et al., 2000).  Further, though redundant and compensatory pathways 
may exist, no direct experimental evidence has been forwarded to support this contention (Rowe 
and Weiss, 2009).  The fact that only Mt1-mmp targeting causes a dramatic increase in the 
morbidity and mortality of knockout mice (Holmbeck et al., 1999; Zhou et al., 2000), and that dual 
targeting of Mt1-mmp and Mt2-mmp results in an embryonic lethal phenotype (Szabova et al., 
2010), has, predictably, catalyzed increased efforts to identify the key functions of these 
proteinases. Recent reports emphasize roles for MT1-MMP and MT2-MMP in events ranging from 
type I collagen deposition and cellular senescence to TGFβ activation (Ager et al., 2015; Gutierrez-
Fernandez et al., 2015; Taylor et al., 2015) – any one of which might have been posited to perturb 
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branching morphogenesis.  As evidenced here, predicted effects fall short of experimental 
outcomes.  Clearly, MT1-MMP and MT2-MMP do exert complex effects on mammary gland 
development, but the observed changes in function are, for the most part, novel and unanticipated 
from the perspective of current paradigms. 
 
Experimental procedures. 
Mouse strains.  
Mt1-mmplacZ/+ mice (Yana et al., 2007) were bred onto a C57BL/6J background (Jackson 
Laboratory, 000664). To generate Mt2-mmplacZ/+ mice, C57BL/6J Mt2-mmplacZ/+ ES cells clones 
from the UC Davis KOMP Repository (KOMP) [MGI allele: Mmp15tm1a (KOMP) wtsi, clone: 
EPD0097_3_B09] were introduced into albino C57BL/6J host blastocysts.  Chimeras were mated 
with C57BL/6J mice to test for germline transmission. Mt2-mmplacZ/+ mice were bred and 
maintained on a C57BL/6J background. The Mt1-mmp+/- mice (Swiss Black background; 
(Holmbeck et al., 1999) were maintained on an outbred Swiss Black background (Charles River, 
NIHBL(S). Mmp3-/- mice (C57BL/6J background) and Mmp2-/- mice (Swiss Black background) 
were genotyped as described (Itoh et al., 1997). To generate Mt2-mmp/Mmp15 global knockout 
(Mt2-mmp-/-) mice, 129/SVJ ES cells were electroporated with a targeting vector for Mmp15 
containing a neomycin selection cassette flanked by FRT sites wherein exons 4 and 5 of the 
catalytic domain were floxed by loxP sites (Fig. 2-S2 A). Following neomycin selection, ES cell 
recombinants were injected into gestation day E3.5 C57BL/6J blastocysts and subsequently 
injected into the uteri of pseudo-pregnant FVB mice. Male chimeras were mated to C57BL/6J 
females, and heterozygous agouti offspring carrying the Mmp15flox allele were mated to C57BL/6J 
FlpE mice to remove the neomycin selection cassette. The resultant Mmp15fl/fl mice were crossed 
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to C57BL/6J EIIA-Cre mice for germline deletion of Mmp15, with Mmp15+/- mice backcrossed 
into C57BL/6J mice (n>10 generations).  All mouse work was performed with IACUC approval 
at the University of Michigan. 
 
Mammary organoid isolation and culture. 
Organoids were prepared from inguinal mammary glands of P10 mice as described (Fata 
et al., 2007). Mammary epithelial organoids were then embedded in 2.2 mg/ml acid-extracted rat-
tail type I collagen (Sabeh et al., 2009) for 3-D culture in 24-well plates with DMEM/F12 media 
containing 0.1 mM nonessential amino acids (GIBCO), 0.3 mg/ml L-glutamine, 1X ITS (Sigma, 
13146), 10 µg/ml insulin (GIBCO, 12585-014), penicillin and streptomycin, with 50 ng/ml FGF-
2  (Simian et al., 2001). Media was changed every 2-3 d over 5-8 d culture periods.  
 
Mammary gland whole mount preparation, imaging and morphometric analysis. 
Inguinal mammary glands were harvested, mounted on glass slides, stained with Carmine 
Alum, and processed (Lu et al., 2008). Whole mounts were imaged (Leica MZFLIII dissecting 
microscope) with Adobe Photoshop and ImageJ used for image processing (Lu et al., 2008).  
 
RNA extraction from intact mammary gland tissue and gene expression analysis. 
Inguinal mammary gland tissue was flash frozen in liquid nitrogen, and homogenized in 1 
mL TRIzol (Ambion, Life Technologies). Total RNA was extracted and purified using QIAGEN 
RNeasy Mini-kit columns (QIAGEN, 74104). RNA quality was confirmed using an Agilent 2100 
Bioanalyzer and samples profiled on Affymetrix Mouse MG–430 PM expression array strips. 
Expression values for each probe set were calculated using a robust multi-array average (RMA) 
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(Irizarry et al., 2003) and filtered for genes with a greater than 2-fold change. The Affymetrix 
microarray data are deposited in the NCBI Gene Expression Omnibus (GEO) database (Edgar et 
al., 2002) and available through GEO Series accession number GSE77679 
(http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE77679). Complementary cDNA was 
prepared with the Invitrogen SuperScript II First-Strand Synthesis System (11904-018). 
Quantitative reverse-transcription PCR was performed with SYBR Green (Applied Biosystems) 
using Arbp/Rplp0 for reference gene expression. Data reported as the mean expression levels with 
error bars representing the standard error (SEM). p values were calculated with an unpaired t-test 
with two tails. 
 
Primers. 
QPCR primers are provided in Table 2-1. Genotyping primers are provided in Table 2-2.   
 
LacZ staining. 
Inguinal Mt1-mmplacZ mammary glands were fixed at 4oC in PBS containing 2% 
paraformaldehyde and 0.2% glutaraldehyde. Mt2-mmplacZ glands were alternatively fixed in 4% 
paraformaldehyde. Tissues were either transferred to 30% sucrose/PBS (w/v) for frozen sections, 
or incubated for 18-24 h in PBS containing 4 mM potassium hexacyanoferrate (III), 4 mM 
potassium hexacyanoferrate (II) trihydrate, 2 mM MgCl2, 0.2% NP-40, 0.1% sodium deoxycholic 
acid and 1 mg/ml Xgal.  Stained tissues and whole mounts were post-fixed with 10% formalin-
phosphate. 
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Immunofluorescence, immunohistochemistry and morphometric analysis.   
Mammary gland tissue was fixed in 10% formalin-phosphate at 4º C overnight and either 
dehydrated in an ethanol/paraffin series for paraffin embedding or transferred to 30% (w/v) 
sucrose/PBS for OCT embedding.  Sections were permeabilized with 0.5% Triton X-100/PBS, and 
blocked for 2 h prior to primary antibody addition. Samples were incubated overnight at 4oC with 
antibodies directed against [ZO-1 (Invitrogen, 617300, 2.5 µg/ml), E-cadherin (BD Transduction 
Laboratories, 610181, 1/400), Cytokeratin-14 (Covance, PRB-155P, Clone AF64, 1/400), 
Cytokeratin-18 (Abcam, ab668, 1/150), α-smooth muscle actin (Abcam, ab5694, 1/400), or UCP1 
(Alpha Diagnostic International, UCP11-A, 200 ng/ml)]. For ECM staining, frozen sections were 
incubated in blocking buffer (10% FBS/1% BSA/PBS) and incubated with primary antibodies 
directed against type IV collagen (Millipore, AB-769, 1/40) (Nguyen-Ngoc et al., 2012), laminin 
(Sigma-Aldrich, L9393, 1/250), or type I collagen (Abcam, ab34710, 1/250) overnight at 4oC. 
Following primary antibody, sections were incubated with Alexa-488 or Alexa-594-conjugated 
secondary antibodies (Invitrogen Molecular Probes).  Nuclear counter-staining was carried out 
with either Toto3 (1/200, Invitrogen Molecular Probes) or 2 µg/ml 4, 6-diamidino-2-phenylindole 
(DAPI). All fluorescence images were acquired with an Olympus FluoView FV500 laser scanning 
confocal microscope and analyzed with Adobe Photoshop and ImageJ software. For 
immunohistochemistry, endogenous peroxidase activity was blocked with H2O2 and tissues 
sections developed with the Vectastain ABC (Vector Laboratories, PK-6100) and DAB kits 
(Vector Laboratories, SK-4100). ImageJ was used to measure the diameter of n>20 adipocytes per 
40X field in H&E-stained paraffin cross-sections. 
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Tissue preparation for TEM. 
Samples were fixed (1% glutaraldehyde/1% tannic acid/0.1 M Sorensen’s buffer, pH 7.2) 
and post-fixed with 1% osmium tetroxide as described (Abrahamson and Perry, 1986) prior to  
embedding in EMbed 812 epoxy resin (Electron Microscopy Sciences).  Thin sections (70 nm) 
were post-stained with uranyl acetate and Reynolds Lead Citrate, and imaged with a JE0L JEM-
1400 Plus electron microscope. Images were recorded digitally using a Hamamatsu ORCA-HR 
digital camera system, operated using AMT software (Advanced Microscopy Techniques Corp., 
Danvers, MA).  ImageJ was used to quantify average number of microvilli per µm from n > 5 
fields per sample and n = 3 per genotype.  Results are expressed as mean ± SEM.   
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Table 2-1.  
 
 
 
Table 2-1. qPCR Primers.  
Gene Forward Primer Reverse Primer 
Gapdh 5’-TGAAGCAGGCATCTGAGGG-3’ 5’-CGAAGGTGGAAGAGTGGGAG-3’ 
Arbp 5’-CACTGGTCTAGGACCCGAGAA-
3’ 
5’-AGGGGGAGATGTTCAGCATGT-
3’ 
Mmp2 5’-TCTGGAGCGAGGATACCCCAA-
3’ 
5’-TTCCAGGAGTCTGCGATGAGC-3’ 
Mmp3 5’-GTT CCT GAT GTT GGT GGC TT-
3’ 
5’-AGC CTC TCC TTC AGA GAT CC-
3’ 
Mmp15 5’-ACATGTCCACCATGCGCTCT-3’ 5’-TACCATGATGTCAGCCTCC-3’ 
Mmp14 5’-CTGCCATTGCCGCCATGCAAAA-
3’ 
5’-TGGCGTGGCACTCTCCCATACT-
3’ 
Ucp1 5’-AGGCTTCCAGTACCATTAGGT-3’ 5’- 
CTGAGTGAGGCAAAGCTGATTT-3’ 
Dio2 5’-AATTATGCCTCGGAGAAGACCG-
3’ 
5’-GGCAGTTGCCTAGTGAAAGGT-
3’ 
Fabp3 5’-ACCTGGAAGCTAGTGGACAG-3’ 5’-TGATGGTAGTAGGCTTGGTCAT-
3’ 
Prdm16 5’-CCACCAGACTTCGAGCTACG-3’ 5’-ACACCTCTGTATCCGTCAGCA-3’ 
Pgc1a 5’-CCACTTCAATCCACCCAGAAAG-
3’ 
5’-
TATGGAGTGACATAGAGTGTGCT-
3’ 
Leptin 5’-GAGACCCCTGTGTCGGTTC-3’ 5’-CTGCGTGTGTGAAATGTCATTG-
3’ 
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Table 2-2.  
 
 
Table 2-2. Genotyping Primers.   
Gene Forward Primer(s) Reverse Primer(s) 
PCR 
Product 
Size 
Mmp14WT 5’-
TAGGCCTGGAACATTCTAA
CGATC-3’ 
5’-
CTTTGTGGGTGACCCTGACTT
GC-3’ 
900bp 
Mmp14KO 5’-
TGCGAGGCCAGAGGCCAC
TTGTGT-3’ 
5’-
CTTTGTGGGTGACCCTGACTT
GC-3’ 
950bp 
Mmp14lacZ
(+) 
5’-
ACCTGCGTGCAATCCATCT
TG-3’ 
5’-
ATGATGGCGGAGGGATCGTT
AG-3’ 
350bp 
Mmp14lacZ
(-) 
5’-
TGAGGTGGAAAACACGAC
CAG-3’ 
5’-
ATGATGGCGGAGGGATCGTT
AG-3’ 
180bp 
Mmp15WT 5’-
CCGCCACCAAGCCTCACTG
TCT-3’ 
5’-
AAAGCCACCCACGCCATCAA
AC-3’ 
400bp 
Mmp15KO 5’-
CGCCACCAAGCCTCACTGT
CT-3’ 
5’-
AATTGCTGGGGATGGAGGAA
GGTA-3’ 
470bp 
Mmp15lacZ 5’-
GAGATGGCGCAACGCAAT
TAATG-3’ 
5’-
TGCACGTCCCATTCTCATGC-
3’ 
292bp 
Mmp2WT 5’-
GTGCTACTGCAGGATAAA
CTGATG-3’ 
5’-
CCGGGACAGGAACGTACTGG
GTTC-3’ 
794bp 
Mmp2KO 5’-
GCGCCTACCGGTGGATGT
GGAATGTGT GCG-3’ 
5’-
CCGGGACAGGAACGTACTGG
GTTC-3’ 
310bp 
Mmp3WT 5’-
ACCGGATTTGCCAAGACA
GAGTG-3’ 
5’-
GCATCTCCATTAATCCCTGGT
CC-3’ 
325bp 
Mmp3KO 5’-
AGGATCTCCTGTCATCTCA
CCTTGCTC CTG-3’ 
5’-
AAGAACTCGTCAAGAAGGCG
ATAGAA GGCG-3’ 
492bp 
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Fig. 2-1. 
 
Fig.  2-1. Early postnatal mammary gland morphogenesis program.  
(A) Carmine-stained whole mounts of mammary glands isolated from female mice at P0, P5 and 
P10 (scale bars = 1.0 mm). (B) H&E staining of cross-sections of mammary glands at P0, P5 and 
P10 (scale bar = 200 µm). (C) Immunofluorescence of cytokeratin-18 (CK18), cytokeratin-14 
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(CK14), and α-smooth muscle actin (α-SMA) in P0 versus P10 mammary glands with DAPI-
mediated nuclear counter-staining (scale bars = 50.0 µm). (D) Immunofluorescence of laminin and 
type IV collagen in P0 and P10 mammary glands with DAPI counter-staining (scale bars = 50.0 
µm). (E) Polarized light images of Sirius Red staining of P0, P5 and P10 mammary gland cross-
sections. Insets show the corresponding bright-field images (scale bars = 200 µm). All images are 
representative of 3 replicates. 
 
  
55 
 
Fig. 2-2.  
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Fig.  2-2. In vitro mammary epithelial branching requires MT1-MMP.  
(A) LacZ staining of mammary gland whole mounts isolated from Mt1-mmplacZ/+ mice at P0, P5, 
and P10 (scale bars = 500 µm, 1.0 mm, and 2.0 mm, respectively). The inset shows LacZ staining 
of the wild-type littermate. (B) Paraffin cross-section through P10 Mt1-mmplacZ/+ mammary gland 
with Eosin counterstaining. Images shown in A, B are representative of 3 replicates. (C) qPCR of 
Mt1-mmp at P0, P5 and P10. Results are expressed as mean expression levels ± SEM of P0 (n=4), 
P5 (n=3) and P10 (n=4) relative to Arbp.  **p<0.005, as calculated with an unpaired t-test. (D) 
LacZ staining of Mt1-mmplacZ/+ mammary epithelial organoids cultured in 3-D type I collagen with 
serum-free media containing 50 ng/ml FGF-2 at time 0 and day 5 (scale bar = 100 µm). The inset 
shows LacZ staining of wild-type littermate organoids. (E,F) Phase contrast images of Mt1-mmp+/+ 
and Mt1-mmp-/- mammary epithelial organoids isolated from mice at P10 and embedded within 3-
D type I collagen or 3-D Matrigel for 6 days with 50 ng/ml FGF-2 alone, or with FGF-2 in the 
presence of 5 µm BB-94 (scale bar = 100 µm) . The insets show the mammary epithelial organoids 
at time 0. Results are representative of 5 experiments performed. 
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Fig. 2-3. 
 
Fig.  2-3. Early mammary gland branching proceeds independently of MT1-MMP. 
(A,C,E) Carmine-stained whole mounts of mammary glands isolated from representative P0, P5, 
and P10 Mt1-mmp+/+ vs. Mt1-mmp-/- female mice. (B,D,F). Ductal length quantifications (mm) of 
Mt1-mmp+/+, Mt1-mmp+/- and Mt1-mmp-/- mice at P0, P5, and P10. Results are plotted with mean 
± SEM in Mt1-mmp+/+ (n=4 per time-point), Mt1-mmp+/- mice at P0 (n=9), P5 (n=18) and P10 
(n=9), and Mt1-mmp-/- mice at P0 (n=4), P5 (n=5) and P10 (n=8). Scale bars represent 500 µm, 1.0 
mm, and 2.0 mm, respectively.  
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Fig. 2-4. 
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Fig.  2-4. MT1-MMP-independent epithelial cell sorting, proliferation, senescence and ECM 
organization.  
(A) Immunofluorescence of cytokeratin-18 (CK18), cytokeratin-14 (CK14) and α-smooth muscle 
actin (αSMA) in P0 Mt1-mmp+/+ vs. Mt1-mmp-/- mammary glands with DAPI counter-staining 
(scale bars = 50 µm). (B) Immunofluorescence of CK18 and αSMA (left), E-cadherin and CK14 
(middle), and Zonula occludens (ZO)-1 with DAPI counter-staining (right) in P10 Mt1-mmp+/+ vs. 
Mt1-mmp-/- mammary glands (scale bars = 50 µm). (C) Quantifications of average number of Ki67-
positive cells per field and TUNEL-positive cells per field from immunofluorescence of P5 
mammary glands at 60X magnification (n=2 per genotype). Results are plotted with mean values 
of n>10 fields ± 1 SD. (D) Senescence-associated β-galactosidase (SA-βgal) staining of P5 Mt1-
mmp+/+ vs. Mt1-mmp-/- mammary glands under pH 6.0 conditions (n=2 per genotype, scale bar = 
200 µm).  (E) Immunofluorescence of type IV collagen and laminin in P5 Mt1-mmp+/+ vs. Mt1-
mmp-/- mammary glands with Toto3-mediated nuclear counter-staining (scale bar = 50 µm). (F) 
Polarized light images of Sirius Red staining of P5 Mt1-mmp+/+ vs. Mt1-mmp-/- mammary gland 
cross-sections. Insets show the corresponding bright-field images (scale bar = 200 µm). Type I 
collagen immunofluorescence in P5 wild-type versus knockout mammary glands with DAPI 
counter-staining (scale bar = 50.0 µm). All images are representative of 3 replicates.  
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Fig. 2-5.  
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Fig.  2-5. Early mammary epithelial branching is MT2-MMP-independent.  
(A) Schematic of targeted Mt2-mmplacZ allele. (B) LacZ staining of P0 Mt2-mmplacZ/+ mammary 
gland whole mount. (C) LacZ staining of P10 Mt2-mmplacZ/+ whole mount (left panel). Inset shows 
LacZ staining of wild-type mammary tissue.  In the right panel, a P10 Mt2-mmplacZ/+ gland was 
sectioned and Eosin-stained to highlight luminal epithelial/myoepithelial-positive cells (scale bars 
= 500 µm, 1.0 mm, and 50 µm, respectively). (D) qPCR of Mt2-mmp at P0, P5 and P10. Results 
are expressed as mean ± SEM expression levels at P0 (n=4), P5 (n=3) and P10 (n=4) relative to 
Arbp.  **p<0.001, *p≤0.01.  (E) qPCR of Mt1-mmp and Mt2-mmp levels in P10 wildtype and Mt2-
mmp-/- mammary glands. Results are expressed as mean expression levels ± SEM of 3 replicates 
relative to Arbp. **p<0.001. (F) Carmine-stained mammary gland whole mounts isolated from P0 
Mt2-mmp+/+ and Mt2-mmp-/- mice.  Ductal lengths for P0 Mt2-mmp+/+ (n=6), Mt2-mmp+/- (n=6) 
and Mt2-mmp-/- (n=2) glands are plotted with the mean ± 1 SD. (G) Carmine-stained whole mounts 
of mammary glands recovered from representative Mt2-mmp+/+ and Mt2-mmp-/- mice at P10.  
Ductal lengths for P10 Mt2-mmp+/+ (n=3), Mt2-mmp+/- (n=4) and Mt2-mmp-/- (n=5) glands are 
plotted with mean ± SEM.  (H) Phase contrast images of mammary epithelial organoids isolated 
from mice at P10 and embedded within 3-D type I collagen or 3-D Matrigel in the presence of 50 
ng/ml FGF-2 (scale bars = 100 µm). p values were calculated with unpaired t-tests. Results are 
representative of 2 experiments performed. 
 
  
62 
 
Fig. 2-6.  
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Fig.  2-6. MT1-MMP and MT2-MMP differentially regulate mammary fat pad development. 
(A) Graphical representation of the enriched DAVID Functional Annotation Clusters in P10 Mt1-
mmp-/- mammary gland tissue relative to Mt1-mmp+/+ littermates, with a cartoon illustrating the 
mammary gland region collected for gene expression profiling. (B) Chart of differentially 
expressed genes related to cellular metabolism in the Mt1-mmp-/- gene expression profile, relative 
to Mt1-mmp+/+ littermates, plotted by fold change values (n=2 per genotype). (C) H&E staining of 
fat pad cross-sections from P10 Mt1-mmp+/+ and Mt1-mmp-/- mammary glands. (D) Chart 
illustrating the fold-changes in the metabolism genes depicted in panel B in the P10 Mt2-mmp-/- 
gene expression profile relative to Mt2-mmp+/+ littermates (n=2 per genotype). (E) H&E staining 
of cross-sections from P10 Mt2-mmp+/+ and Mt2-mmp-/- mammary glands. (F) qPCR of 
thermogenic and metabolic genes up-regulated in Mt2-mmp-/- mammary gland stroma relative to 
Mt2-mmp+/+ littermates as normalized to Arbp. Results are expressed as mean values ± 1 SD of 
n=2 mice per genotype. (G) Immunohistochemistry for UCP1 in P10 Mt2-mmp-/- and Mt1-mmp-/- 
mammary gland cross-sections with wild-type littermates (scale bars = 200 µm). Results are 
representative of 3 replicates. (H) qPCR of the genes monitored in panel F in P10 Mt1-mmp-/- 
mammary gland tissue relative to Mt1-mmp+/+ littermates in Mt1-mmp+/+ (n=7) and Mt1-mmp-/-  
(n=5). Results are expressed as mean expression levels ± SEM as normalized to Arbp. **p<0.001, 
*p<0.05. p values were calculated with unpaired t-tests.  
 
 
64 
 
Fig. 2-S1.  
 
 
Fig. 2-S1. Mmp2 and Mmp3 global knockouts establish early postnatal mammary glands. 
(A) qPCR of Mmp2 at P0, P5 and P10 in wild-type mammary glands. Results are expressed as 
mean expression levels ± SEM at P0 (n=4), P5 (n=3) and P10 (n=4) relative to Arbp.  **p<0.001, 
*p<0.05. (B) Carmine-stained whole mounts of mammary glands isolated from P10 Mmp2+/+ vs. 
Mmp2-/- mice (scale bar = 2.0 mm) with quantifications of duct elongation (mm). Results are 
plotted with mean ± SEM for Mmp2+/+ (n=8), Mmp2+/- (n=7) and Mmp2-/- (n=4) mice. (C) qPCR 
of Mmp3 at P0, P5 and P10 in wild-type mammary glands. Results are expressed as mean ± SEM 
for P0 (n=3), P5 (n=3) and P10 (n=4) relative to Arbp. **p<0.001, *p<0.05. (D) Carmine-stained 
whole mounts of P10 mammary glands (scale bars = 1.0 mm) from Mmp3+/- mice (n=7) and  
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Mmp3-/- mice (n=3) with quantification of duct elongation (mm). Results are plotted with mean ± 
SEM. (E) Immunofluorescence of CK18, CK14, and αSMA in P10 Mmp2-/- and Mmp3-/- mammary 
glands with DAPI counter-staining (scale bars = 50 µm). p values were calculated with unpaired 
t-tests. Images shown are representative of 2 replicates.  
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Fig. 2-S2.  
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Fig. 2-S2. MT2-MMP-independent orchestration of mammary epithelial cell organization, 
mammary cell proliferation and ECM. 
(A) Schematic of Mt2-mmp global knockout targeting strategy and the Mt2-mmpflox allele. (B-C) 
Immunofluorescence of CK14, αSMA and E-cadherin in P0 Mt2-mmp+/+ and Mt2-mmp-/- 
mammary glands with DAPI nuclear counter-staining (scale bars = 50 µm). (D) 
Immunofluorescence of CK18, CK14, and E-cadherin in P10 Mt2-mmp+/+ and Mt2-mmp-/- 
mammary glands with DAPI counter-staining. (E) Quantification of average number of Ki67-
positive cells per field and TUNEL-positive cells per field from immunofluorescence of P5 
mammary glands (60X magnification). Results are plotted with mean values of n>10 fields per 
genotype. (F) Immunofluorescence of type IV collagen, laminin, and type I collagen with DAPI 
counter-staining in P5 Mt2-mmp+/+ and Mt2-mmp-/- mammary glands (scale bars = 50 µm). 
Polarized light images of Sirius Red staining of P5 mammary gland cross-sections are also shown. 
Insets show the corresponding bright-field images (scale bar = 200 µm). All images are 
representative of n≥2 replicates. 
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Fig. 2-S3.  
 
Fig. 2-S3. MT1-MMP-dependent regulation of epithelial cell junctions and microvilli in vivo. 
(A) Transmission electron micrographs (TEM) of representative P10 Mt1-mmp+/- and Mt1-mmp-/- 
mammary ducts (15000X) (n=3 per genotype). Arrows denote cell-cell junctions and adjacent 
spaces in Mt1-mmp+/+ ducts with corresponding regions in Mt1-mmp-/- ducts (scale bars = 1 µm). 
(B) TEM of P10 mammary duct microvilli (15000X) with quantification of average number of 
microvilli per µm plotted with mean ± SEM (n=3 per genotype). *p<0.02.  Asterisks mark the 
mammary duct lumen (scale bar = 1 µm). p value was calculated with an unpaired t-test. 
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Fig. 2-S4.  
 
Fig. 2-S4. Mt2-mmp knockout mammary glands maintain global gene expression profile and 
epithelial ultrastructure. 
(A) Charts of the up-regulated and down-regulated genes in P10 Mt2-mmp-/- mammary glands 
relative to Mt2-mmp+/+ mammary glands (n=2 per genotype). (B) TEM of representative Mt2-
mmp+/+ and Mt2-mmp-/- mammary ducts (15000X) (scale bar = 1 µm). Arrows mark corresponding 
cell junctions (n=2 per genotype). (C) TEM of representative P10 mammary duct microvilli 
(15000X) (n=2 per genotype; scale bars = 1 µm). Asterisks mark the mammary duct lumen. 
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Note.  
* This chapter was submitted as a manuscript, entitled: “Functional Roles of MT1-MMP and MT2-
MMP in Early Postnatal Mammary Gland Development,” by Tamar Y. Feinberg, R. Grant Rowe, 
Thomas L. Saunders and Stephen J. Weiss.  
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CHAPTER 3: Periductal Remodeling of the Interstitial Matrix Regulates Mammary Gland 
Morphogenesis  
 
Abstract. 
During puberty, the mouse mammary gland initiates a morphogenetic program wherein 
primordial networks of epithelial tubes elongate and branch into the surrounding mesenchyme. 
Mechanisms underlying this controlled invasion program remain uncharacterized, but mammary 
epithelial cells have been posited to mobilize proteolytic enzymes in order to penetrate 
extracellular matrix barriers in vivo.  Nevertheless, transgenic models have failed to identify 
required proteolytic effectors, raising the possibility of redundant systems, compensatory 
networks or a requirement for heretofore undefined proteinases.  Herein, we demonstrate that the 
membrane-anchored matrix metalloproteinase, MT1-MMP/MMP14, serves as the dominant 
effector of mammary gland branching morphogenesis in vivo.  Unexpectedly, epithelial cell-
specific targeting of Mmp14 fails to impair branching, while deleting Mmp14 expression in the 
periductal stroma ablates morphogenesis coincident with striking defects in type I collagen 
remodeling.  The effects of conditional knockout of stromal cell-derived Mmp14 are 
recapitulated by the in vivo knock-in of MMP14-resistant type I collagen, thereby identifying a 
stromal MMP14-type I collagen axis as the key regulator of morphogenesis. 
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Introduction. 
Epithelial tube formation and branching defines tissue development, function, and 
homeostasis in a variety of organ systems (Affolter et al., 2009; Khokha and Werb, 2011; Varner 
and Nelson, 2014).  The outgrowth of branching epithelial tubules depends on complex reciprocal 
crosstalk between the epithelium and the surrounding mesenchyme for inducing the proliferation, 
signaling and differentiation programs required for tissue morphogenesis (Ochoa-Espinosa and 
Affolter, 2012; Robinson, 2007), yet the relative functions of the epithelial and stromal 
compartments in this dynamic process remain unclear.  Similar to other epithelial organs, 
mammary glands initiate branching programs during late embryogenesis when ectoderm-derived 
epithelial buds mount a coordinated cell invasion program that supports sprout formation into the 
surrounding mesenchyme (Huebner and Ewald, 2014; Robinson, 2007). Unlike most other 
epithelial organs, however, mammary gland branching largely occurs postnatally in concert with 
the onset of puberty where the bi-layered mammary tubules, composed of inner-facing luminal 
epithelial cells and basal-oriented myoepithelial cells, navigate through an interstitial extracellular 
matrix (ECM) dominated by type I collagen-enmeshed fibroblasts and a surrounding adipocyte-
rich mesenchyme (Affolter et al., 2009; Huebner and Ewald, 2014; Khokha and Werb, 2011; 
Robinson, 2007; Varner and Nelson, 2014).  
Evidence culled from in vitro models supports a model where epithelial tubules deploy 
proteolytic enzymes from the matrix metalloproteinase (MMP) family of zinc-dependent 
endopeptidases to remodel interstitial ECM barriers so as to create the microenvironmental 
changes that are permissive for the cellular rearrangements and signaling cascades required for 
branching morphogenesis (Correia et al., 2013; Mori et al., 2009; Mori et al., 2013; Rebustini et 
al., 2009; Weaver et al., 2014). However, extensive analyses of transgenic mouse models have 
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thus far failed to identify any proteolytic enzyme that plays a dominant role in branching, its tissue 
of origin or mechanism of action (Affolter et al., 2009; Huebner and Ewald, 2014; Khokha and 
Werb, 2011; Ochoa-Espinosa and Affolter, 2012; Robinson, 2007; Varner and Nelson, 2014). 
 
Results. 
MMP14 regulates postnatal mammary gland branching morphogenesis in vivo. 
Following the onset of puberty in ~3 week-old female mice, increasing levels of estrogen 
and progesterone stimulate the elongation and bifurcation of a primordial network of branching 
ducts into the surrounding adipocyte-rich mammary stroma (i.e., fat pad) (Huebner and Ewald, 
2014; Khokha and Werb, 2011). By 4 weeks of age, the ductal network increases 2-to-3 fold in 
size and complexity as marked by the progression of the advancing ducts toward the inguinal 
lymph node (Fig. 3-S1 A). By 8-to-10 weeks of age, the mammary epithelium effectively branches 
to the edges of the mammary fat pad to form a complex, arborized tree-like network (Fig. 3-S1 A).  
Coincident with the onset of branching morphogenesis, the postnatal mammary gland is 
known to express several proteolytic enzymes belonging to the matrix metalloproteinase gene 
family, including Mmp2/Gelatinase A, Mmp3/Stromelysin-1 and Mmp13/Collagenase 3, as well 
as two closely related membrane-anchored MMPs, Mt1-mmp/Mmp14 and Mt2-mmp/Mmp15 
(Nielsen et al., 2008; Szabova et al., 2005; Wiseman et al., 2003). However, the relative 
requirements for these proteases in branching morphogenesis in vivo, a process demanding 
coordinated patterns of cell invasion and proliferation, remain undefined. Having confirmed that 
each of these MMPs is expressed in postnatal mammary glands in both 2 week and 4 week -old 
mice (data not shown), we characterized branching morphogenesis in each of the respective global 
knockout mice.  Though MMP2 has been implicated in mammary duct elongation and lateral 
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branching (Wiseman et al., 2003), Mmp2+/+ and Mmp2-/- mammary glands display comparable 
branching structures at the postnatal 4 week time-point (Fig. 3-S1 B). Similarly, whereas recent 
reports have identified protease-dependent as well as protease-independent roles for secreted 
MMP3 in mammary gland development (Correia et al., 2013; Wiseman et al., 2003), Mmp3-/- 
mammary glands establish branching ductal networks indistinguishable from those of Mmp3+/+ 
and Mmp3+/- littermates (Fig. 3-S1 C). Likewise, targeting Mmp13 did not affect morphogenic 
responses in 4 week-old mice (Fig. 3-S1 D).  
Recent studies have identified protease-dependent and protease-independent roles for 
membrane-anchored MMP14 in several developmental processes in vivo, including mesenchymal 
stem cell differentiation (Tang et al., 2013), lung alveolar septal development (Atkinson et al., 
2005; Oblander et al., 2005) and adipocyte differentiation (Chun et al., 2006). Yet, efforts to 
ascertain roles for MMP14 in postnatal mammary gland or epithelial cell branching have relied 
largely on in vitro assay systems (Mori et al., 2009; Mori et al., 2013; Weaver et al., 2014).  Using 
2 week or 4 week -old Mmp14-lacZ knock-in mice (Tang et al., 2013), MMP14 can be detected 
throughout the mammary gland compartment in luminal epithelial cells, myoepithelial cells and 
surrounding stromal cells (Fig. 3-1 A,B). The closely related membrane-anchored matrix 
metalloproteinase, Mt2-mmp/Mmp15, is also enriched in the mammary epithelial compartment as 
visualized in mammary glands isolated from Mmp15-lacZ knock-in mice (Fig. 3-1 C,D; Fig. 3-S2 
A). To begin to address requirements for MMP14 or MMP15 in postnatal mammary gland 
development, glands were next harvested from Mmp14 global knockout mice (Holmbeck et al., 
1999; Zhou et al., 2000). In contrast to the Mmp2, Mmp3 and Mmp13 knockouts, while Mmp14+/+ 
and Mmp14+/- mammary ducts effectively branch through the mammary fat pad toward the 
inguinal lymph node, both 2 week and 4 week -old Mmp14-/- mice fail to mount branching 
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programs and harbor 2-fold and ~7-fold smaller branching networks at 2 weeks and 4 weeks, 
respectively (Fig. 3-1 E; Fig. 3-S2 B,C).  
To characterize the role of MMP15 in mammary gland development, global knockout mice 
were generated wherein exons 4 and 5 of the catalytic domain were flanked by loxP sites using 
homologous recombination and deleted by breeding homozygous Mmp15flox/flox mice with 
germline-specific EIIA-Cre mice (Fig. 3-S2 D). Mmp15-/- mice were born in normal Mendelian 
ratios and remain viable throughout adulthood. However, unlike Mmp14 global knockouts, 
mammary glands isolated from 4 week-old Mmp15-/- mice mount a branching program 
indistinguishable from littermate controls (Fig. 3-1 F).  Hence, only Mmp14-/- mammary glands 
display marked defects in branching morphogenesis.  However, the impaired sexual development 
of Mmp14-/- mice (Holmbeck et al., 1999; Zhou et al., 2000) precludes attempts to assign definitive 
mammary gland-autonomous roles for the proteinase in branching morphogenesis. 
 
Mammary gland branching proceeds independently of epithelial cell-derived MMP14 in 
vivo. 
Current paradigms hold that epithelial cell-derived proteolytic machinery directs mammary 
gland branching morphogenesis (Inman et al., 2015; Khokha and Werb, 2011; Mori et al., 2009; 
Mori et al., 2013; Varner and Nelson, 2014; Weaver et al., 2014).  As such, Mmp14-floxed mice 
were crossed with a transgenic line wherein Cre recombinase expression is largely restricted to the 
postnatal mammary epithelium, i.e., MMTV-Cre (line A) (Wagner et al., 2001), with epithelial 
cell-specific targeting confirmed by breeding MMTV-Cre expressing mice into a Rosa26R reporter 
background (Soriano, 1999) (Fig. 3-2 A). Unexpectedly, however, despite achieving >90% 
excision of mammary epithelial cell-derived Mmp14 (Fig. 3-2 B), MMTV-Cre+/-Mmp14fl/fl mice 
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mount a mammary gland branching program that is comparable in complexity, duct elongation 
and branch points to Mmp14fl/fl controls as assessed in either 4 week or 8 week –old mice (Fig. 3-
2 C,D; Fig. 3-S3 A,B). Furthermore, using MMTV-Cre+/-Mmp14fl/flRosa26R+/loxP mice to 
differentially track Cre-targeted (i.e., Mmp14+/- and Mmp14-/-) versus non-targeted epithelial (i.e., 
Mmp14+/+) cells, we fail to observe a competitive advantage for Mmp14-expressing cells in duct 
formation (Fig. 3-S3 C).  Nevertheless, it remains possible that a small sub-population of non-Cre-
targeted cells serve as leader-like tip cells that rescue the branching program (Weavers and Skaer, 
2014).  As such, to unequivocally rule out a required role for epithelial cell-derived MMP14 in 
branching, ductal fragments were harvested from Gfp+/-Mmp14+/- or Gfp+/-Mmp14-/- donor mice 
and transplanted into the cleared mammary fat pads of wild-type recipients (Fig. 3-2 E). Despite 
the marked impact of global Mmp14 deletion on mammary gland branching morphogenesis, Gfp+/-
Mmp14+/- and Gfp+/-Mmp14-/- ductal fragments form comparable branching networks at 6-8 weeks 
post-transplantation (Fig. 3-2 F). Further, the established ducts display normal epithelial cell 
organization as marked by myoepithelial cell-associated cytokeratin-5 (CK5) and luminal 
epithelial cell-associated cytokeratin-18 (CK18) (Fig. 3-2 G) as well as comparable levels of the 
luminal epithelial cell adherens junction protein, E-cadherin (Fig. 3-2 G), and the tight junction 
protein, zonula occludens (ZO)-1 (Fig. 3-2 G) (Huebner and Ewald, 2014). Hence, contrary to 
current dogma, epithelial cell-derived MMP14 is not required for mammary gland branching 
morphogenesis in vivo.  A compensatory role for MMP15 was also ruled out by demonstrating 
normal branching in MMTV-Cre+/-Mmp14fl/flMmp15fl/fl mice (Fig. 3-S3 D,E). 
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Stromal cell-derived MMP14 regulates branching morphogenesis in vivo. 
The inability of Mmp14 global knockouts to mount a mammary gland branching program, 
coupled with the fact that Mmp14 expression is not restricted to the epithelial compartment, but 
also extends into the periductal stroma (Fig. 3-S4 A), raises the possibility that the postnatal 
branching phenotype might result from defects outside the ducts themselves. Mmp14 was therefore 
targeted alternatively in the mammary stroma by crossing Mmp14fl/fl mice with a Dermo1/Twist2-
Cre expressing knock-in line, wherein Cre expression is largely confined to mesenchymal cell 
populations (Tang et al., 2013). As expected, Dermo1-Cre-expressing mice crossed onto a 
RosamTmG background confirm widespread Cre expression in the mammary stromal cell 
compartment [with green fluorescence highlighting the periductal fibroblasts and surrounding 
mammary adipocytes, and red fluorescence chiefly restricted to the mammary epithelium (Fig. 3-
3 A).  Stromal targeting in Dermo1-Cre+/-Mmp14fl/fl epithelium-free mammary gland tissue 
resulted in > 90% excision of the Mmp14 locus at the mRNA level (Fig. 3-3 B) with near complete 
excision of MMP14 protein expression (Fig. 3-3 C). Remarkably, as these mice age, Dermo1-
Cre+/-Mmp14fl/fl mammary glands fail to undergo postnatal branching by either 4 or 8 weeks of 
age (Fig. 3-3 D; Fig. 3-S4 B,C). Mammary gland cross-sections of the Dermo1-Cre+/-Mmp14fl/fl 
mammary glands reveal an expansion of periductal fibroblast-like cells surrounding the truncated 
mammary epithelial ducts (Fig. 3-S4 D,E), and a coincident decrease in adipocyte cell size (Fig. 
3-S4 D). While the mammary gland fat pad can, under specific circumstances, regulate branching 
morphogenesis (e.g., via PPARϒ-dependent pathways or leptin secretion) (Hu et al., 2002; Wang 
et al., 2013), neither Pparg, Cebpa, Cebpb, nor Leptin expression are affected in Dermo1-Cre+/-
Mmp14fl/fl mice. Likewise, specific targeting of adipocyte Mmp14 expression using Adipoq-Cre 
mice (Wang et al., 2013)  – though decreasing adipocyte size to a degree similar to that observed 
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in Dermo1-Cre+/-Mmp14fl/fl mice (Fig. 3-S4 F) – does not impact mammary gland morphogenesis 
(Fig. 3-S4 G).  Interestingly, Dermo1-Cre+/-Mmp14fl/fl ducts display unaltered luminal epithelial 
cell and myoepithelial cell organization, as defined by CK18 and CK5 expression, respectively, 
and comparable E-cadherin localization and abundance (Fig. 3-3 E), suggesting the preservation 
of wild-type epithelial cell organization and structure.  Nevertheless, Dermo1Cre+/-Mmp14fl/fl 
mammary glands display widespread decreases in proliferation (determined by Ki67 
immunohistochemistry) in both the epithelial and stromal cell compartments (Fig. 3-3 F). Finally,  
to rule out possible confounding effects on branching arising as a consequence of Dermo1-Cre-
mediated Mmp14 deletion in stromal cell populations residing in other organ systems, intact 
mammary glands recovered from Dermo1-Cre+/-Mmp14fl/fl, Dermo1-Cre+/-Mmp14+/+, and 
Mmp14fl/fl donors were transplanted into syngeneic, adult wild-type recipients, and mammary 
gland branching monitored (Fig. 3-S5 A). By 5 weeks post-transplantation, control Dermo1-Cre+/-
Mmp14+/+ or Mmp14fl/fl mammary glands branch effectively towards the edges of the transplanted 
glands (Fig. 3-S5 B). By contrast, the Dermo1-Cre+/-Mmp14fl/fl transplants remain unable to 
undergo branching (Fig. 3-S5 B), confirming an organ-autonomous role for stromal cell-derived 
MMP14.  
The combination of underdeveloped mammary stroma, widespread proliferation defects, 
and a concomitant block in postnatal mammary duct advancement in Mmp14-targeted mice could 
potentially be explained as a consequence of defects in the expression of stromal cell-derived 
growth factors or signaling components critical for postnatal mammary gland branching 
(Robinson, 2007). Gene expression profiling of tissues isolated from mammary glands of 
Dermo1Cre+/-Mmp14fl/fl and Mmp14+/+ mice were therefore carried out, revealing >1000 transcript 
changes (using a 2-fold enrichment cutoff; p<0.05; n=3 per genotype) with 757 genes down-
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regulated and 257 genes up-regulated in the targeted mice. Functional annotation clustering and 
enrichment analysis of these data (DAVID Bioinformatics Resource) indicate wide-ranging effects 
on Gene Ontology (GO) categories, including those associated with cell adhesion, plasma 
membranes and chemotaxis, gland morphogenesis and epithelial cell development (Fig. 3-3 G).  
In terms of stromal cell gene expression, however, growth factors and signaling molecules that 
have been previously implicated in mammary gland branching (Robinson, 2007), including 
cytokines (e.g., Hgf, Igf1, Fgf2, Fgf7, Fgf10, Egf, Tgfa and Tgfb), Wnt family members, and growth 
factor/signaling receptors (e,g, Esr1, Pgr, Vdr, Met, Ghr, Fgfr2, Egfr, Erbb2, Erbb3 and Src) 
(Robinson, 2007) are not altered significantly (Fig. 3-S6 A,B). Further, despite recent reports that 
MMP14 regulates cellular proliferation and tissue development by engaging a cellular senescence-
associated gene program (Gutierrez-Fernandez et al., 2015), senescence-associated β-gal (SA-
βgal) expression levels are globally reduced, rather than increased, in the mammary epithelium 
and surrounding stroma of Dermo1-Cre+/-Mmp14fl/fl mammary tissue relative to wild-type 
littermates (Fig. 3-S6 C). While other stromal cell types have been shown to play critical roles in 
postnatal mammary gland branching, including macrophages, vascular endothelial cells and 
lymphatic endothelial cells (Inman et al., 2015; Khokha and Werb, 2011; Varner and Nelson, 
2014), macrophage distribution is unaffected in Dermo1-Cre-/- Mmp14fl/fl glands in tandem with 
normal, if not increased, numbers of blood vessels and lymphatics (Fig. 3-S7 A,B). Further, 
specific targeting of macrophage Mmp14 or endothelial Mmp14/Mmp15, using Csf1r-Cre or Tie2-
Cre crosses (Deng et al., 2010; Landskroner-Eiger et al., 2015), respectively, has no effect on 
mammary gland branching (Fig. 3-S8 A,B).   
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Stromal cell-derived MMP14 regulates mammary gland extracellular matrix remodeling in 
vivo. 
In normal mammary glands, ductal networks are surrounded by a sleeve of type I collagen 
fibrils (Fig. 3-4 A) (Huebner and Ewald, 2014; Khokha and Werb, 2011).  Remarkably, when 
Mmp14 is targeted in the stromal cell compartment, periductal type I collagen protein levels as 
assessed by Sirius Red/polarized light analysis are increased more than 10-fold (Fig. 3-4 A).  
Further, the basement membrane, a specialized form of ECM that subtends the ductal epithelial 
cells (Huebner and Ewald, 2014; Khokha and Werb, 2011; Varner and Nelson, 2014), display a 
~2-fold increase in type IV collagen levels (Fig. 3-4 B).  When assessed by transmission electron 
microscopy, massive increases in type I collagen fibrils are readily confirmed in tandem with a 
distinctively thickened basement membrane (Fig. 3-4 C).  As analyses of differentially expressed 
gene products demonstrate that Mmp14 targeting down-regulates, rather than upregulates, 
interstitial and basement membrane-associated transcripts (Fig. 3-4 D), we sought to determine 
whether the mammary gland ECM undergoes active proteolytic remodeling during branching 
morphogenesis. Interestingly, despite the fact that MMP14 is a potent pericellular collagenase 
(Chun et al., 2006; Tang et al., 2013), mammary gland ductal morphogenesis has not previously 
been linked to collagenolytic remodeling in the in vivo setting.  To this end, type I collagen 
proteolysis was assessed in situ with triple-helical, fluorescently conjugated, collagen mimic 
peptides (CF-CMPs) (Li et al., 2012). Following heat-mediated denaturation into their single-
strand form, CF-CMPs stably hybridize to proteolyzed collagen to reform triple helices that 
facilitate fluorescent labeling of degraded collagen in vivo (Fig. 3-4 E) (Li et al., 2012). Application 
of CF-CMPs to mammary gland tissues recovered from control Mmp14fl/fl mice reveals dense 
fields of extracellular degraded collagen fibrils along developing mammary epithelial ducts (Fig. 
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3-4 F), thereby confirming that ductal morphogenesis engages a matrix remodeling program.  In 
marked contrast, almost no collagen degradation products surround ductal networks in 
Dermo1Cre+/- Mmp14fl/fl glands (Fig. 3-4 F).  Taken together, these data support a previously 
undescribed role for MMP14 in remodeling the periductal ECM of branching mammary glands.  
 
An Mmp14-type I collagen axis controls mammary gland branching morphogenesis. 
The increased collagen content of Mmp14-targeted glands establishes a correlation 
between MMP14-dependent collagenolysis and branching, but falls short of establishing a causal 
relationship.  Nevertheless, accumulating evidence indicates that type I collagen organization, 
structure and density can each impact mammary gland branching (Brownfield et al., 2013; Guo et 
al., 2012; Nguyen-Ngoc et al., 2012). As type I collagen is the most markedly elevated ECM 
protein in stromal cell Mmp14-targeted mice, we sought to establish a direct requirement for type 
I collagen remodeling in branching morphogenesis by using a mouse knock-in model wherein the 
collagenase cleavage site in type I collagen is mutated, rendering the molecule collagenase-
resistant (Hotary et al., 2003; Liu et al., 1995). Though Col1a1r/r, Col1a1r/+ and Col1a1+/+ 
mammary glands express comparable protein levels of MMP14 (Fig. 3-5 A), interstitial collagen 
levels surrounding Col1a1r/r mammary ducts are increased dramatically relative to Col1a1+/+ or 
Col1a1r/+ mammary tissues (Fig. 3-5 B). Likewise, as assessed by transmission electron 
microscopy, while Col1a1+/+ mammary ducts are surrounded by bundles of sparse or loosely-
packed interstitial fibrils (Fig. 3-5 C), Col1a1r/r ducts are ensheathed by an almost 100-fold 
increase in collagen bundles (Fig. 3-5 C) similar to that observed in Dermo1-Cre+/- Mmp14fl/fl mice 
(Fig. 3-4 C). Interestingly, Col1a1r/r mammary ducts are also ensheathed by a ~5-fold thicker 
basement membrane despite unchanged type IV collagen and laminin protein levels (Fig. 3-5 C,D). 
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Most importantly, coincident with these changes in the periductal ECM, Col1a1r/r mice display 
profound defects in ductal branching relative to wild-type littermates with attendant decreases in 
mammary epithelial cell and stromal cell proliferation and without changes in cellular senescence, 
in a manner similar, if not identical, to that observed in Mmp14-targeted mice (Fig. 3-5 E-G; Fig. 
3-S9 A,B).  Hence, by rendering type I collagen alone resistant to MMP14-dependent hydrolysis, 
we recapitulate the key phenotypic features observed in Mmp14-deficient mammary gland stroma, 
thereby identifying the MMP14-type I collagen axis as a dominant regulator of the branching 
morphogenetic program that characterizes postnatal mammary gland development. 
 
Discussion. 
Early studies demonstrated that periductal fibroblasts play critical roles in depositing ECM 
in the postnatal mammary gland (Keely et al., 1995), yet the notion that mammary stromal cells 
control ECM remodeling to create conditions permissive for branching morphogenesis has not 
been considered previously.  Largely, this is due to the prevailing notion that epithelial tubules 
themselves remodel the surrounding stromal environment while the mammary stromal cells more 
passively supply the necessary instructive signals for morphogenesis (Correia et al., 2013; Inman 
et al., 2015; Khokha and Werb, 2011; Mori et al., 2009; Mori et al., 2013; Rebustini et al., 2009; 
Weaver et al., 2014; Wiseman et al., 2003). Using in vivo models, we alternatively demonstrate 
that MMP14 arising from the periductal stromal compartment regulates postnatal mammary gland 
branching through a requisite process involving remodeling of the periductal type I collagen 
matrix. Though MMP14 can also serve as an upstream activator of MMP2 and MMP13 zymogens 
(Rowe and Weiss, 2009), neither of these secreted proteinases play an accessory role here.  At first 
glance, the widespread defects in mammary gland proliferative responses and terminal end bud 
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formation, coupled with global changes in gene expression in Mmp14 conditional knockouts, 
suggest that the proteinase likely regulates events that extend beyond type I collagenolysis per se. 
Nevertheless, it is remarkable that the Col1a1r/r mammary glands, despite expressing wild-type 
MMP14 levels, display defects in branching and proliferation similar to that observed in stromal 
Mmp14-targeted glands.  Taken together, these data demonstrate that inhibiting interstitial type I 
collagen turnover alone exerts far reaching effects on both primary and lateral branching programs, 
a finding consistent with the fact that type I collagen density, rigidity and fibril alignment all 
impact cell function (Brownfield et al., 2013; Guo et al., 2012; Nguyen-Ngoc et al., 2012; Riching 
et al., 2014). 
 Early studies with Mmp14 global knockout mice uncovered more subtle roles for MMP14 
in the morphogenic responses of other epithelial organ systems, namely the kidney, salivary glands 
and lung (Atkinson et al., 2005; Oblander et al., 2005; Riggins et al., 2010). Yet, we find that 
deletion of stromal cell-derived Mmp14 does not significantly impact kidney morphogenesis (Fig. 
3-S10 A), nor does the absence of stromal Mmp14 impact the overall branching architecture of the 
sublingual salivary gland (Fig. 3-S10 B). Interestingly, with regard to each of these morphogenetic 
programs, the bulk of their respective branching programs occur in utero at a time when type I 
collagen levels are maintained at low levels (Carver et al., 1993; Mays et al., 1988; Van Exan and 
Hardy, 1984). As such, we posit that there is little requirement for the MMP14/type I collagen 
remodeling axis during the early development of most branching networks.  Importantly, the 
embryonic and early postnatal mammary gland branching programs that occur in mesenchymal 
tissues characterized by sparsely populated networks of type I collagen, proceed independently of 
MMP14 as well (Chapter 2). Interestingly, the lung also undergoes a distinct phase of postnatal 
morphogenesis marked for alveolar development (Atkinson et al., 2005) wherein we find that 
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Dermo1-Cre+/-Mmp14fl/fl lungs display decreases in alveologenesis (Fig. 3-S10 C). However, as 
this morphologic defect fails to coincide with an increase in interstitial ECM (Fig. 3-S10 D), it 
appears that stromal cell-derived MMP14 regulates postnatal lung morphogenesis through a 
distinct, but as yet, uncharacterized mechanism.  
Taken together, we demonstrate that elongating mammary ducts are completely dependent 
upon the surrounding stromal cells to remodel the periductal type I collagen network.  In the 
absence of the type I collagenolysis, the basement membrane thickens in a process that cannot be 
reversed by epithelial cell-derived MMP14 or MMP15, despite their known ability to remodel type 
IV collagen as well as laminin during tissue-invasive processes (Hotary et al., 2006; Ota et al., 
2009).  Interestingly, cancer cell invasion has been linked to fibroblast-mediated remodeling of the 
interstitial matrix (Albrengues et al., 2014; Gaggioli et al., 2007), but in preliminary studies, we 
find that mammary carcinoma cells themselves mobilize MMP14 and MMP15 to mediate invasion 
and metastasis, a finding in keeping with the ability of cancer cells to establish direct contacts with 
type I collagen after perforating basement membrane barriers (Rowe and Weiss, 2009).  In this 
regard, developmental and neoplastic “solutions” for traversing tissue barriers in the postnatal state 
– though commonly viewed as conserved – appear distinct, with controlled mammary 
morphogenetic programs remaining completely reliant on MMP14-mediated, stromal cell-
dependent remodeling. 
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Experimental procedures.  
Mouse strains.  
Mmp14lacZ/+ mice (Tang et al., 2013) were bred onto a C57BL/6J background (Jackson 
Laboratory, 000664). To generate Mmp15lacZ/+ mice, C57BL/6J Mmp15lacZ/+ ES cell clones from 
the UC Davis KOMP Repository (KOMP) [MGI allele: Mmp15tm1a (KOMP) wtsi, clone: 
EPD0097_3_B09] were introduced into albino C57BL/6J host blastocysts.  Chimeras were mated 
with C57BL/6J mice to test for germline transmission. Mmp15lacZ/+ mice were bred and maintained 
on a C57BL/6J background. Mmp14+/- mice (Holmbeck et al., 1999) were mated n>5 generations 
onto a FVB background or bred with a transgenic mouse line expressing enhanced GFP under the 
control of a chicken beta-actin promoter (FVB background, Jackson Laboratories, 003291). Mmp3-
/- mice (C57BL/6J background), Mmp13-/- (C57BL/6J background), and Mmp2-/- mice (129/SvEv 
background, Taconic) were genotyped as described (Nielsen et al., 2008; Wiseman et al., 2003) . 
To generate Mmp15 global knockout (Mmp15-/-) mice, 129/SVJ ES cells were electroporated with 
a targeting vector for Mmp15 containing a neomycin selection cassette flanked by FRT sites 
wherein exons 4 and 5 of the catalytic domain were floxed by loxP sites (Fig. 3-S2 D). Following 
neomycin selection, ES cell recombinants were injected into gestation day E3.5 C57BL/6J 
blastocysts and subsequently injected into the uteri of pseudo-pregnant FVB mice. Male chimeras 
were mated to C57BL/6J females, and heterozygous agouti offspring carrying the Mmp15flox allele 
were mated to C57BL/6J FlpE mice to remove the neomycin selection cassette. The resultant 
Mmp15fl/fl mice were crossed to C57BL/6J EIIA-Cre mice for germline deletion of Mmp15, with 
Mmp15+/- mice backcrossed into C57BL/6J mice (n>10 generations).  Mmp14flox mice were 
generated as described previously (Tang et al., 2013) and maintained on either a C57BL/6J or FVB 
background (n>10 generations). MMTV-Cre transgenic mice (line A)(Wagner et al., 2001) 
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(Jackson Laboratory, 003551) on a congenic FVB background (n>10 generations) were mated 
with Mmp14fl/fl mice (FVB background) or Mmp14fl/flMmp15fl/fl mice (FVB background, n>5 
generations). Dermo1/Twist2-Cre mice (Tang et al., 2013) (Jackson Laboratory, 008712) were 
bred with Mmp14fl/fl mice (C57BL/6J background) and maintained on a congenic C57BL/6J 
background or crossed onto a mixed C57BL/6J:FVB background. Col1a1r/r mice (Liu et al., 1995) 
were maintained on a 129/SvEv background. Tie2-Cre transgenic mice (Jackson Laboratory, 
004128) and Csflr-Cre transgenic mice (Jackson Laboratory, 021024) were maintained on mixed 
C57BL/6J:FVB and congenic FVB backgrounds, respectively. All mouse work was performed 
with IACUC approval at the University of Michigan. 
 
Genotyping Primers. 
Genotyping was performed on purified chromosomal DNA prepared from tail tips. 
Genotyping primers include the following. For Mt1-mmp/Mmp14 global knockout litters: 
Mmp14WT-F: 5’-CTA GGC CTG GAA CAT TCT AAC GAT C-3’ and Mmp14-R: 5’-CTT TGT 
GGG TGA CCC TGA CTT GC-3’; Mmp14KO-F:  5’-GTG CGA GGC CAG AGG CCA CTT GTG 
T-3’ and Mmp14-R: 5’-CTT TGT GGG TGA CCC TGA CTT GC-3’. For Mmp14lacZ litters: 
Mmp14lacZ (+)-F: 5’-ACCTGCGTGCAATCCATCTTG-3’ and Mmp14lacZ (+)-R: 5’-
ATGATGGCGGAGGGATCGTTAG-3’; Mmp14lacZ (-)-F: 5’-
TGAGGTGGAAAACACGACCAG-3’ and Mmp14lacZ (-)-R: 5’-
ATGATGGCGGAGGGATCGTTAG-3’. For Mmp15-targeted litters: Mmp15loxA -F: 5’-CCG CCA 
CCA AGC CTC ACT GTC T-3’ and Mmp15loxB-R: 5’-AAA GCC ACC CAC GCC ATC AAA C-
3’; Mmp15KO-F: 5’-CGC CAC CAA GCC TCA CTG TCT-3’ and Mmp15KO-R: 5’-AAT TGC 
TGG GGA TGG AGG AAG GTA-3’. For Mmp15lacZ litters: Mmp15lacZ-F: 5’-GAG ATG GCG 
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CAA CGC AAT TAA TG-3’ and Mmp15lacZ-R: 5’-TGC ACG TCC CAT TCT CAT GC-3’. For 
Mmp2 global knockout litters: Mmp2WT- F: 5’-GTGCTACTGCAGGATAAACTGATG-3’ and 
Mmp2WT- R: 5’-CCGGGACAGGAACGTACTGGGTTC-3’; Mmp2KO-F: 5’-
GCGCCTACCGGTGGATGTGGAATGTGT GCG-3’ and Mmp2KO-R: 5’-
CCGGGACAGGAACGTACTGGGTTC-3’. For Mmp3 global knockout litters: Mmp3WT-F: 5’-
ACC GGA TTT GCC AAG ACA GAG TG-3’ and Mmp3WT-R: 5’-GCA TCT CCA TTA ATC 
CCT GGT CC-3’; Neo-F: 5’-AGGATCTCCTGTCATCTCACCTTGCTC CTG-3’ and Neo-R: 5’-
AAGAACTCGTCAAGAAGGCGATAGAA GGCG-3’. Mmp13 genotyping was carried out as 
described (Nielsen et al, 2008). For Mmp14flox litters: Mmp14flox-F: 5’- GTT GAG GCA GGA 
GGA TTG TGA GTT-3’ and Mmp14flox-R: 5’- CCT GGA AAA GTG GGC GAG AAG-3’; CreU:  
5’-AGG TGT AGA GAA GGC ACT TAG C-3’ and CreD: 5’-CTA ATC GCC ATC TTC CAG 
GAG G -3’; iCre-F: 5’-CCG TTT GCC GGT CGT GGG-3’ and iCre-R: 5’-CGA ATA TCC TGG 
CAG CGA TC-3’.  
 
Mammary gland whole mount preparation, imaging and morphometric analysis. 
Inguinal mammary glands were harvested, mounted on glass slides, stained with Carmine 
Alum, and processed as described previously (Wiseman et al., 2003). Whole mounts were imaged 
with a Leica MZFLIII dissecting microscope.  Adobe Photoshop and ImageJ were used to process 
images. 
 
RNA extraction and gene expression analysis. 
Inguinal mammary gland tissue was flash frozen in liquid nitrogen, and homogenized in 
TRIzol (Ambion, Life Technologies). Mammary epithelial cells were isolated from inguinal 
88 
 
mammary glands as described (Mori et al., 2013), washed with PBS and directly lysed in TRIzol. 
Total RNA was extracted and purified using QIAGEN RNeasy Mini-kit columns (QIAGEN, 
74104). RNA quality was confirmed using an Agilent 2100 Bioanalyzer and samples profiled on 
Affymetrix Mouse MG–430 PM expression array strips. Expression values for each probe set were 
calculated using a robust multi-array average (RMA) (Irizarry et al., 2003) and filtered for genes 
with a greater than 2-fold change.  
 
Quantitative real-time PCR. 
Complementary cDNA was prepared from total RNA with the Invitrogen SuperScript II 
First-Strand Synthesis System (11904-018). Quantitative reverse-transcription PCR was 
performed with SYBR Green (Applied Biosystems) using Gapdh or Arbp/Rplp0 for reference gene 
expression. Quantitative PCR primers include the following: Gapdh-Forward: 5’-
TGAAGCAGGCATCTGAGGG-3’ and Gapdh-Reverse: 5’-CGAAGGTGGAAGAGTGGGAG-
3’; Arbp-Forward: 5’-CACTGGTCTAGGACCCGAGAA-3’ and Arbp-Reverse: 5’-
AGGGGGAGATGTTCAGCATGT-3’; Mmp14-Forward: 5’-
CTGCCATTGCCGCCATGCAAAA-3’ and Mmp14-Reverse: 5’-
TGGCGTGGCACTCTCCCATACT-3’; Mmp15-Forward: 5’-ACATGTCCACCATGCGCTCT-
3’ and Mmp15-Reverse: 5’-TACCATGATGTCAGCCTCC-3’; Mmp2-Forward: 5’-
TCTGGAGCGAGGATACCCCAA-3’ and Mmp2-Reverse: 5’-
TTCCAGGAGTCTGCGATGAGC-3’; Mmp3-Forward: 5’-GTT CCT GAT GTT GGT GGC TT-
3’ and Mmp3-Reverse: 5’-AGC CTC TCC TTC AGA GAT CC-3’; Mmp13-Forward: CTT TTC 
CTC CTG GAC CAA ACT and Mmp13-Reverse: TCA TGG GCA GCA ACA ATA AA. Data 
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reported as the mean expression levels with error bars representing the standard error (SEM). p 
values were calculated with an unpaired t-test with two tails.  
 
Western Blotting. 
Inguinal mammary gland tissue was flash frozen in liquid nitrogen and homogenized in 
lysis buffer. Protein concentrations were determined with the Pierce BCA Protein Assay Kit 
(Thermo Scientific), and extracts (40-to-50 µg) were analyzed by standard techniques with 
horseradish peroxidase–conjugated secondary antibodies (Santa Cruz Biotechnology).  
 
LacZ and cellular senescence staining. 
Inguinal Mmp14lacZ/+ mammary glands were fixed at 4oC in PBS containing 2% 
paraformaldehyde and 0.2% glutaraldehyde. Mmp15lacZ/+ glands were alternatively fixed in 4% 
paraformaldehyde. Tissues were either transferred to 30% sucrose/PBS (w/v) for frozen sections, 
or incubated for 18-24 h in PBS containing 4 mM potassium hexacyanoferrate (III), 4 mM 
potassium hexacyanoferrate (II) trihydrate, 2 mM MgCl2, 0.2% NP-40, 0.1% sodium deoxycholic 
acid and 1 mg/ml Xgal.  Stained tissues and whole mounts were post-fixed with 10% formalin-
phosphate. Senescence-associated β-gal staining was carried out on mammary gland cryo-sections 
as described for the Senescence β-galactosidase Staining Kit (Cell Signaling, 9860). Sections were 
stained overnight (12-to-15 h) in a non-humidified 37oC incubator, counter-stained with Eosin, 
and dehydrated with a graded ethanol/xylene series before mounting with Permount Toluene 
Solution (Fisher Scientific, SP15-100).  
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Immunofluorescence, immunohistochemistry and morphometric analysis. 
Mammary gland tissue was fixed in 10% formalin-phosphate at 4º C overnight and either 
dehydrated in an ethanol/paraffin series for paraffin embedding or transferred to 30% (w/v) 
sucrose/PBS for OCT embedding.  Following rehydration with a xylene/ethanol series and 
microwave-mediated antigen retrieval, paraffin sections were permeabilized with 0.3% Triton X-
100/PBS, and blocked for 2 hours prior to primary antibody addition. Samples were incubated 
overnight at 4oC with antibodies directed against [ZO-1 (Invitrogen, 617300), E-cadherin (BD 
Transduction Laboratories, 610181), Cytokeratin-5 (Covance, PRB-160p), Cytokeratin-14 
(Covance, PRB-155P, Clone AF64), Cytokeratin-18 (Abcam, ab668), Ki67 (Abcam, ab15580), 
GFP (Abcam, ab290), α-smooth muscle actin (Abcam, ab5694), and vimentin (Abcam, ab20346)]. 
Frozen sections were used for immunostaining of basement membrane (BM), macrophages (F4/80, 
ab6640, Abcam), blood vessels (CD31, 553370, BD Biosciences) and lymphatics (Lyve-1, 
ab14917, Abcam). For BM staining, frozen sections were permeabilized with 0.5% Triton X-100/ 
PBS, incubated in blocking buffer (10% FBS/1% BSA/PBS) for 2 hours, and incubated with 
primary antibodies directed against type IV collagen (Millipore, AB-769) or laminin (Sigma-
Aldrich, L9393) overnight at 4oC. Following primary antibody incubations, sections were 
incubated with Alexa-488 or Alexa-594-conjugated secondary antibodies (Invitrogen Molecular 
Probes).  Nuclear counter-staining was carried out with either Toto3 (Invitrogen Molecular Probes) 
or 4, 6-diamidino-2-phenylindole (DAPI). All fluorescence images were acquired with an 
Olympus FluoView FV500 laser scanning confocal microscope and analyzed with Adobe 
Photoshop and ImageJ software. For immunohistochemistry, endogenous peroxidase activity was 
blocked with H2O2 and tissues sections developed with the Vectastain ABC (Vector Laboratories, 
PK-6100) and DAB kits (Vector Laboratories, SK-4100).  
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Mammary tissue and whole gland transplants. 
Mammary tissue fragment transplants were carried out as described previously (Robinson 
et al., 2000). In brief, inguinal mammary glands of recipient mice (postnatal day 21, 10-to-11 
grams body weight) were “cleared” of their endogenous epithelium by surgical removal of the 
mammary gland tissue between the cauterized femoral artery and the inguinal lymph node. The 
isolated epithelium-containing mammary tissue was mounted on glass slides for whole mount 
Carmine staining to confirm clearing. Single 1-to-2 mm fragments of donor mammary epithelium-
containing tissue from 2-week-old mice were transplanted into the remaining epithelium-free 
recipient mammary gland for in vivo growth. Transplants were allowed to branch in vivo for 6-to-
8 weeks prior to whole mount and histological assessments. For transplant of whole mammary 
glands, the inguinal mammary glands from 6-to-8 week-old recipient mice were excised in entirety 
following cauterization of the femoral artery, in order to remove the host epithelium, and the 
isolated tissue was mounted on glass slides for whole mount Carmine staining to confirm clearing. 
Intact whole mammary glands from 5-to-10 day-old donor mice were sutured onto the gland-free 
subcutaneous surface. The transplants were allowed to branch in vivo for 4-to-5 weeks prior to 
whole mount assessments. Athymic nude mice (Harlan) were used as recipients for the transplant 
of Gfp+/-Mmp14+/- and Gfp+/-Mmp14-/- ductal fragments. Syngeneic C57BL/6J mice (Jackson 
Laboratory) were used as recipients for the transplant of Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl 
mammary glands.  
 
CMP peptide assay. 
Mammary gland cryosections (10-to-30 µM thickness) were washed in 1X PBS and 
blocked in 1% BSA/ 3% goat serum/ PBS at room temperature for 1 hour. During blocking, heat-
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activated fluorescently labeled CMP stock solution (CF-CMP [CF-G-(GPO)9]) and sequence-
scrambled control peptide stock solution (Li et al., 2012)  were diluted to 10-to-30 µM in PBS and 
incubated at 70oC for 10 minutes, followed by a brief (10-to-30 second) incubation on ice before 
immediate application to blocked tissue for overnight incubation at 4oC while protected from light. 
Following washes with PBS, nuclei were counterstained with DAPI and sections were mounted 
with Prolong Gold anti-fade reagent.  
 
Tissue preparation for TEM. 
Samples were fixed (1% glutaraldehyde/1% tannic acid/0.1 M Sorensen’s buffer, pH 7.2) 
and post-fixed with 1% osmium tetroxide prior to embedding in EMbed 812 epoxy resin (Electron 
Microscopy Sciences).  Thin sections (70 nm) were post-stained with uranyl acetate and Reynolds 
Lead Citrate, and imaged with a JE0L JEM-1400 Plus electron microscope. Images were recorded 
digitally using a Hamamatsu ORCA-HR digital camera system, operated using AMT software 
(Advanced Microscopy Techniques Corp., Danvers, MA).  
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Fig. 3-1. 
 
Fig. 3-1. Postnatal mammary gland branching is MMP14-dependent. 
(A) LacZ staining of whole mount from Mmp14lacZ/+ mice at 2 and 4 weeks (bars=1.0 mm) (B) 
Cross-section of 4 week-old Mmp14lacZ/+ mammary gland (bar=100 µm). (C) LacZ staining of 4 
week-old Mmp15lacZ/+ gland (bar=2.0 mm). Insets (a,c) show LacZ of littermate controls. (D) 
Cross-section of 4 week-old Mmp15lacZ/+ gland (bar=100 µm). (E) Whole mounts from 4 week-
old Mmp14+/+ and Mmp14-/- mice. Ductal penetration (DP) (mm) and branch points/mm duct for 
Mmp14+/+ (n=3), Mmp14+/- (n=3), and Mmp14-/- (n=2) glands (mean±s.d.). (F) Whole mounts 
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from 4 week-old Mmp15+/+ and Mmp15-/- mice. DP and branch points/mm for Mmp15+/+ (n=6) 
and Mmp15-/- (n=4) (mean±s.e.m.). (E,F) (bar=5.0 mm). 
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Fig. 3-2.  
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Fig. 3-2. Mammary gland branching is independent of epithelial cell-derived MMP14. 
(A) LacZ staining of cross-sections from 4 week-old MmtvCre+/-Rosa26RloxP/+ mouse (bar=100 
µm). (B) Mmp14 qPCR in epithelial cells harvested from 4 week-old mice (n=3, ** p<0.001). (C) 
Whole mounts from 4 week-old Mmp14fl/fl (n=4) and MmtvCre+/-Mmp14fl/fl (n=4) mice (bar=5.0 
mm). (D) DP and branch points/mm (mean±s.d.). (E) Cartoon of mammary duct transplantation. 
(F) Whole mounts of mammary tissue at 8 weeks post-transplantation of Gfp+/-Mmp14+/- and 
Gfp+/-Mmp14-/- ducts (n=10 per genotype of 3 replicates) (bar=5.0 mm). (G) Immunofluorescence 
of GFP with DAPI counter-staining (bar=50.0 µm), Cytokeratin-18 (CK18), Cytokeratin 5 (CK5), 
E-cadherin and Zonula occludens (ZO)-1 (bar=20.0 µm) at 8 weeks post-transplantation (n=4). 
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Fig. 3-3.  
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Fig. 3-3. Stromal cell-derived MMP14 controls mammary gland branching. 
(A) Cross-section of gland isolated from 4 week-old Dermo1Cre+/-RosamtmgloxP/+ mouse with 
DAPI counter-staining (bar=50 µm). (B,C) Mmp14 excision at the mRNA and protein level as 
normalized to Gapdh (n=3 replicates, ** p<0.001). (D) Carmine-stained whole mounts isolated 
from Mmp14fl/fl, Dermo1Cre+/-, and Dermo1Cre+/-Mmp14fl/fl mice at 4 weeks and 8 weeks (n≥4 
per genotype) (bar=5.0 mm). (E) CK18, CK5 and E-cadherin immunofluorescence (bar=50.0 µm), 
and (F) Ki67 staining with haematoxylin counterstaining (bar=200 µm) in 4 week-old Mmp14fl/fl 
and Dermo1Cre+/-Mmp14fl/fl glands (n=3) (G) Gene ontology (GO) categories differentially 
expressed in 4 week-old Dermo1Cre+/-Mmp14fl/fl and wildtype mammary tissue (n=3 per 
genotype).  
 
  
99 
 
Fig. 3-4.  
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Fig. 3-4. Stromal cell-derived MMP14 regulates extracellular matrix remodeling in vivo. 
(A) Polarized images of Sirius red staining in 4 week-old Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl  
glands (bar=200µm). Insets show bright-field images. (B) Type IV collagen and laminin 
immunofluorescence in Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl sections with DAPI counter-
staining (bar=20µm). (C) TEM of mammary glands isolated from 4 week-old Dermo1Cre+/- and 
Dermo1Cre+/-Mmp14fl/fl mice (bar=500nm). (D) Changes in ECM transcriptomes from 4 week-old 
Dermo1Cre+/-Mmp14fl/fl and wild-type glands (n=3 per genotype). (E) Schematic of in situ labeling 
of degraded type I collagen with CF-CMPs. (F) 3-D reconstructions of CF-CMP 
immunofluorescence in mammary glands harvested from 4 week-old Mmp14fl/fl and Dermo1Cre+/-
Mmp14fl/fl  mice with DAPI counterstaining (bars=30µm; n=3). 
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Fig. 3-5.  
 
Fig. 3-5. Postnatal mammary gland branching requires type I collagen remodeling. 
(A) Western blot of MMP14 in glands harvested from 5 week-old Col1a1+/+, Col1a1r/+ and 
Col1a1r/r mice. (B) Polarized images of Sirius red staining in 5 week-old Col1a1+/+ and Col1a1r/r 
glands. Insets show bright-field images (bar=200 µm). (C) TEM of 5 week-old Col1a1+/+ and 
Col1a1r/r glands (bar=500 nm). (D) Type IV collagen and laminin Immunofluorescence in 5-6 
week-old Col1a1+/+ and Col1a1r/r glands (bar=50µm). (E) Ki67 staining in 5-6 week-old 
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Col1a1+/+ and Col1a1r/r glands (bar=200µm; n=3). (F,G) Carmine staining of 5-6 week-old 
Col1a1+/+ and Col1a1r/r glands (bar=5.0 mm) with DP and branch points/mm in Col1a1+/+ (n=6), 
Col1a1r/+ (n=3), and Col1a1r/r (n=5) littermates. **p<0.0001. 
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Fig. 3-S1. 
 
Fig. 3-S1. Postnatal mammary gland branching independent of MMP2, MMP3 and MMP13. 
(A) Carmine staining of mammary gland whole mounts isolated from wildtype female mice at 2, 
4 and 9 weeks postnatal (“LN” marks the inguinal lymph node). (B) Carmine-stained mammary 
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gland whole mounts from 4 week-old Mmp2+/+ and Mmp2-/- mice with quantification of ductal 
penetration (DP) (mm) and branch points/mm duct in n≥7 mice per genotype. Results expressed 
as mean ± s.e.m. (C) Carmine-stained mammary gland whole mounts from 4 week-old Mmp3+/- 
(n=5) and Mmp3-/- (n=2) mice with quantification of DP (mm) and branch points/mm. Results 
expressed as mean ± s.d. (D) Carmine-stained mammary gland whole mounts from 4 week-old 
Mmp13+/+ (n=4) and Mmp13-/- (n=3) mice with quantifications of DP (mm) and branch points/mm. 
Results expressed as mean ± s.e.m. (A-D) scale bar=5.0 mm. 
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Fig. 3-S2.  
 
 
106 
 
Fig. 3-S2. Postnatal mammary gland branching requires MMP14. 
(A) Schematic of Mmp15lacZ allele. (B) Carmine staining of mammary gland whole mounts 
isolated from 2 week-old Mmp14+/- or Mmp14-/- mice (scale bar=5.0 mm). (C) Quantification of 
DP (mm) and branch points/mm in Mmp14+/+ (n=3), Mmp14+/- (n=3), and Mmp14-/- (n=4) mice. 
**p<0.002.  (D) Schematic of the Mmp15 targeting strategy and the Mmp15flox conditional allele.  
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Fig. 3-S3.  
 
Fig. 3-S3. Mammary gland branching is independent of epithelial cell-derived MMP14 and 
MMP15.  
(A) Carmine-staining of mammary gland whole mounts isolated from 8 week-old Mmp14fl/fl or 
MmtvCre+/-Mmp14fl/fl mice (scale bar=5.0 mm) (B) Quantification of DP (mm) and branch 
points/mm from n≥3 mice per genotype. (C) LacZ staining of Mmtv-cre+/-Mmp14fl/flRosa26R+/loxP 
mammary gland whole mount at 7 week-old mice (scale bar=2.0 mm). A box circumscribes the 
region at higher magnification (scale bar=500 µm). Arrows indicate the wild-type (Cre-negative) 
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ducts. Image is representative of 3 replicates. (D) Carmine-stained mammary gland whole mounts 
isolated from 8 week-old Mmp14fl/flMmp15fl/fl and MmtvCre+/-Mmp14fl/flMmp15fl/fl mice (scale 
bar=5.0 mm). (E) Quantification of DP (mm) and branch points/mm in Mmp14fl/flMmp15fl/fl (n=2) 
and MmtvCre+/-Mmp14fl/flMmp15fl/fl (n=6) mice.   
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Fig. 3-S4.  
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Fig. 3-S4. Stromal cell-derived MMP14 regulates mammary gland branching and postnatal 
mammary gland development.  
(A) Cross-sections of 4 week-old Mmp14lacZ/+ mammary gland recovered from 4 week-old mice 
with Eosin counter-stain (scale bar=100 µm). Dotted lines circumscribe the mammary ducts. 
Image is representative of 3 replicates. (B) Quantification of DP (mm) and branch points/mm in 4 
week Mmp14fl/fl (n=11), Dermo1Cre+/-Mmp14fl/+ (n=6), and Dermo1Cre+/-Mmp14fl/fl (n=7) mice. 
**p<0.0001. (C) Quantification of DP (mm) and branch points/mm in mammary glands from 8 
week-old Mmp14fl/fl (n=9), Dermo1Cre+/- (n=4), Dermo1Cre+/-Mmp14fl/+ (n=4), and 
Dermo1Cre+/-Mmp14fl/fl (n=6) mice. **p<0.0001. (D) H&E staining in mammary gland cross-
sections from 4 week-old Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl mice (scale bar=200 µm). (E) 
Vimentin immunofluorescence with DAPI nuclear counter-staining in cross-sections of mammary 
glands isolated from 4 week-old Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl mice (scale bar=50.0 µm). 
Images are representative of 3 replicates. (F) H&E staining of representative mammary gland 
cross-sections from 8 week-old Mmp14fl/fl and Adipoq-Cre+/- Mmp14fl/fl mice (scale bar=200 µm). 
(G) Carmine staining of mammary gland whole mounts isolated from 8 week-old Mmp14fl/fl and 
Adipoq-Cre+/-Mmp14fl/fl mice (n=2) (scale bar=5.0 mm). 
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Fig. 3-S5.  
 
Fig. 3-S5. Stromal cell-derived MMP14 regulates branching in an organ-autonomous 
manner.  
(A) Schematic of whole mammary gland transplant procedure. (B) Carmine-stained whole mounts 
of transplanted donor mammary glands from Mmp14fl/fl or Dermo1Cre+/-Mmp14fl/fl mice at 10 d 
and 5 weeks post-transplantation (scale bar=2.0 mm). “LN” indicates donor inguinal lymph node. 
Images are representative of 3 replicates.  
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Fig. 3-S6.  
 
Fig. 3-S6. MMP14-independent regulation of stromal cell growth factors, growth 
factor/signaling receptors and cellular senescence.  
(A) Fold-changes of stromal cell-derived cytokines in Dermo1Cre+/-Mmp14fl/fl mammary glands 
isolated from 4 week-old mice relative to wild-type littermates (n=3 per genotype). (B) Fold-
changes of stromal cell-associated growth factor/signaling receptors in 4 week Dermo1Cre+/-
Mmp14fl/fl mammary glands isolated from 4 week-old mice relative to wild-type littermates (n=3 
per genotype). (C) Senescence-associated β-galactosidase (SA-βgal) staining (pH 6.0) of 
mammary gland cross-sections from 4 week-old Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl mice with 
eosin counterstaining (scale bar=200 µm). Images are representative of 2 replicates.  
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Fig. 3-S7.  
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Fig. 3-S7. Stromal cell-targeted mammary glands retain normal distributions of 
macrophages, blood vessels and lymphatics.  
(A) Immunofluorescence for macrophage-associated F4/80 protein with α-smooth muscle actin 
(αSMA) to delineate the myoepithelial cell compartment and DAPI counter-staining (scale bar=50 
µm) in Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl mammary gland cross-sections. (B) 
Immunofluorescence for CD31 (vascular endothelial cells) and Lyve1 (lymphatic endothelial 
cells) with DAPI counter-staining in Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl mammary gland 
cross-sections (scale bar=100µm). Images are representative of 2 replicates.  
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Fig. 3-S8.  
 
Fig. 3-S8.  Postnatal mammary bland branching does not require macrophage-derived 
Mmp14 or endothelial cells-derived Mmp14/Mmp15.   
(A) Carmine staining of mammary gland whole mounts isolated from 8 week-old Mmp14fl/fl and 
Csflr-Cre+/-Mmp14fl/fl littermates (scale bar=5.0 mm), (B) Carmine staining of mammary gland 
whole mounts isolated from 7 week-old Mmp14fl/flMmp15fl/fl and Tie2-Cre+/-Mmp14fl/flMmp15fl/fl 
littermates (n=2) (scale bar=5.0 mm). 
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Fig. 3-S9.  
 
Fig. 3-S9. Type I collagen remodeling regulates the periductal stroma independent of cellular 
senescence.  
(A) H&E staining of cross-sections of Col1a1r/r and Col1a1+/+ littermate mammary glands isolated 
from 5 week-old mice (scale bar=200 µm). (B) Senescence-associated β-galactosidase (SA-βgal) 
staining (pH 6.0) of Col1a1r/r and Col1a1+/+ littermate mammary glands isolated from 5 week-old 
mice.  Cross-sections with Eosin counter-staining are shown (scale bar=200 µm). Images are 
representative of 2 replicates.  
 
  
117 
 
Fig. 3-S10.  
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Fig. 3-S10. Stromal Mmp14 deletion does not increase interstitial ECM deposition in other 
epithelial organ systems.  
(A) H&E staining of kidney cross-sections isolated from 4 week-old Mmp14fl/fl and Dermo1Cre+/-
Mmp14fl/fl mice (scale bar=200 µm). (B) H&E staining of sublingual and submandibular salivary 
gland cross-sections isolated from 4 week-old Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl mice (scale 
bar=200µm). (C) H&E staining of lung tissues recovered from 4 week-old Mmp14fl/fl and 
Dermo1Cre+/-Mmp14fl/fl mice (scale bar=200 µm). (D) Bright-field images of Sirius red staining 
of kidney, sublingual salivary gland, submandibular salivary gland, and lung cross-sections from 
4 week Mmp14fl/fl and Dermo1Cre+/-Mmp14fl/fl mice (scale bar=200 µm). Images are representative 
of 2 replicates. 
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Note.  
* This chapter was submitted as a manuscript, entitled: “Periductal Remodeling of the Interstitial 
Matrix Regulates Mammary Gland Morphogenesis,” by Tamar Y. Feinberg, Rui Liu, Gertraud W. 
Robinson and Stephen J. Weiss.  
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CHAPTER 4: MT1-MMP-Mediated Pericellular Proteolysis controls the KASH∙SUN-
Dependent Regulation of Vascular Cell Nuclear Architecture and Function 
 
Abstract.  
During blood vessel development, endothelial cells and investing mural cells respond to 
exogenous stimuli that trigger the proteolytic remodeling of the surrounding 3-dimensional (3-D) 
extracellular matrix (ECM).  Changes in the structural properties of the tissue microenvironment 
result in the transmission of transcriptional cues to the vessel wall that guide morphogenetic 
programs, but the underlying mechanisms remain undefined.  Here, we characterize a novel 
regulatory axis wherein the coordinated proteolysis of the pericellular ECM by the membrane-
anchored matrix metalloprotease, MT1-MMP, and the deposition of a fibronectin network 
unexpectedly govern nuclear architecture and function.  The MT1-MMP/fibronectin 
fibrillogenesis/nuclear axis is operative specifically within the 3-D – but not 2-dimensional (2-D) 
– ECM environment in vitro as well as in vivo wherein mechanical cues are transduced via the cell 
cytoskeleton to the nucleus via Klarsicht, ANC-1, Syne homology domain (KASH)-containing 
nuclear envelope bridges.  These studies define a proteinase-regulated mechanotransduction 
program wherein endothelial and mural cells sculpt chromatin organization and transcriptional 
activity by relaying signals received from the 3-D ECM directly to the nuclear compartment.
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Introduction. 
In response to wounding, inflammation or neoplasia, endothelial cells and associated mural 
cells (i.e., pericytes and vascular smooth muscle cells) engage morphogenetic programs to drive 
neovessel formation within the confines of a surrounding, three-dimensional (3-D) extracellular 
matrix (ECM) (Adams and Alitalo, 2007; Carmeliet and Jain, 2011).  However, the ECM is not a 
static scaffold; dynamic endothelial and mural cell-mediated remodeling of the pericellular 3-D 
ECM is required during vasculogenesis as well as angiogenesis.  Current evidence indicates that 
cells engaged in morphogenetic programs within a 3-D ECM display a unique dependence on 
ECM remodeling relative to cells operating atop a planar, 2-D ECM (Engler et al., 2006; Huang et 
al., 1998; McBeath et al., 2004; Wang et al., 2009; Yamada and Cukierman, 2007).  Indeed, in a 3-
D-specific fashion, remodeling of the local ECM microenvironment via pericellular proteolysis 
and fibronectin matrix assembly impact programs that govern cell proliferation, motility and 
differentiation (Chun et al., 2006; Hotary et al., 2003; Zhou et al., 2008).  However, the means by 
which matrix remodeling regulates cell function in a 3-D ECM-specific fashion remain undefined.   
While examining endothelial cell growth responses and neovessel formation within 3-D 
ECM environments, we uncovered an unexpected link between the membrane-anchored 
metalloproteinase, MT1-MMP, fibronectin fibrillogenesis, and the regulation of transcriptional 
activity.  In the absence of MT1-MMP activity or fibronectin matrix assembly, chromatin 
organization and structure fail to reorganize, while the transcriptional profile of 3-D-embedded 
cells is “frozen” in a resting state. In tandem with these events, nuclear architecture in endothelial 
cells as well as vascular smooth muscle cells is dramatically altered in vitro and in vivo, with cells 
displaying markedly distorted nuclear shapes that closely mimic those commonly observed in the 
laminopathies (Burke and Stewart, 2006; Dechat et al., 2008; Starr, 2009). Further studies reveal 
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that both MT1-MMP activity and fibronectin fibrillogenesis impact nuclear structure and function 
by controlling the relay of mechanical cues from the ECM to a network of cytoskeleton proteins 
that interact with a family of Klarsicht, ANC-1, Syne homology domain (KASH)–containing 
proteins that serve as physical bridges to the nuclear envelope.  These findings support a new 
model wherein the remodeling of the 3-D ECM directs cell function by coordinately regulating 
nuclear architecture and function. 
 
Results.   
ECM remodeling regulates endothelial cell shape and nuclear envelope architecture.  
Endothelial cells embedded within 3-D hydrogels comprised of cross-linked fibrin or type 
I collagen (the dominant matrix proteins found at most sites of neovessel formation) (Baker et al., 
2012; Yana et al., 2007; Zhou et al., 2008) and stimulated with a pro-angiogenic cocktail containing 
vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF) (Zhou et al., 
2008), rapidly alter their cell shape over a 48 h culture period and adopt a distinct elongated, 
bipolar morphology (Fig. 4-1 A).  Cells incorporated within 3-D ECMs require two major types 
of extracellular matrix remodeling to execute the cell shape changes necessary for motility, 
proliferation and morphogenesis - both MT1-MMP-dependent proteolysis and the deposition of a 
neomatrix of fibronectin fibrils (Chun et al., 2006; Chun et al., 2004; Hiraoka et al., 1998; Sabeh 
et al., 2009; Tang et al., 2013; Zhou et al., 2008). Indeed, when endothelial cells are cultured in 3-
D with the pan-specific MMP inhibitor, BB-94, cell shape changes are blocked and the cells 
assume a distinct spherical shape while adopting a “dormant” status (i.e., immotile and non-
proliferative) (Fig. 4-1 A; Fig. 4-S1 A).  Consistent with a dominant role for the membrane-
anchored MMP, MT1-MMP, in mediating pericellular proteolysis, shRNAs directed against the 
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protease likewise abrogate VEGF/HGF-initiated cell shape changes in fibrin or type I collagen 
hydrogels (Fig. 4-1 A). As expected, endothelial cell shape changes are similarly blocked when 
hydrogels are supplemented with the fibronectin fibrillogenesis inhibitor, FUD, a 49-amino acid-
long peptide  known to block fibronectin matrix assembly (Zhou et al., 2008) (Fig. 4-1 A).  
Importantly, treatment of endothelial cells with BB-94 or FUD, or knockdown of MT1-MMP with 
shRNAs does not affect cell shape, cell survival, or VEGF/HGF-induced proliferation under 2-D 
culture conditions (Fig. 4-S1 B-C; Fig. 4-S2 A; data not shown); nor do these manipulations induce 
apoptosis in 3-D culture conditions (Fig. 4-S2 B; data not shown). 
While examining changes in endothelial cell morphology, 3-D imaging of the DAPI signal 
from ECM-embedded cells revealed marked changes in nuclear shape (Fig. 4-1 B).  In contrast to 
the elliptical-shaped nuclei observed in VEGF/HGF-stimulated endothelial cells in 3-D hydrogels, 
endothelial cells cultured with BB-94 or FUD, or expressing shRNAs targeting MT1-MMP, harbor 
multi-lobed, dysmorphic nuclei in 3-D hydrogels (Fig. 4-1 B).  Nuclear shape and the distribution 
of the nuclear pore complexes is largely determined by a scaffolding of nucleus-associated 
filaments, termed the lamins (Davidson and Lammerding, 2014; Swift et al., 2013). To first 
determine the structural status of the lamin shell, endothelial cells were engineered to express a 
GFP-tagged form of lamin A. Further, nuclear pore complexes were also immunostained for the 
nuclear pore component, NUP153 (Glynn and Glover, 2005; Goldman et al., 2004; Hawryluk-
Gara et al., 2005). VEGF/HGF-stimulated endothelial cells harboring oval-shaped nuclei in 3-D 
display a uniform distribution of lamin A and NUP153-containing complexes (Fig. 4-1 C). Under 
conditions where MT1-MMP activity or fibronectin fibrillogenesis are inhibited, the distorted 
nuclei show distinct infoldings of the lamin A matrix as well as nuclear pore complex aggregates 
124 
 
within zones of nuclear membrane invaginations (Fig. 4-1 C). Cells cultured under these conditions 
do not differ in their nuclear architecture in 2-D (Fig. 4-1 C).   
 
ECM remodeling regulates transcriptional activity and chromatin structure in endothelial 
cells cultured under 3-D culture conditions.  
Similar distortions in nuclear matrix architecture have also been observed in the 
laminopathies, a pleiotropic series of genetic disorders wherein mutations in the genes encoding 
lamins or associated nuclear envelope proteins give rise to complex phenotypes, which include 
muscular dystrophies, lipodystrophy and progeria/premature aging (Dechat et al., 2008; 
Gruenbaum and Foisner, 2015; Starr, 2009). Given the evidence that laminopathy cell nuclei have 
altered transcriptional activity (Shumaker et al., 2006; Starr, 2009; Stewart et al., 2007), nascent 
RNA synthesis was directly assessed in endothelial cells cultured under either 3-D or 2-D 
conditions (Paulsen et al., 2014; Paulsen et al., 2013).  Pulse labeling of VEGF/HGF-stimulated 
endothelial cells within 3-D ECM at 48 h with the bromouridine (BrU) metabolite reveals a marked 
induction of mRNA transcription, as shown by diffuse nucleoplasmic labeling of BrU-RNA [Fig. 
4-2 A; (Paulsen et al., 2013)]. However, this activation process is attenuated significantly when 
either pericellular proteolysis or fibronectin fibrillogenesis are inhibited in 3-D, but not 2-D, 
culture conditions (Fig. 4-2 A-D).  Importantly, while treatment of endothelial cells with high doses 
of actinomycin D to block transcription from RNA polymerase I, II and III (5 µg/ml, (Pellizzoni 
et al., 2001)) abrogates BrU incorporation and the detection of nascent transcripts, actinomycin D 
treatment does not affect nuclear shape (Fig. 4-S3 A), indicating that the nuclear shape changes 
observed under conditions with abrogated ECM remodeling are not a consequence of the 
attenuated transcriptional activity. More accurate assessments of the levels of polyadenylated-
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RNA, as an indicator of mRNA adundance, in VEGF/HGF-stimulated 3-D cultures at 48 h revealed 
a 50% decrease in mRNA levels in endothelial cells cultured under VEGF/HGF-stimulated 
conditions in the presence of BB-94 or FUD peptide, relative to the mRNA levels of cells cultured 
under VEGF/HGF-stimulation with vehicle controls (n=3, in triplicate). The distribution of 
chromatin in endothelial cell nuclei was therefore assessed by monitoring the localization of GFP-
tagged histone H2B (Tang et al., 2008).  While the nuclei of growth factor-stimulated endothelial 
cells contain uniformly-distributed histone H2B, blockade of ECM remodeling in 3-D, but not 2-
D, triggers chromatin condensation at discrete peripheral nuclear locations, generating significant 
increases in chromatin-free areas in the nucleus - consistent with an accumulation of inactive 
heterochromatin (Fig. 4-2 E).  Further, using the acetylation status of histone H3 at lysine 9 
(Acetyl-H3K9) as a marker of euchromatin - chromatin accessible to transcriptional machinery 
(Finlan et al., 2008; Haberland et al., 2009), inhibition of MMP activity or fibronectin 
fibrillogenesis markedly decreases Acetyl-H3K9 levels in a 3-D-specific fashion (Fig. 4-2 F). 
Importantly, endothelial cells cultured in the absence or presence of these inhibitors showed 
equivalent levels of an independent histone modification, heterochromatin-associated 
trimethylated lysine 27 of histone H3 (H3K27Me3), in both 2-D and 3-D conditions (Fig. 4-2 G).  
In order to evaluate RNA synthesis on a genome-wide scale and uncover the 
transcriptionally active regions in the genome of endothelial cells confined in 3-D hydrogels 
without ECM remodeling activities, the newly generated BrU-RNA was sequenced by BrU-Seq 
(Paulsen et al., 2014; Paulsen et al., 2013). Interestingly, ~ 200 genes were differentially expressed 
using a >2-fold change cutoff and the majority of these genes were down-regulated following 
inhibition of pericellular proteolysis, with enriched Gene Ontology (GO) categories related to cell 
cycle progression, proliferation and DNA packaging (Fig. 4-2 H). To evaluate whether inhibition 
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of proliferation induces a similar change in nuclear architecture, DNA polymerase A was inhibited 
with aphidicolin (Ewald et al., 2008). However, addition of aphidicolin (10 µM) for 48 h failed to 
induce marked changes in either cell shape or nuclear morphology in 3-D ECM (Fig. 4-S3 B), 
suggesting that the ECM remodeling-dependent changes in nuclear shape are not an indirect result 
of reduced proliferative activity.  
 
A cytoskeleton-LINC complex axis couples cell and nuclear shapes. 
Recent studies have identified an axis wherein physical interactions between the 
cytoskeleton and the nuclear envelope are mediated by a family of Klarsicht, ANC-1, Syne 
homology (KASH) domain-containing proteins, which span the outer nuclear membrane and 
intermembrane space where they interact with members of the SUN protein family and form the 
linker of cytoskeleton and nucleus (LINC) complex (Crisp et al., 2006; Dechat et al., 2008; Starr, 
2009; Stewart et al., 2007; Wilhelmsen et al., 2006).  SUN proteins then span the inner nuclear 
membrane to establish binding interactions with a scaffold of lamin family members and nuclear 
pore complexes (Dechat et al., 2008; Starr, 2009; Stewart et al., 2007).  Endothelial cells express 
the KASH domain-containing proteins, nesprins-1 and 2 (also termed Syne-1 and -2), which bind 
F-actin and microtubules, as well as nesprin-3, which indirectly interacts with intermediate 
filaments via binding to plectin. These KASH domain-containing nesprin proteins all localize to 
the nuclear envelope and are diffusely present in the cytoplasm due to their localization in the 
endoplasmic reticulum [Fig. 4-3 A; (Starr, 2009; Stewart et al., 2007)].  While endothelial cells 
cultured in 3-D under VEGF/HGF-stimulation display a uniform distribution of nesprins in the 
nuclear envelope (Fig. 4-3 A), inhibition of MMP activity or fibronectin fibrillogenesis induces 
the aggregation of nesprin complexes at nuclear membrane invagination sites (Fig. 4-3 A).   
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As endothelial cell shape changes in 3-D ECM in response to VEGF/HGF-stimulation are 
accompanied by a reorganization of the actin cytoskeleton and cytosolic microtubule network, the 
nesprin proteins likely regulate nuclear structure via their simultaneous interactions with plasma 
membrane-associated cytoskeletal fibers and the nuclear envelope. Indeed, blockade of 
pericellullar proteolysis or fibronectin fibrillogenesis inhibits assembly of F-actin, β-tubulin and 
vimentin into longitudinal fibers, resulting in an amorphous cortical collection of molecules (Fig. 
4-3 B) - effects that are not observed under 2-D culture conditions (Fig. 4-S4 A). Blockade of ECM 
remodeling in 3-D ECM abrogates the contractile force that VEGF/HGF-stimulated endothelial 
cells exert on 3-D ECM by more than 60% (Fig. 4-3 C, *p<0.05), and impairs the ability of 
endothelial cells to generate the cytoskeletal tension necessary to transduce forces from the cell 
surface to the nuclear compartment, as reflected in the 2-fold decrease in pericellular matrix 
rigidity detected by atomic force micro-indentation (Liu and Tschumperlin, 2011) (Fig. 4-3 D). To 
address the functional role of the cytoskeleton in directly regulating nuclear structure, VEGF/HGF-
stimulated endothelial cells were treated with either blebbistatin, which inhibits myosin ATPase-
mediated isometric tension, or nocodazole, which interferes with microtubule assembly 
(Salpingidou et al., 2007; Zhou et al., 2008).  Endothelial cells cultured in the presence of 
blebbistatin or nocodazole display (i) multi-lobed nuclei with perturbations in nuclear pore 
distribution, (ii) chromatin condensations at the nuclear periphery with increased interchromatin 
space,  (iii) abrogated nascent transcript production, and iv) attenuated acetylation of histone H3 
in response to VEGF/HGF (Fig. 4-3 E-I; Fig. 4-S5 A-D). 
Finally,  to perturb cytoskeleton/nesprin interactions directly, endothelial cells were 
transduced with dominant-negative GFP-KASH, which acts as a truncated nesprin protein that still 
binds the SUN proteins, but lacks the domains required for interacting with cytoskeletal elements 
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- resulting in the functional uncoupling of the nucleus and cytoplasm (Brosig et al., 2010; Crisp et 
al., 2006).  In contrast to VEGF/HGF-stimulated endothelial cells expressing the empty retroviral 
vector, endothelial cells expressing GFP-KASH retrovirus in 3-D ECM adopt the multi-lobed, 
highly concave nuclear architecture characteristic of cells with inhibited ECM remodeling 
activities (Fig. 4-4 A-B). Importantly, uncoupling of the cytoskeletal and nuclear compartments 
via GFP-KASH expression induces peripheral chromatin condensation, impairs transcriptional 
activity of endothelial cells in 3-D and attenuates acetylation of histone H3, independently of 
directly targeted pericellular ECM remodeling (Fig. 4-4 C-D). Similarly, RNAi-mediated 
knockdown of Nesprin-2 alone, which directly tethers the nuclear envelope to both the actin 
cytoskeleton and microtubule filaments (Chang et al., 2015), recapitulates the effects of GFP-
KASH expression on nuclear architecture, nascent transcript production and chromatin structure 
(Fig. 4-4 E-G).  
 
Direct coupling of cell geometry with nuclear and chromatin structure. 
Taken together, ECM-dependent changes in 3-D cell geometry appear to regulate nuclear 
architecture. As such, directly modulating endothelial cell shape without inhibiting ECM 
remodeling activities or cytoskeleton-nuclear membrane interactions would be predicted to impact 
nuclear organization, chromatin structure and transcriptional activity.  As such, endothelial cells 
were cultured within 3-D, biomimetic poly(ethylene glycol) (PEG) hydrogels containing RGD 
peptides incorporated pendantly within a transglutaminase-crosslinked structure that is engineered 
to be either susceptible, or resistant, to MMP-mediated hydrolysis [Fig. 4-5 A; (Ehrbar et al., 2007; 
Raeber et al., 2007)].  In this framework, endothelial cell shapes are affected as a function of the 
susceptibility of the 3-D hydrogel to MMP-dependent proteolysis.  Within MMP-sensitive gels, 
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endothelial cells stretch in response to VEGF/HGF and display elliptical nuclei (Fig. 4-5 B-C), but 
predictably fail to stretch in the presence of BB-94 and exhibit multi-lobed, highly concave nuclei 
(Fig. 4-5 B).  In contrast, in MMP-resistant gels, endothelial cells remain locked in a spherical 
shape and harbor multi-lobed nuclei in the absence of MMP inhibition (Fig. 4-5 B-C).  Further, 
cells cultured within MMP-degradable hydrogels displayed ~ 4-fold reduced transcriptional 
activity (*p<0.01) and near complete repression of histone H3 acetylation (i.e. 0.0004 ± 0.0003 
AU versus 1.0 ± 0.16 AU, P < 0.0001), relative to cells cultured within MMP-sensitive hydrogels 
(Fig. 4-5 D).   
Alternatively, endothelial shape can be modulated independently of proteolysis under 2-D 
conditions by culturing cells atop micropatterned fibronectin islands printed onto 
polymethylsiloxane substrates to generate ECM-adhesive patches surrounded by regions blocked 
with a non-adhesive surface coating (Chen et al., 1997; McBeath et al., 2004). In contrast to the 
freely spreading cells present on homogeneously-coated fibronectin substratum, cells cultured atop 
35 x 35 μm fibronectin ‘islands’ with constrained cell spreading display (i) concave nuclear shape, 
(ii) condensation of chromatin, and (iii) decreased histone acetylation (Fig. 4-S6 A-C). Hence, 
ECM-directed control of cell geometry directly determines nuclear shape and architecture as well 
as chromatin structure. 
 
Nuclear architecture directly regulates transcriptional activity. 
This work shows that the cell shape changes associated with pericellular proteolysis and 
fibronectin fibrillogenesis directly regulate nuclear architecture through the LINC complex, and 
that morphological changes in both cell and nuclear shape correlate with transcriptional activity. 
To examine whether the link between nuclear architecture and transcriptional activity is direct or 
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indirect, we isolated nuclei and performed nuclear run-on transcription assays. Endothelial cell 
nuclei were extracted in polyethylene glycol (PEG) at 12% w/v in order to mimic the “crowding” 
forces exerted by insoluble cytoplasmic proteins on the nuclear envelope that dictate nuclear size 
and the organization of intranuclear compartments in intact cells (Fulton, 1982; Hancock, 2004a; 
Minton, 2001; Rosania and Swanson, 1995; Zimmerman and Minton, 1993). Endothelial cell 
nuclei were extracted in the presence of digitonin detergent in order to selectively permeabilize 
the plasma membrane, conserve the bulk of the nuclear envelope structure, and thereby model the 
nuclei present under physiologic conditions (Adam et al., 1992; Hancock, 2004b; Hancock and 
Hadj-Sahraoui, 2009). 
Incubation of intact isolated endothelial cell nuclei under the “physiologic,” 12% w/v PEG 
condition, yields a range of nuclear shapes, as visualized in their 3-D reconstructions (Fig. 4-6 A). 
Relative nuclear concavity measurements show that 20% of the nuclei in 12% w/v PEG exhibit an 
oval shape (Fig. 4-6 A).  Despite the heterogeneity in nuclear shape, only the oval-shaped nuclei 
under the 12% w/v PEG condition are transcriptionally active. The more concave nuclei under 
12% w/v PEG exhibit a 3-fold drop in transcriptional activity (*p<0.0001), as demonstrated by 
incorporation of Br-UTP (Fig. 4-6 A). When the PEG concentration was elevated to 25% w/v, 
isolated nuclei uniformly adopted a folded state with abrogated transcriptional activity (*p< 
0.0001, Fig. 4-6 B-E), with a BrU-RNA comparable to that of isolated nuclei pre-treated with a 
high dose of actinomycin D (Fig. 4-6 E).  Transfer of isolated nuclei from 25% w/v PEG to the 
physiologic 12% w/v PEG condition reversibly rescues both nuclear shape and transcriptional 
activity (Fig. 4-6 B-E). Lastly, while the oval-shaped isolated nuclei under 12% w/v PEG are 
enriched for euchromatin-associated Acetyl-H3K9 marks, the crumpled nuclei present under 25% 
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PEG lack Acetyl-H3K9 staining (Fig. 4-6 F). Taken together, these data identify a cell shape-
independent role for nuclear architecture in determining transcriptional competence.  
 
Control of nuclear structure and chromatin activity by ECM remodeling pathways in 
vascular cells in vivo. 
While the endothelial cells of patent, fully formed blood vessels exist in 2-D, the vascular 
smooth muscle cells (VSMCs) that surround the endothelium are enmeshed in 3-D ECM. To 
determine whether the requirement for pericellular ECM remodeling is confined to the vascular 
endothelium, aortic VSMCs isolated from Mt1-mmpflox/flox mice (Tang et al., 2013) were incubated 
with adenoviral β-gal or Cre-expression vectors, and embedded in 3-D type I collagen – the 
predominant ECM component surrounding aortic VSMCs in vivo (Filippov et al., 2005; Yana et 
al., 2007). Just like endothelial cells, VSMCs show major changes in cell and nuclear morphology 
when MT1-MMP is targeted. While wild-type VSMCs assume an elongated, bipolar cell shape in 
3-D hydrogels in the presence of angiogenic growth factors and display elliptical nuclei; Mt1-
mmp-silenced VSMCs assume a distinct dendritic morphology and retain multi-lobed nuclei (Fig. 
4-7 A). Similar to endothelial cells, transcriptional activity and euchromatin-associated Acetyl-
H3K9 levels are significantly reduced following MT1-MMP inhibition (Fig. 4-S7 A,B). 
To determine whether MT1-MMP serves as a regulator of genomic activity in VSMCs 
within 3-D ECM in vivo, aortae were isolated from Mt1-mmp-/- global knockout mice (Holmbeck 
et al., 1999) or wild-type (Mt1-mmp+/+) littermates.  Aortae exhibit grossly indistinguishable 
morphologies across genotypes with respect to the VSMC compartment (Fig. 4-7 B). Yet whereas 
wild-type VSMCs show stress fiber-like α-smooth muscle actin (α-SMA) staining and contain 
elongated, elliptical nuclei, Mt1-mmp-/- VSMCs display a more cortical α-SMA arrangement in 
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association with distinctly spherical nuclei (Fig. 4-7 B). 3-D reconstructions of wild-type and Mt1-
mmp-/- VSMC nuclear shapes show that the Mt1-mmp-/- VSMCs harbor significantly more folded 
and multi-lobular nuclei in vivo  (43.8% folded nuclei, n=4 fields) than wild-type smooth muscle 
cells (2.6% folded nuclei, n=4 fields) (Fig. 4-7 C). Further, when transcriptional activity was 
monitored in vivo 5’ fluorouracil (5’FU) to label nascent transcripts (Spencer et al., 2011), wild-
type VSMC nuclei show high levels of F-RNA, and Mt1-mmp-/- VSMC nuclei display significantly 
abrogated transcriptional activity (Fig. 4-7 D). In agreement with these data, aortae from  
Mt1-mmp-/- mice also show markedly reduced levels of Acetyl-H3K9 in the VSMC compartment 
(Χ2 = 28.9, P < 0.0001; n = 3; Fig. 4-7 E); thereby identifying MT1-MMP as a central regulator of 
nuclear morphology and transcriptional activity in 3-D ECM in both in vitro and in vivo milieu.  
 
Discussion. 
Growth Factor-Triggered, ECM-Dependent Regulation of Nuclear Architecture.  
Recent analyses of cells recovered from patients bearing mutations in the genes encoding 
lamin A/C, emerin or nesprins have demonstrated that perturbation of normal nuclear architecture 
impacts tissue morphogenesis and global organism homeostasis – resulting in a family of genetic 
diseases termed the laminopathies (Cohen et al., 2007; Dechat et al., 2008; Holaska, 2008; Zhang 
et al., 2007).  However, the idea that nuclear structure may be purposefully remodeled during 
normal development to govern differentiation and morphogenesis has not been investigated.  
Given the recently described characterization of mechanical linkages between the cell surface and 
the nuclear envelope (Dahl et al., 2008; Starr, 2009; Stewart et al., 2007), we considered the 
possibility that growth factor-triggered cell shape changes control tissue morphogenesis by directly 
impacting nuclear architecture and function.  Indeed, using the distribution of the nuclear proteins 
lamin A and emerin as markers of nuclear envelope architecture (Dahl et al., 2008; Dechat et al., 
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2008; Goldman et al., 2004; Holaska, 2008), we find that 3-D-embedded, unstimulated endothelial 
cells display convoluted nuclei with multiple lobulations and surface invaginations containing 
nuclear pore complex aggregates.  To our knowledge, the appearance of such lobulated, 
laminopathy-like nuclear shapes has never been described in any normal cell population – likely 
due to the paucity of analyses performed in 3-D culture.  Nevertheless, following stimulation with 
VEGF/HGF, endothelial cells resculpt nuclear architecture to generate elliptical nuclei marked by 
a uniformly distributed array of nuclear pore complexes.  Surprisingly, under standard, 2-D culture 
conditions atop mechanically rigid, adhesive substrata, cell shape changes – and consequent 
nuclear shape changes – are not regulated by vasculogenic signals; this observation compelled us 
to consider the means by which nuclear structure is controlled by growth factor signals under 3-
D-specific conditions. 
 
An ECM-Cytoskeleton-LINC Complex Interaction Continuum Dictates 3-D Nuclear 
Dynamics. 
Pericellular ECM degradation and neomatrix deposition are central modulators of diverse 
cellular functions ranging from proliferation and differentiation to morphogenesis in a largely 3-
D specific manner (Chun et al., 2006; Chun et al., 2004; Hiraoka et al., 1998; Hotary et al., 2003; 
Saunders et al., 2006; Zhou et al., 2008).  Evidence to date indicates that both the mechanical and 
structural properties of the ECM regulate cellular responses to exogenous soluble signals; 
however, the mechanism by which ECM-derived cues are interpreted into cellular responses has 
remained elusive (Ben-Ze'ev et al., 1980; Chen et al., 1997; Chun et al., 2006; Chun et al., 2004; 
Discher et al., 2005; Engler et al., 2006; Hotary et al., 2003; McBeath et al., 2004; Paszek et al., 
2005; Zajac and Discher, 2008; Zhou et al., 2008).  Hence, we asked if the growth factor-
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dependent, 3-D-specific cell and nuclear shape remolding we observed during vasculogenesis 
required local ECM proteolysis and deposition, thus providing a possible pathway by which the 
cell-mediated shifts in the biomechanics of the ECM regulate cell activity.  We found that 
inhibition of either MT-MMP-mediated local proteolysis or fibronectin fibril deposition 
completely abrogated growth factor triggered endothelial cell and nuclear shape changes in 3-D.  
In contrast, under 2-D culture conditions where cell shape changes are not constrained by 
surrounding ECM fibrils, ECM remodeling plays no role in control of nuclear structure.   
 
How might biophysical cues from the ECM be transmitted to the nuclear envelope?  The 
cytoskeleton serves as a central mechanotransducer on the basis of its ability to ‘sense’ and respond 
to extracellular rigidity as well as changes in cell shape, though the means by which rigidity 
sensing is interpreted into regulation of cell function is not well understood (Engler et al., 2006; 
McBeath et al., 2004; Wang et al., 2009; Wozniak and Chen, 2009; Zajac and Discher, 2008).  
Recently, a multi-protein complex spanning the nuclear envelope, termed the LINC complex, has 
been shown to physically connect the cytoskeleton to the nuclear envelope (Crisp and Burke, 2008; 
Starr, 2009; Stewart et al., 2007), suggesting that ECM-derived cues are mechanically transmitted 
directly to the nucleus via a continuous network of protein:protein associations.  In accordance 
with their proposed roles in mediating cytoskeletal-nuclear envelope crosstalk, disruption of 3-D 
endothelial cell cytoskeletal assembly, actomyosin-mediated tension, or physical cytoskeleton-
nucleus interactions with the dominant-negative LINC complex protein, GFP-KASH, reproduced 
the lobulated nuclear structure characteristic of cells unable to recruit pericellular ECM remodeling 
pathways in response to vasculogenic signals.  These data led us to speculate that pericellular ECM 
remodeling provides a mechanism by which cells actively fine-tune their local 3-D niche to 
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regulate cell and nuclear geometry via cytoskeleton-LINC complex interactions for appropriate 
responses to soluble cues.   
 
Nuclear Structure Governs Genome Activity: Clues from Human Disease. 
In considering the functional ramifications of ECM remodeling-dependent changes in 
nuclear shape, we noted that the multi-lobed nuclei and distorted nuclear pore distribution 
observed in our studies bore striking resemblance to the nuclear shapes observed in cells recovered 
from human laminopathy patients (Crisp and Burke, 2008; Dechat et al., 2008; Goldman et al., 
2004; Holaska, 2008).  Study of such cells or mouse models of human laminopathy, as well as 
cells engineered to silence lamin expression, has demonstrated that disrupted nuclear matrix 
architecture induces spatial and functional reorganization of the genome, resulting in global 
alterations in transcription and consequent effects on cell function (Columbaro et al., 2005; Csoka 
et al., 2004; Dechat et al., 2008; Malhas et al., 2007; Meaburn et al., 2007; Shimi et al., 2008; 
Shumaker et al., 2006; Tang et al., 2008).  While the functional impact of mutations in nuclear 
envelope proteins on cell function have not been considered to be of necessary relevance to normal 
cell behavior, the structural changes we observed in endothelial cell nuclei in 3-D culture led us to 
hypothesize that chromatin re-organization might purposefully accompany the nuclear envelope 
restructuring that occurs during capillary morphogenesis.  Consistent with the proposition that 
chromatin organization is a critical regulator of endothelial cell function (Haberland et al., 2009), 
VEGF/HGF stimulation induces the translocation of endothelial cell chromatin from a condensed 
peripheral location to a dispersed, uniform distribution with coincident induction of histone 
acetylation, a process completely reliant upon fibronectin matrix- or MMP- dependent cell shape 
changes, cytoskeletal dynamics, and an intact LINC complex.   
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Inside:Outside Modulation of the Nuclear Compartment. 
Our findings suggest a new model wherein pericellular remodeling of the ECM represents 
a required step in allowing cells to remodel their nuclei in order to activate the transcriptional 
machinery responsible for controlling growth and differentiation.  While our studies have focused 
on endothelial cell behavior, these findings may apply to all cell populations that reside within a 
3-D ECM.  By linking ECM remodeling to the ordered transmission of mechanical signals to the 
nuclear envelope, subtle changes in pericellular ECM remodeling activity – such as proteolysis - 
would be predicted to profoundly impact phenotype.  Indeed, we are intrigued by the fact that the 
phenotype of Mt1-mmp-null mice – characterized by a markedly shortened lifespan with a 
profound reduction in growth that is associated with the onset of severe bone, muscle, vascular 
and adipose tissue-related defects shortly after birth - bear considerable similarity to mouse models 
of laminopathy (Chun et al., 2006; Chun et al., 2004; Holmbeck et al., 1999; Mounkes et al., 2003; 
Ohtake et al., 2006; Sullivan et al., 1999; Zhou et al., 2000).  The overlapping phenotypes raise 
the possibility that modulating nuclear shape by interfering with ECM remodeling may impact cell 
function to a degree similar to that observed by directly targeting the nuclear envelope.  We 
conclude that the complex changes in gene expression and cell function known to accompany 
ECM remodeling are interconnected with matrix-derived cues transmitted to the nuclear envelope, 
chromatin and transcriptional machinery by a network of protein: protein interactions that span 
from the cell-ECM interface to the nuclear interior. 
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Experimental procedures. 
Antibodies. 
The following commercial antibodies against proteins, histone modifications, and modified 
nucleotides were used for immunohistochemistry: Acetyl Histone H3 (Lys9) and β-tubulin (Cell 
Signaling Technologies), Tri-methyl Histone H3 (Lys27) (07-449, Millipore), Vimentin (ab20346, 
Clone [VI-10] from Abcam), Anti-BrdU (Clone 3D4 from BD Biosciences for immune-labeling 
BrU-RNA in vitro; and ab6326, Clone BU1/75 (ICR1) from Abcam for immunostaining F-RNA 
in vivo), Ki67 (Abcam), and α-smooth muscle actin (ab5694, Abcam).  Nesprin-1 and Nesprin-2 
antibodies were generously provided by Dr. Angelika A. Noegel (University of Cologne, 
Germany).  To generate the nesprin-3 antibody, full-length human nesprin-3 from FLJ16564 cDNA 
was cloned into pGEX-2T and expressed in E.coli strain BL21 codon-plus and purified according 
to the manufacturer’s protocol.  Rabbits were injected with the nesprin-3: GST purified fusion 
proteins at the laboratory of Comparative Pathology at the School of Veterinary Medicine at UC 
Davis.   
 
Transgene expression in primary endothelial cells. 
To express GFP-KASH (provided by B. Burke, University of Florida) or GFP-lamin 
(provided by T. Glover, University of Michigan) at high efficiency, endothelial cells were 
transduced with amphotropic retroviruses in the presence of 50 ng/ml VEGF and 6 µg/ml 
polybrene (Sigma) and embedded in 3-D fibrin 48 hours later.  A GFP-encoding lentivirus was 
purchased from the University of Michigan Vector Core.  The shRNA lentiviral constructs used to 
target human MT1-MMP were (target sequence lower case; hairpin in upper case): Sh-1: 5’ 
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ggccaatgttcgaaggaagtgCTTCCTGTCAcgcttccttcgaacattggcc 3’ and Sh-2: 5’ 
ggcacacaaacgaggaatgagCTTCCTGTCActcattcctcgtttgtgtgcc 3’. 
 
Ectopic gene expression in primary endothelial cells. 
For expression of GFP-histone H2B or DsRed-Histone H2B, cells were transfected via 
Lipofectamine 2000 (Invitrogen) according to the manufacturer’s protocol. For knockdown of 
Nesprin-2 with siRNA, Stealth RNAi siRNA were ordered from Invitrogen of the following 
sequences: Nesprin-2 (siRNA 1) – (RNA) - ucugucaacgugagcagcaaggaau, and (RNA) – 
auuccuugcugcucacguugacaga; Nesprin-2 (siRNA 2) – (RNA) – cagcagucaggugccuucgacagau, and 
(RNA) – aucugucgaaggcaccugacugcug. The medium G/C content negative universal control (46-
2001, Invitrogen) was used as the scrambled siRNA control. For exogenous expression of 
scrambled and nesprin 2-targeting siRNA, PepMute siRNA transfection reagent was used 
according to the manufacturer’s protocol (SignaGen Laboratories).  
 
Cell culture.   
Human umbilical vein endothelial cells were isolated from umbilical cords by perfusion of 
the umbilical vein with type 3 collagenase (Worthington Biochemical Corporation) and cultured 
in Medium-199 (Invitrogen) with 20% human serum and 50 µg/ml endothelial cell growth 
supplement (ECGS; BD Biosciences).  Human vascular smooth muscle cells were purchased from 
the ATCC (Manassas, VA).  Murine Mt1-mmp conditional knock-out aortic vascular smooth 
muscle cells were isolated from mice bearing homozygous Mt1-mmpflox/flox alleles, and transduced 
with either Adenovirus expressing β-galactosidase or Adenovirus expressing Cre recombinase 
(University of Michigan Vector Core). 
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3-D cell culture conditions. 
For 3-D culture within fibrin, endothelial cells were suspended in a solution of thrombin 
and aprotinin (Sigma) and mixed 1:1 with a solution of 6 mg/ml fibrinogen (Calbiochem).  For 3-
D culture within type I collagen, endothelial cells were embedded in a neutralized solution of acid-
extracted rat-tail type I collagen at 2.2mg/ml final concentration, as described previously (Sabeh 
et al., 2009). Vasculogenesis was triggered in endothelial cells by treatment with 100ng/ml VEGF, 
and 50ng/ml HGF (Genentech). Aortic vascular smooth muscle cells were cultured within 
neutralized type I collagen (Sabeh et al., 2009) in DMEM with 10% FBS, in the presence of PDGF-
BB and FGF-2 (10ng/ml each, Sigma) (Filippov et al., 2005). Fibronectin fibrillogenesis by 
endothelial cells was inhibited by treatment with FUD peptide (Zhou et al., 2008) and MMPs were 
inhibited in both endothelial cells and vascular smooth muscle cells with broad-range MMP 
inhibitor BB-94 (Tocris).  Endothelial cells and vascular smooth muscle cells were similarly 
cultured atop 3-D fibrin or type I collagen for parallel assessments under 2-D planar conditions. 
Actomyosin contractility and microtubule assembly were inhibited with blebbistatin and 
nocodazole, respectively (25 µM and 5 µM, respectively; Calbiochem).   
 
3-D synthetic hydrogels. 
MMP-resistant or MMP-degradable PEG hydrogels were formed by FXIIIa catalyzed 
reaction as described (Ehrbar et al., 2007). Briefly, 8-arm PEG-Gln and PEG-Lys were blended to 
generate stoichiometrically balanced ([Gln]/[Lys]) PEG precursor solutions. The PEG-Lys 
component was either chosen to contain a linker peptide that is susceptible (GPQG/IWGQ, with / 
indicating the cleavage site) or resistant (GDQGIAGF) to MMP-mediated degradation. The PEG 
precursor solutions (1.5, 2.0 and 2% w/v) were cross-linked upon addition of 10 U/mL FXIIIa in 
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presence of 50mM TrisHCl pH 7.6, 50mM CaCl2, 50μM Lys-RGD (Ac-FKGGRGDSPG-NH2, 
NeoMPS Strasbourg, France) and cells suspended in medium 12% (v/v) of the total volume. To 
form hydrogel discs, 20μL drops of the still liquid reaction mixture were sandwiched between 
sterile, hydrophobic glass microscopy slides that were separated by 1 mm spacers and clamped 
with binder clips. Polymerization was then allowed to take place for 30min. at 37°C in a humidified 
incubator. To visualize the matrix, 25μM Lys-FITC (Ac-FKGGGK-FITC-NH2, NeoMPS) was 
added prior to reaction, leading to a homogenous covalent tethering of FITC to the matrix. 
 
Cell culture atop micropatterned substrata. 
Micro-contact printing techniques were used to fabricate substrates patterned with regions 
that were coated with fibronectin and regions that resisted such adsorption, as previously described 
(Singhvi et al., 1994).  1225 µm2 islands (35 µm x 35 µm) were used to constrain cell spreading, 
while continuous surfaces of fibronectin allowed for full spreading.  Briefly, PDMS stamps bearing 
the relevant pattern of islands were washed with ethanol, dried, immersed for 1 hour in an aqueous 
solution of 25 mg/ml fibronectin, rinsed thoroughly in water, dried, and placed in conformal 
contact against the culture substrate, blocked with 0.2% Pluronic F127 (BASF), and used under 
standard culture conditions. 
 
Isolation of nuclei in situ.  
Endothelial cell nuclei were extracted in situ using the following method. Endothelial cells 
were seeded at 1.5 X 105 cells per ml on 4-well Gelatin-coated chamber glass slides, prepared as 
described previously (Yana and Weiss, 2000), and incubated at 37oC in 5% CO2 for 20-24 hours. 
Endothelial cells were then washed twice with Dulbecco’s PBS, and treated with a hypotonic 
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reducing solution containing 5mM MgCl2, 6mM KCl, 50mM Tris-HCl (pH 7.4), 75mM 
(NH4)2SO4, 25% w/v glycerol and 1mM dithiothreitol to partially extract the cell monolayer and 
reduce the sedimentation of extracellular and cytoplasmic material.  After 3 minutes of incubation 
at room temperature, this reducing solution was removed, and the partially extracted cell 
monolayer was washed twice with 12% w/v polyethylene glycol (PEG) (Average MW 8kDa, 
Promega) solution, containing 100µM K-Hepes (Sigma) buffer at pH 7.4, in order to mimic the 
macromolecular crowding present in intact cells and maintain the physiologic nuclear shape 
(Hancock and Hadj-Sahraoui, 2009). The adherent, partially extracted cells were then further 
extracted and permeabilized in situ with 12% w/v PEG solution containing 50µg/ml digitonin for 
30 minutes at room temperature on a gentle rotating platform (Hancock and Hadj-Sahraoui, 2009). 
Isolated nuclei were then washed three times with 12% w/v PEG solution to remove the detergent 
and incubated in 12% or 25% w/v PEG polymer solutions containing  100µM K-Hepes (pH 7.4), 
at room temperature for 30 minutes in a humidified chamber. For reversibility studies, control 
wells were left in 12% or 25% w/v PEG solution for another 30 minutes, and test wells were 
washed gently twice with 12% w/v PEG solution, and transferred to 12% w/v PEG solution for 
another 30 minutes of room temperature incubation. For assessments of chromatin structure in 
isolated nuclei, cell monolayers were pre-treated with 50ng/ml trichostatin A (TSA) for 1 hour at 
37oC prior to their extraction to counteract the elevation in histone deacetylase activity following 
nuclear extraction (Mulholland et al., 2003; Pivot-Pajot et al., 2003). 
 
Nuclear run-on transcription assays.  
For assessments of transcriptional activity in intact cells, 2-D and 3-D cultures were 
incubated with 2mM Bromouridine (BrU) (Sigma) for 1 hour at 37oC (Pellizzoni et al., 2001) 
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following their 48 hour culture period, and processed as described below.  For the actinomycin D-
treated negative control, cultures were pre-incubated with actinomycin D at 5µg/ml (Sigma) for 3 
hours before the addition of BrU (Pellizzoni et al., 2001).  For assessments of transcriptional 
activity in isolated nuclei, the in situ isolated nuclei were equilibrated to 37oC for 10 minutes, the 
PEG solutions were gently pipetted off and exchanged for 500ul of the same PEG solutions 
containing 1mM KCl, 100µM ATP, 100µM CTP, 100µM GTP, 100µM Br-UTP and 100units/mL 
rRNAsin (Promega) for another 30 minutes of incubation at 37oC [modified from (Hancock and 
Hadj-Sahraoui, 2009)]. For the actinomycin D treatment condition, isolated nuclei were pre-
incubated at 37oC for 10 minutes in the presence of 5µg/ml actinomycin D (Pellizzoni et al., 2001), 
and the above transcription mix was added in the presence of 5µg/ml actinomycin D.  Nuclei were 
then fixed by overlaying them for 1 hour with the same PEG solution containing 2% PFA, and 
processed as detailed below for immunofluorescence. For BrU-Seq, approaches were employed as 
described previously (Paulsen et al., 2013) with the following modifications. Endothelial cells 
were embedded at 150,000 cells per hydrogel of 3-D type I collagen at 106 cells per condition 
(n=2). Following a 1h incubation with 2 mM BrU, wells with washed twice with ice-cold PBS and 
homogenized in TRIzol (Ambion, Life Technologies).  Total RNA was extracted and purified using 
QIAGEN RNeasy Mini-kit columns (QIAGEN, 74104). BrU-containing RNA was isolated with 
anti-BrdU antibodies, processed and sequenced as described (Paulsen et al., 2013). 
 
Isolation of and quantification of poly (A) RNA fractions from 3-D cultures.  
Following isopropanol precipitation of RNA from Trizol extracts and overnight 
incubation in 75% ethanol, the poly(A) fraction was isolated with Oligo(dT)25 cellulose beads 
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(S1408, New England BioLabs) according to the manufacturer’s protocol and quantified with the 
Quant-iT RiboGreen RNA Assay Kit (Invitrogen) using a 96-well plate reader.  
 
Immunofluorescence, proliferation and apoptosis assays. 
For immunofluorescent labeling of protein in intact endothelial cells cultured within or atop 
3-D hydrogels, or in isolated nuclei, cultures were fixed with 4% paraformaldehyde – unless 
otherwise noted, washed with PBS, and permeabilized with 0.1% Triton X-100.  Cultures were 
blocked with 3% normal goat serum, and incubated with primary antibodies for 12-to-15 hours. 
For immunostaining of nascent transcripts labeled with bromouridine, cultures were fixed in 4% 
paraformaldehyde containing 2% sucrose, permeabilized in 0.1% Triton X-100, and blocked in 
1% normal goat serum containing 5% fetal calf serum. After washing with PBS, cultures were 
incubated with secondary antibodies (Alexa- 488 or 594 -labeled goat anti-mouse or anti-rabbit 
antibodies; Invitrogen), Alexa- 488 or 594 -labeled phalloidin, or propidium iodide for 1-2 hours, 
washed with PBS, incubated for 10 minutes with DAPI counterstain (Invitrogen), and washed 
overnight in PBS. Apoptosis was assessed by TUNEL assay (In situ cell death detection kit, 
Fluorescein, Roche).   
 
Image acquisition and analysis. 
All images were captured using an Olympus FV500 confocal microscope with Fluoview 
software, and a 60X water immersion objective (1.2 numerical aperture; Olympus).  3-D 
reconstructions were generated using Volocity (Perkin-Elmer) and Imaris (Bitplane) software. 
Analysis of chromatin distribution within 2-D and 3-D nuclei was performed using Metamorph 
software (Molecular Devices). The integrated density and mean fluorescence signal of Acetyl-
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H3K9, H3K27Me3 and BrU levels within intact cells (in vitro and in vivo) were quantified from 
confocal Z-slices using Image J software (National Institutes of Health). For quantification of the 
fluorescence signal within isolated nuclei, Imaris imaging software was used to map the surface 
of the DAPI-stained nuclei and determine the total masked fluorescence signal (BrU or Acetyl-
H3K9) within the 3-D reconstructed nuclear surface.  
 
Atomic force microscopy (AFM) micro-indentation.   
Fibrin gels were washed briefly with PBS after removing culture medium. Samples were 
mechanically characterized using an Asylum MFP-3D atomic force microscope (Asylum 
Research) by performing micro-indentation using a sphere-tipped probe (Novascan) with a sphere 
diameter of 5 µm and a nominal spring constant of ~60 pN/nm. The cantilever spring constant was 
confirmed by thermal fluctuation method (Thundat et al., 1994). The AFM system was calibrated 
by following the manufacturer’s recommended standard procedure before each indentation 
measurement. AFM micro-indentation was performed in PBS solution at room temperature. 
Individual force-indentation profile was acquired at an indentation rate of 2 µm/s using deflection 
trigger mode with a trigger value of 200 nm. The AFM tip was positioned either adjacent to or 
away from a cell. Shear modulus at each position was calculated from fitting force-indentation 
data using a Hertz sphere model (Richert et al., 2004).   
 
Mice and in vivo studies. 
Constitutive Mt1-mmp-/- mice have been described previously (Holmbeck et al., 1999).  To 
examine nuclear structure within intact aortae, mice were anesthetized with ketamine/xylazine and 
perfused through the left ventricle with 4% paraformaldehyde to fix aortic mural cells in situ.  Mice 
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were then euthanized, and aortae were harvested and frozen in optimal cutting temperature (OCT) 
medium (Tissue-Tek) for processing by standard techniques. For detection of de novo transcripts 
in the mouse aorta, a 0.1M solution of 5’Fluorouracil (Sigma) prepared in sterile Dulbecco’s PBS 
(DPBS) was injected into the peritoneal cavity at a dose of 2 µmol/g mouse into 17-21 day old 
MT1 knockout mice and corresponding wild-type littermate controls, and allowed to incorporate 
for 2 hours. The mice were then euthanized, and their aortas were excised, flash frozen in OCT 
medium, sectioned at a thickness of 30µm, and immunostained with an antibody against BrdU, as 
described previously (Spencer et al., 2011).  
 
  
146 
 
Fig. 4-1.  
 
 
Fig. 4-1.  Control of nuclear architecture through fibronectin matrix assembly and MT1-
MMP-dependent pericellular proteolysis.  
(A)  Endothelial cells transduced with GFP lentivirus, with lentivirus expressing GFP-tagged 
scrambled shRNA, or with shRNA targeting MT1-MMP, and embedded within 3-D fibrin gels for 
culture with VEGF (100 ng/ml) and HGF (50 ng/ml) (VEGF/HGF) alone or in the presence of BB-
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94 (5 µM) or FUD (250 nM) for 48 h. Cell morphology was assessed from 3-D reconstructions of 
the GFP signal (1 unit = 21.3 µm). (B) 3-D reconstructions of DAPI nuclear staining in 
VEGF/HGF-stimulated endothelial cells cultured in 3-D fibrin alone or in the presence of BB-94 
or FUD; and 3-D reconstruction of the DAPI staining in endothelial cells transduced with MT1-
MMP shRNA and cultured in 3-D fibrin under VEGF/HGF stimulation (1 unit = 21.3 µm). (C)  
Endothelial cells expressing GFP-tagged lamin A within (3-D) fibrin gels or atop (2-D) fibrin gels 
in the presence or absence of BB-94 or FUD with DAPI nuclear staining. Phalloidin staining 
highlights the filamentous (F)-actin arrangements in the control and targeted conditions (scale bar 
= 20 µm). Immunofluorescence for the nuclear pore complex component NUP153 in VEGF/HGF-
stimulated endothelial cells cultured under 2-D or 3-D conditions alone, or in the presence of BB-
94 or FUD. Nuclei were stained with DAPI (scale bar = 2 µm). Arrowheads indicate nuclear 
membrane invagination sites.  
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Fig. 4-2.  
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Fig. 4-2. Regulation of chromatin structure and transcriptional activity through fibronectin 
matrix assembly and MT1-MMP-dependent pericellular proteolysis.   
(A) In situ transcriptional activity in endothelial cells cultured within 3-D fibrin hydrogels for 48 
h with VEGF/HGF alone, or in the presence of BB-94 or FUD, or in endothelial cells cultured in 
3-D following their transduction with MT1-MMP-targeting shRNA. Following a 1 hour incubation 
with bromouridine (BrU), labeled RNA (BrU-RNA) was detected by indirect immunofluorescence 
(scale bar = 5 µm).  (B) Quantifications represent the integrated density of the fluorescence signal 
within individual endothelial cell nuclei from n>10 fields per condition.  For a negative control, 3-
D cultures were incubated with Actinomycin D (5 µg/ml) prior to the 1 hour incubation with BrU 
(*p<0.001). (C) Immunofluorescence for BrU-RNA in endothelial cells cultured atop 2-D fibrin 
gels for 48 h with VEGF/HGF alone or together with BB-94 or FUD, or endothelial cells 
transduced with MT1-MMP-targeting shRNA and cultured on 2-D fibrin gels for 48 h with 
VEGF/HGF (scale bar = 5 µm). (D) Quantifications represent the integrated density of the 
fluorescence signal within individual endothelial cell nuclei from n>10 fields per condition.  For 
a negative control, 3-D cultures were incubated with Actinomycin D (5 µg/ml) prior to the 1 hour 
incubation with BrU (*p<0.001). (E)  Endothelial cells expressing a construct encoding GFP-
labeled histone H2B under 2-D or 3-D conditions with VEGF/HGF-stimulation alone or in the 
presence or absence of BB-94 or FUD.  Arrowheads indicate chromatin condensed at the nuclear 
periphery (scale bar = 5 µm). Quantification of the relative chromatin-negative area in endothelial 
cell nuclei under 2-D and 3-D conditions (**p<0.05).  (F)  Immunofluorescence of Acetyl-H3K9 
in VEGF/HGF-stimulated endothelial cells cultured alone or in the presence of BB-94 or FUD 
under 2-D and 3-D condition with DAPI counter-staining, with quantification of the fluorescence 
density per nuclei from n>10 fields per condition (n=3 experiments). **p<0.001. (G) 
Immunofluorescence of H3K27Me3 in VEGF/HGF-stimulated endothelial cells cultured alone or 
in the presence of BB-94 or FUD under 2-D and 3-D conditions (scale bar = 5 um), with 
quantification of fluorescence density per nuclei from n>10 fields per condition and n=3 
experiments. (H) Chart of the Gene Ontology (GO) categories enriched in the BrU-RNA 
sequencing (BrU-Seq) of VEGF/HGF-stimulated endothelial cells cultured in 3-D ECM alone or 
in the presence of BB-94 (n=2, pooled replicates) with a 2-fold change cutoff. Pink columns 
represent the GO categories enriched in the 162 down-regulated transcripts. Green columns 
represent the GO categories enriched in the 39 upregulated genes.   
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Fig. 4-3.  
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Fig. 4-3.  Regulation of nuclear architecture and transcriptional activity by the cytoskeleton 
in 3-D.  
(A) Immunofluorescence for nesprin-1 (top row), nesprin-2 (middle row), and nesprin-3 (bottom 
row) in VEGF/HGF-stimulated endothelial cells cultured within 3-D fibrin gels for 48 h in the 
presence or absence of BB-94 or FUD with DAPI nuclear staining (scale bar = 5 µm). (B) 
Fluorescence of F-actin (top row), β-tubulin (middle row) and vimentin (bottom row) in 
VEGF/HGF-stimulated endothelial cells cultured in the presence or absence of BB-94 or FUD in 
3-D ECM (scale bar = 20 µm). (C) Endothelial cells were cultured in 3-D ECM hydrogels with 
VEGF/HGF alone or with BB-94 or FUD for 48 h, the hydrogels were released from the culture 
wells, and the percentage of gel contraction was quantified (*p< 0.05). (D) Pericellular ECM 
rigidity in 3-D cultures of endothelial cells stimulated with VEGF/HGF alone or with BB-94 or 
FUD was quantified by atomic force microscopy micro-indentation, and the shear modulus of the 
pericellular ECM environment was determined. The inset shows a representative image of a 3-D-
embedded endothelial cell interfacing with the atomic force microscopy probe (scale bar = 40 µm). 
(E) 3-D reconstructions of the DAPI signal from serial Z-sections through endothelial cells 
cultured in the presence of DMSO (vehicle), blebbistatin (25 µM) or nocodazole (5 µm) for 48 h 
(scale bar = 5µm). (F) Endothelial cells expressing GFP-lamin A and cultured in 3-D ECM in the 
presence of DMSO, blebbistatin or nocodazole for 48 h with DAPI and F-actin staining (scale bar 
= 15 µm). (G) Immunofluorescence for NUP153 in endothelial cells cultured with VEGF/HGF in 
the presence of DMSO, blebbistatin or nocodazole. Nuclei were counter-stained with DAPI (scale 
bar = 2 µm). Arrowheads indicate nuclear pore complex aggregates at nuclear membrane 
invaginations. (H) Endothelial cells expressing GFP-H2B chromatin and embedded in 3-D ECM 
for culture in the presence of DMSO, blebbistatin or nocodazole. Arrowheads indicate peripheral 
chromatin aggregations (scale bar = 10 µm). (I) Immunofluorescence for BrU-RNA or Acetyl-
H3K9 in VEGF/HGF-stimulated endothelial cells cultured in 3-D ECM in the presence of DMSO, 
blebbistatin or nocodazole (scale = 5 µm).  All images are representative of n=3 experiments.  
 
  
152 
 
Fig. 4-4.  
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Fig. 4-4. Perturbations of the LINC complex recapitulate ECM remodeling-dependent 
changes in nuclear shape and nascent transcript production.  
Endothelial cells were transduced with an empty (vector) retrovirus or a retrovirus expressing 
GFP-KASH (green) and embedded within 3-D fibrin for 48 h. (A) Morphology of control and 
GFP-KASH nuclei in 3-D ECM, as visualized from 3-D reconstructions of DAPI staining (1 unit 
= 21.3 µm). Nuclear concavity was quantified in endothelial cells by morphometric analysis of 
confocal Z-sections (*p<0.05). (B) Nuclear envelope and F-actin organization in GFP-KASH cells 
relative to control with DAPI counter-staining (scale bar = 15 µm). Immunofluorescence for 
NUP153 with DAPI counter-staining. Arrowhead indicates a nuclear pore aggregate at a nuclear 
membrane invagination site (scale bar = 2 µm). (C) Chromatin organization in vector- and GFP-
KASH-transduced endothelial cells in 3-D, as visualized by DsRed-labeled histone H2B (scale bar 
= 5 µm). Immunofluorescence for BrU-RNA and Acetyl-H3K9 with DAPI counter-staining (scale 
bar = 5 µm). (D) Quantifications of the integrated density of BrU-RNA and Acetyl-H3K9 per 
nuclei in vector and GFP-KASH-transduced endothelial cells cultured in 3-D ECM with 
VEGF/HGF (n>10 fields per condition, *p<0.001, n=3 experiments). (E) qPCR for Nesprin-2 in 
endothelial cells transfected with scrambled siRNA or Nesprin-2 siRNA as normalized to Gapdh 
and expressed as mean values (n=2 experiments). (F) 3-D reconstructions of nuclei within 
endothelial cells transfected with scrambled siRNA or Nesprin-2 siRNA and embedded within 3-
D fibrin for 48 h-culture with VEGF/HGF. Immunofluorescence for BrU-RNA and Acetyl-H3K9 
in 3-D-cultured endothelial cells expressing scrambled siRNA or Nesprin-2 siRNA with DAPI 
counter-staining. (G) Quantifications of the mean fluorescence density per nuclei for BrU-RNA 
(top) and Acetyl-H3K9 (bottom) in Nesprin-2 -targeted endothelial cells cultured within 3-D ECM 
(n>10 fields per condition, **p<0.001).   
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Fig. 4-5.  
 
 
Fig. 4-5. Direct modulation of 3-D cell shape using synthetic PEG-hydrogels controls nuclear 
architecture and function.  
(A)  Schematic of PEG-hydrogel structure. Factor XIIIa was used to crosslink two multi-arm PEG-
peptide conjugates bearing complementary transglutaminase peptide substrates (NQEQVSPL) 
derived from the N-terminus of α2-plasmin inhibitor and the synthetic lysine donor peptide Ac-
FKGG at a final concentration of 2.0%. To render the gels susceptible to degradation by MMPs, 
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the lysine donor peptide was designed to contain the MMP substrate GPQG↓IWGQ, derived from 
the native sequence GPQG↓IAGQ found in α1(I) collagen chain (↓ indicates the cleavage site). 
The sequence GDQGIAGF was chosen as a MMP-insensitive control linker. To provide cell 
adhesion sites, the integrin-binding peptide H-NQEQVSPLRGDSPG-NH2 was grafted to both gel 
types at constant concentration. (B)  Cell shape of VEGF/HGF-stimulated (GFP-labeled) 
endothelial cells cultured for 48 h within 3-D PEG hydrogels with MMP-degradable cross-links 
alone or in the presence of BB-94, or within MMP-nondegradable hydrogels, as visualized with 
3-D reconstructions of GFP signal. Morphologies of the corresponding nuclei, as indicated by 3-
D reconstructions of the DAPI signal (1 unit = 21.3 µm).  (C)  Endothelial cells expressing GFP-
lamin were embedded in MMP-degradable or MMP-nondegradable hydrogels and stained for F-
actin and DAPI following 48 h culture with VEGF/HGF. (D) Immunofluorescence for BrU-RNA 
or Acetyl-H3K9 in VEGF/HGF-stimulated endothelial cells cultured within 3-D MMP-degradable 
and MMP-nondegradable hydrogels. Nuclei were counter-stained with DAPI (scale = 5 µm). 
Quantification of the integrated density of BrU-RNA fluorescence (left) and Acetyl-H3K9 
fluorescence (right) per nuclei from n>10 fields and n=3 experiments. *p<0.01.  
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Fig. 4-6.  
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Fig. 4-6. Nuclear shape directly regulates chromatin structure and transcriptional activity. 
(A) 3-D reconstructions of isolated nuclei incubated with 12% w/v PEG solution for 30 min at 
room temperature followed by a 30-min nuclear run-on transcription assay with Br-UTP. 
Immunofluorescence for BrU-RNA with DAPI counter-staining and quantification of the mean 
fluorescence intensity within oval and crumpled nuclei from n=3 experiments. (B) 
Immunofluorescence for BrU-RNA with DAPI nuclear counter-staining and 3-D reconstructions 
of the DAPI signal after a 30-min nuclear run-on assay for the following conditions: (i) a 1 hour 
pre-incubation in 12% w/v PEG, (ii) a 1 hour pre-incubation in 25% w/v PEG, or (iii) a 30 min 
pre-incubation in 25% w/v PEG followed by a 30 min pre-incubation in 12% w/v PEG. Nuclear 
run-on assays were performed in the final % w/v PEG. (C) Percentage of oval or crumpled nuclei 
following 1 hour incubation in 12% or 25% w/v PEG, or a 30 min incubation in 25% w/v PEG 
followed by a 30 min incubation in 12% w/v PEG. (D) Relative nuclear concavity values of the 
isolated nuclei from n>10 fields, as normalized to the sum of the nuclear concavities present under 
the 12% PEG condition (n=3 experiments).  (E) Quantification of mean fluorescence intensity for 
BrU-RNA in the isolated nuclei (F) Immunofluorescence for Acetyl-H3K9 with DAPI counter-
staining in isolated nuclei. Following pre-treatment of cells with 50 ng/ml trichostatin A (TSA), 
intact endothelial cell nuclei were isolated in situ, incubated in either 12% or 25% w/v PEG 
solution and subjected to a 30-min nuclear run-on transcription assay with Br-UTP. The intensity 
of the Acetyl-H3K9 fluorescence signal per nuclei was quantified from n>10 fields (n=2 
experiments).  
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Fig. 4-7.  
 
Fig. 4-7. Regulation of 3-D VSMC morphology, nuclear shape and transcriptional activity by 
MT1-MMP in vivo.  
(A) Mouse vascular smooth muscle cells (VSMCs) harvested from Mt1-mmpfl/fl mice, treated with 
either adenovirus encoding β-galactosidase (Adeno-βgal) or Cre recombinase (Adeno-Cre), and 
embedded within 3-D type I collagen for 48 h-culture. 3-D projections of VSMC morphology and 
corresponding nuclear architecture as assessed from 3-D reconstructions of α-smooth muscle actin 
(αSMA) and DAPI counter-staining. (1 unit = 21.3 µm). (B) H&E staining of aorta isolated from 
wildtype (Mt1-mmp+/+) and global knockout (Mt1-mmp-/-) mice (left) (scale bar = 100 µm). 
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Immunofluorescence for αSMA in frozen sections of aorta from the same Mt1-mmp+/+ and Mt1-
mmp-/- mice with DAPI counter-staining (right).  (C) 3-D reconstructions of DAPI staining in 
cross-sections of Mt1-mmp+/+ and Mt1-mmp-/- aorta (1 unit = 21.3 µm). (D) Aorta were harvested 
from Mt1-mmp+/+ and Mt1-mmp-/- mice injected with vehicle or 5’fluorouracil (5’FU). 
Immunofluorescence for 5’FU-labeled transcripts (F-RNA) was used as a read-out of 
transcriptional activity. Images are representative of n>150 nuclei per genotype from n=4 
replicates. (E) Immunofluorescence for Acetyl-H3K9 in cross-sections of Mt1-mmp+/+ and Mt1-
mmp-/- aorta with DAPI counter-staining (scale = 20 µm). VSMC nuclei were classified as having 
‘high’, ‘medium’, or ‘low’ signal intensity based on integrated density of the Acetyl-H3K9 
fluorescence signal.  The mean frequency of nuclei with each signal is presented. 
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Fig. 4-S1.  
 
Fig. 4-S1. ECM remodeling-dependent regulation of endothelial cell proliferation under 3-
D, and not 2-D, conditions.  
(A) F-actin staining of endothelial cells cultured in 3-D fibrin for 6 d in the presence of serum 
alone (basal), or together with 100ng/ml VEGF and 50ng/ml HGF (VEGF/HGF), or with 
VEGF/HGF and BB-94 (5 µm). Nuclei were counter-stained with DAPI (n=3 experiments) (scale 
bar = 50 µm). (B) Phase contrast imaging of endothelial cells cultured atop 2-D fibrin under basal 
or VEGF/HGF conditions, or with VEGF/HGF and either BB-94 or 250 nM of the FUD for 72 h 
(scale bar = 200 µm). (B) Quantification of endothelial cell number (X105) following culture atop 
2-D fibrin under basal or VEGF/HGF conditions, or with VEGF/HGF and either BB-94 inhibitor 
or FUD for 72 h.  
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Fig. 4-S2.  
 
Fig. 4-S2. Pericellular ECM remodeling-inhibition does not induce apoptosis under either 2-
D or 3-D conditions.  
Endothelial cells were either cultured atop 2-D fibrin or embedded in 3-D ECM under basal or 
VEGF/HGF conditions, or with VEGF/HGF and either BB-94 inhibitor or FUD for 48 h. 
Apoptosis was assessed by TUNEL assay. (A) Quantification of TUNEL-positive nuclei following 
2-D culture. (B) Quantification of TUNEL-positive nuclei following 3-D culture. Endothelial cells 
were embedded within 3-D fibrin under the indicated conditions.   
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Fig. 4-S3.  
 
Fig. 4-S3. Blockade of transcriptional activity or S-phase progression do not induce 
changes in nuclear shape in 3-D ECM.  
(A) Phase imaging and DAPI nuclear staining of endothelial cells cultured within 3-D ECM with 
VEGF/HGF for 42 h, followed by 3 h culture with either vehicle control or Actinomycin D (5 
µg/ml). 3-D reconstructions of DAPI staining (right) (1 unit = 21.3 µm). (B) Phase imaging and 
DAPI nuclear staining of endothelial cells cultured within 3-D ECM with VEGF/HGF alone or 
together with BB-94 (5 µm) or Aphidicolin (10 µM) inhibitors for 48 h. Insets show close-up of 
representative DAPI staining without Phase overlay.  
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Fig. 4-S4.  
 
Fig. 4-S4.  2-D cytoskeletal organization is modulated independently of ECM Remodeling 
Pathways.  
(A) Immunofluorescence for F-actin (labeled with phalloidin) (top row), β-tubulin (middle row), 
or vimentin (bottom row) in endothelial cells cultured with VEGF/HGF alone or in the presence 
of BB-94 or FUD peptide atop a substratum of fibrin for 48 h. Nuclei were counter-stained with 
DAPI.  
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Fig. 4-S5.  
 
Fig. 4-S5. Regulation of nuclear architecture and transcriptional activity by the cytoskeleton 
in 3-D.  
(A) Relative nuclear concavity of nuclei from VEGF/HGF-stimulated endothelial cells cultured in 
3-D fibrin in the presence or absence of DMSO (vehicle), blebbistatin (25 µM) or nocodazole (5 
µM) for 48 h. (*p<0.0001; **p=0.0003). (B) Relative chromatin distribution in nuclei of 
VEGF/HGF-stimulated endothelial cells expressing the GFP-H2B construct and cultured in 3-D 
fibrin in the presence of DMSO, blebbistatin or nocodazole. (**p<0.05).  (C) The mean density of 
the BrU-RNA fluorescence signal per individual nuclei in endothelial cells cultured in 3-D fibrin 
in the presence of DMSO, blebbistatin or nocodazole (n>10 fields per condition, **p<0.0001, n=3 
experiments). (D) The mean density of Acetyl-H3K9 fluorescence within nuclei of VEGF/HGF-
stimulated endothelial cells cultured in 3-D fibrin in the presence of DMSO, blebbistatin or 
nocodazole (n>10 fields per condition, *p<0.001, n=3 experiments).  
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Fig. 4-S6.  
 
Fig. 4-S6. Nuclear shape and chromatin structure atop micropatterned substrata. 
(A) Phase contrast imaging of endothelial cells cultured atop uniformly-coated fibronectin 
substrata or 35x35 µm fibronectin ‘islands’ and cell morphology (left panels, scale = 50 µm). F-
actin and DAPI staining of respective cells (middle panels, scale = 30 µm).  Arrowhead indicates 
a nuclear membrane infolding.  Immunofluorescence of NUP153 with DAPI nuclei counter-
staining with arrowhead indicating nuclear member indentation (right panels, scale = 4 µm). (B) 
Chromatin distribution in endothelial cells expressing GFP-H2B atop unpatterned substrata or 
fibronectin islands with quantification of the relative chromatin-free area (scale = 5 µm; *p<0.05). 
(C) Immunofluorescence for Acetyl-H3K9 in endothelial cells atop unpatterned substrata or 
islands with DAPI counter-staining. Relative histone acetylation signal was quantified by 
morphometric analysis (scale = 30 µm; *p<0.05). 
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Fig. 4-S7.  
 
Fig. 4-S7. Pericellular ECM remodeling-dependent regulation of nuclear shape and 
transcriptional activity in vascular smooth muscle cells.  
(A) Immunofluorescence for Acetyl-H3K9 in vascular smooth muscle cells embedded in 3-D type 
I collagen for 48 h in the presence of PDGF-BB and FGF-2 (10 ng/ml each) (PDGF-BB/FGF-2) 
with vehicle control or BB-94 inhibitor. Nuclei were counter-stained with DAPI. Quantification of 
the integrated density of Acetyl-H3K9 immunofluorescence from n>10 fields per condition and 
n=3 experiments. *p<0.01. (B) Immunofluorescence for BrU-RNA and DAPI staining in vascular 
smooth muscle cells embedded in 3-D type I collagen for 48 h in the presence of PDGF-BB/ FGF-
2 with vehicle control or BB-94 inhibitor. Quantification of the integrated density of BrU 
immunofluorescence from n>10 fields per condition and n=3 experiments. *p<0.01.  
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Note.  
* This chapter is in preparation for submission as a manuscript, entitled: “MT1-MMP-Mediated 
Pericellular Proteolysis controls the KASH∙SUN-Dependent Regulation of Vascular Cell Nuclear 
Architecture and Function,” by Tamar Y. Feinberg*, R. Grant Rowe*, Martin Ehrbar, Matthias P. 
Lutolf, Stephen I. Lentz, Colette J. Shen, Christopher S. Chen, Heidi N. Fridolfsson, Daniel A. 
Starr, Fei Liu, Daniel Tschumperlin, Deane F. Mosher and Stephen J. Weiss. (* denotes equal 
contribution). 
 
168 
 
CHAPTER 5: Discussion 
 
Herein, we document central roles for MT-MMPs and pericellular ECM remodeling in 
governing the cell motility, proliferation, transcription, and differentiation programs required for 
postnatal branching morphogenesis. In vivo, a subtending and contiguous BM barrier separates 
mammary epithelial tubules as well as vascular endothelial cells from their surrounding interstitial 
matrix environment (Williams and Daniel, 1983). However, while normal mammary epithelial 
cells never establish direct contact with the type I collagen-rich stromal matrix, endothelial cells 
uniquely respond to angiogenic signals by traversing the BM and directly interfacing with the 
interstitial ECM (Carmeliet and Jain, 2011). In mature postnatal tissue environments, we find that 
mammary stromal cell populations rely on MT-MMP-directed proteolytic activity to coordinate 
morphogenesis. While the roles of MT-MMPs in angiogenic responses in vivo remain to be 
determined, endothelial cells cultured in vitro likewise depend on MT-MMP-derived proteolytic 
activity to alter cell shape and proliferate in 3-D hydrogels of type I collagen or fibrin. In the 
specific case of endothelial cells, pericellular proteolysis of the 3-D interstitial matrix governs cell 
function as well as cell behavior by modulating nuclear architecture, and subsequently gauging 
transcriptional activity to meet the signaling needs required morphogenic responses. Ongoing 
work will address the in vivo role of pericellular ECM remodeling during angiogenic responses as 
well as its role in controlling nuclear architecture and function of mammary stromal cell 
populations, including fibroblast-like cells and adipocyte precursors. 
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 Despite accumulating in vitro evidence implicating MMP family members in mammary 
epithelial branching (Alcaraz et al., 2011; Bonnans et al., 2014; Brownfield et al., 2013; Mori et 
al., 2009; Rebustini et al., 2009; Weaver et al., 2014), embryonic and early postnatal mammary 
gland branching programs proceed in an unabated fashion following the in vivo targeting of the 
dominant MMPs reported to regulate epithelial morphogenesis, including MT1-MMP and MT2-
MMP.  Importantly, deletion of epithelial cell-derived Mt1-mmp alone, Mt2-mmp alone, or both 
Mt-mmps together, failed to impede later stages of postnatal morphogenesis, countering current, 
largely in vitro – based paradigms, where epithelial-derived proteases orchestrate branching organ 
development when the cells establish direct – albeit artefactual – contact with type I collagen. 
Alternatively, our study of early postnatal mammary gland development unexpectedly revealed 
key regulatory roles for both MT1-MMP and MT2-MMP in the mammary stromal fat pad. While 
global knockout of Mt1-mmp down-regulates adipogenesis, Mt2-mmp deletion enhances the 
formation of beige/ brown adipocytes. Beige and brown adipocytes have been reported in wild-
type mammary tissue before the onset of puberty, yet disappear by ~ 9 weeks after birth (Gouon-
Evans and Pollard, 2002). To evaluate the persistence of this thermogenic gene signature under 
Mt2-mmp-null conditions, mammary fat pad tissue was isolated from 4-to-5 month-old mice. 
Interestingly, both male and female Mt2-mmp-/- mice retain elevated levels of UCP1 protein, as 
well as increased expression of Prdm16 and Pgc1α (n=3) - two central regulators of brown/beige 
adipogenesis (Cohen et al., 2014; Wu et al., 2013). As both paracrine and systemic signals from 
the sympathetic nervous system has been shown to regulate thermogenesis (Whittle et al., 2012), 
stromal vascular cells will be harvested in subsequent experiments for culture under 2-D versus 3-
D conditions to evaluate their preferential differentiation into white versus brown lineages (Chun 
et al., 2006; McDonald et al., 2015; Tang et al., 2013). Further studies will also evaluate whether 
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the smaller adipocytes present in stromal cell-targeted Dermo1Cre+/-Mmp14fl/fl mice or adipocyte-
targeted AdipoqCre+/-Mmp14fl/fl mice stem from attenuated adipogenesis and lipid metabolism or 
from changes in lineage commitment and cell fate.  
Given the expression of MT1-MMP in the mammary stroma and its evident functional 
roles during early mammary gland development, we sought to evaluate the consequences of 
targeting stromal cell-derived Mt1-mmp on postnatal mammary gland development. Contrary to 
current dogma, postnatal mammary gland branching through mature ECM relies on MT1-MMP 
expression from the stroma, rather than from the epithelium, to orchestrate the remodeling of the 
interstitial ECM.  The abrogated postnatal mammary gland branching in mice with stromal cell-
targeted Mt1-mmp coincides with a block in interstitial ECM remodeling and a concomitant 
increase in ECM. While mice with MT1-MMP-resistant type I collagen largely recapitulate the 
branching defect observed in the stromal cell-targeted model, further studies are needed to 
determine the mechanisms by which increased type I collagen levels ablate morphogenetic 
responses. In the simplest scenario, the dense network of type I collagen “simply” presents itself 
as a physical barrier to tubule elongation. More likely, however, the increased rigidity of the 
surrounding matrix alters epithelial cell gene expression. We hope to gain better insight into 
epithelial cell-collagen interactions by culturing wild-type mammary tubule fragments in 
increasingly dense collagen hydrogels in vitro and interrogating changes in gene expression.  
Although mammary glands isolated from AdipoqCre+/-Mt1-mmpfl/fl mice show 
uninterrupted postnatal mammary gland branching, ruling out a critical role for MT1-MMP-
expressing adipocytes, preliminary data points to a critical role for the mammary periductal 
fibroblasts, the dominant cells known to express the interstitial ECM components that surround 
the mammary epithelium (Keely et al., 1995). Preliminary data show that the tamoxifen-inducible 
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transgenic mouse model, Col1a2-CreER, wherein the Col1a2 promoter drives Cre recombinase 
expression, displays more specific expression in the mammary periductal fibroblasts. Further, 
preliminary data suggests that Col1a2-CreER+/-Mt1-mmpfl/fl mice display a similar block in 
postnatal mammary gland branching relative to that present in Dermo1Cre+/-Mt1-mmpfl/fl mice. As 
gene changes from intact tissue lysates would reflect the transcriptional profile of the entire 
mammary gland, future experiments will use the RiboTag mouse model (Sanz et al., 2009) to 
specifically isolate and profile the mammary fibroblasts. In the RiboTag model, the presence of 
Cre recombinase fuses an HA-tag to the ribosomal protein subunit, RPL22, generating RPL22-
HA, that can be used to selectively immune-precipitate polyribosomes from cells expressing the 
Col1a2-Cre and evaluate the transcripts that are actively being translated into protein.  
Targeting of stromal cell-derived MT1-MMP with Dermo1-Cre also results in a marked 
decrease in terminal end bud (TEB) size and proliferative activity. Since TEBs are thought to drive 
mammary gland branching (Hinck and Silberstein, 2005; Jackson-Fisher et al., 2004; Kurley et al., 
2012), further studies will address whether the postnatal mammary ducts fail to elongate, in part, 
due to a defect in the TEBs, themselves. A TEB defect might arise from any number of factors, 
including an insufficiency in paracrine signals from the mammary mesenchyme (Jackson-Fisher 
et al., 2004; Kurley et al., 2012; Visbal et al., 2011). While the gene expression profile did not 
reveal sufficient changes in the stromal cell-derived growth factors and signaling receptors to 
explain the halt in postnatal branching, stromal cell-derived MT1-MMP might still regulate the 
growth factor/cytokine repertoire at a post-transcriptional level, especially given the proposed 
roles for MT1-MMP in activating a suite of cell surface- and ECM-bound growth factors with 
critical roles in tissue morphogenesis (Barbolina and Stack, 2008; Itoh, 2015; Rowe and Weiss, 
2009). As intact Mt1-mmp-/- mammary epithelial ducts from TEB-deficient glands mount a normal 
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branching program through wild-type mammary stroma, any defect in TEB function is likely 
reversible.  
 Nevertheless, the functional roles of MT1-MMP and MT2-MMP in the epithelial cell 
compartment in vivo remain to be defined – either during virgin branching morphogenesis or 
during postnatal stages of adult mammary gland remodeling, including pregnancy, lactation and 
involution. With regard to epithelial cell-derived MT1-MMP, mammary epithelial compartments 
have been harvested from 4-week MMTV-Cre+/-Mt1-mmpfl/fl and Mt1-mmpfl/fl littermates and 
evaluated by Affymetrix gene expression profiling (n=2 per genotype). However, only 21 genes 
were differentially expressed in conditional knockout mammary epithelial cells relative to 
littermate controls using a 2-fold enrichment cutoff. Upon closer inspection, the most down-
regulated genes appear tightly related to mammary epithelial cell differentiation, and include 
Glycam-1 (41-fold) and Casein genes Csn1s1 (7-fold), Csn2 (5-fold) and Csn1s2b (2-fold) 
(Dowbenko et al., 1993; Hou et al., 2000; Yamaji et al., 2013). As MMTV-Cre-expressing (line A) 
mice have reported defects in mammary epithelial cell differentiation (Robinson and 
Hennighausen, 2011; Yuan et al., 2011), mammary epithelial cells were also harvested from 
MMTV-Cre+/- and wild-type littermates on the same FVB mouse background (n=2 per genotype) 
and the gene expression profile was evaluated. However, the transcriptome profiling failed to 
uncover significant changes in these genes, supporting a potential positive role for MT1-MMP in 
promoting mammary epithelial cell differentiation. Parallel studies will also be performed for 
epithelial cells harvested from MMTV-Cre+/-Mt2-mmpfl/fl mice. More importantly, future studies 
will examine the roles of MT1-MMP and MT2-MMP in pregnancy, lactation and involution. 
Indeed, preliminary studies indicate the MT1-MMP is most highly expressed in involuting 
mammary glands, a developmental program wherein the ECM undergoes its most striking 
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remodeling. While the reported defects in lactation in MMTV-Cre (line A) mice preclude the use 
of this model for such studies, future studies to uncover roles for MT1-MMP in pregnancy, 
lactation and involution will employ a combination of transplant approaches and conditional 
targeting with transgenic mice expressing Cre recombinase from the Beta-lactoglobulin (Blg) 
promoter, which allow efficient targeting of floxed alleles during all stages of pregnancy, lactation, 
and involution (Naylor et al., 2005). Mice bearing transplanted epithelial ducts from Mt1-mmp-/- 
mice can also be bred to evaluate the roles of epithelial cell-derived MT1-MMP during pregnancy 
(Miyoshi et al., 2001; Zhang et al., 2011).  
 Interestingly the unaltered viability of Mt2-mmp-/- mice, efforts to mate Mt2-mmp-/- mice 
and address the roles of Mt2-mmp in the mammary gland during pregnancy, lactation and 
involution failed to generate offspring (n>10 females). Further, while Mt2-mmp-/- mammary glands 
showed unaltered branching programs at 4 weeks, whole mount assessments at 8 weeks revealed 
a delay in duct elongation (n=3 replicates). Since ovaries are key regulators of mammary gland 
morphogenesis and reproduction, the ovaries of Mt2-mmplacZ/+, Mt2-mmp-/- and wild-type 
littermates were assessed. LacZ staining of ovaries harvested from 4 week-old mice reveal marked 
staining of Mt2-mmp, in the secondary follicles (composed of an inner-lying oocyte and several 
layers of circumscribing granulosa cells) as well as in the surrounding stromal (thecal) cells.  
Unexpectedly, while adult wild-type mice harbor ovaries with numerous secondary follicles at 8 
weeks, serial sections through Mt2-mmp-/- ovaries revealed degenerated structures that lacked 
distinct follicles even at earlier time-points (postnatal day 10). As ovarian follicles are surrounded 
by a patent basement membrane that undergoes pericellular remodeling during ovulation, this 
system offers an alternate model to investigate roles for MT-MMP-dependent pericellular ECM 
remodeling in tissue morphogenesis.   Importantly, as the observed defect in ovarian development 
174 
 
precludes assessments of Mt2-mmp-/- mammary glands during pregnancy, lactation, and 
involution, similar conditional targeting and transplant approaches will be employed. 
Finally, while deletion of Mt1-mmp and Mt2-mmp in the mammary epithelial cells with 
MMTV-Cre fails to block postnatal branching morphogenesis, MT1-MMP and MT2-MMP may 
still modulate mammary gland development from different cellular compartments (i.e., stromal 
and epithelial, or vice versa). Consistent with the notion that MT1-MMP and MT2-MMP 
collaborate in the developing embryo to orchestrate tissue morphogenesis, Mt1-mmp-/-Mt2-mmp-/- 
mice die in utero ~ E10.5 (unpublished observation) (Szabova et al., 2010). Szabova et al argue 
that this lethality results from defects in placental development and the establishment of the 
extraembryonic tissues required for nutrient exchange with the maternal blood supply (Szabova et 
al., 2005). However, preliminary attempts to generate conditional knockout mice with the Meox2-
Cre knock-in line, which drives Cre expression exclusively in the embryo proper (epiblast) by 
E7.5 while sparing extraembryonic tissues (Tallquist and Soriano, 2000), have failed to generate 
dual-targeted Meox2-Cre+/-Mt1-mmpfl/flMt2-mmpfl/fl offspring (P0/ birth, n=4 litters). Further work 
will explore the stage and cause of this lethality, as it would provide the first example of an MMP 
requirement during embryonic development in either vertebrate or invertebrate model systems.  
 To date, most of our efforts to determine the in vivo role of MT-MMPs in branching 
morphogenesis have focused on the mammary gland. Nevertheless, both Mt1-mmp and Mt2-mmp 
are expressed in the developing vasculature. However, preliminary studies indicate the in vivo 
targeting of endothelial cell Mt1-mmp alone, or Mt1-mmp and Mt2-mmp in combination with Tie2-
Cre (Landskroner-Eiger et al., 2015) fails to abrogate blood vessel development or the 
angiogenesis that coincides with postnatal mammary gland branching. Importantly, as in the case 
of embryonic and early postnatal mammary gland development, the vascular bed is assembled 
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early in embryogenesis and has already formed a highly ramified network of blood vessels by birth 
(Carmeliet and Jain, 2011). As such, the initial sprouting angiogenesis that contributes to organ 
growth during early postnatal development occurs through an environment with low interstitial 
ECM (Carver et al., 1993; Mays et al., 1988). Given the marked angiogenesis that take place during 
pregnancy in both the postnatal mammary gland and the developing extraembryonic tissue 
(Betterman et al., 2012; Chaiworapongsa et al., 2014; Chen and Zheng, 2014), ongoing studies 
will assess conditionally targeted mice as these stages. Further, it remains unclear whether similar 
rules apply in the vasculature as in the developing mammary gland, i.e., whether endothelial cells 
are working alone or together with the surrounding mural cells for branching morphogenesis. As 
such, Mt1-mmp and Mt2-mmp will be targeted in endothelial cells alone, in mural cells alone, or 
in both populations in combination.  
 In sum, we have identified new and important roles for MT1-MMP and MT2-MMP in the 
distinct morphogenetic programs that apply to both mammary gland development and 
angiogenesis. In the mammary gland, MT1-MMP-dependent periductal remodeling of type I 
collagen networks, presumably by stromal fibroblasts, regulates postnatal branching, while both 
MT1-MMP and MT2-MMP control adipocyte differentiation programs and function. In our 
analyses of vascular branching morphogenesis programs, we again identify a key role for MT1-
MMP in pericellular matrix remodeling, but in this case, we focused our attention on a new axis 
that links ECM proteolysis to the control of nuclear architecture and function. Together, these 
studies should encourage efforts to characterize the impact of mammary gland remodeling on 
LINC complex-dependent transcriptional activity and conversely, the role of endothelial versus 
mural cell MT-MMPs on angiogenic responses in vivo.  
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